WO2014079804A1 - Pesticidal mixtures - Google Patents
Pesticidal mixtures Download PDFInfo
- Publication number
- WO2014079804A1 WO2014079804A1 PCT/EP2013/074054 EP2013074054W WO2014079804A1 WO 2014079804 A1 WO2014079804 A1 WO 2014079804A1 EP 2013074054 W EP2013074054 W EP 2013074054W WO 2014079804 A1 WO2014079804 A1 WO 2014079804A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- compound
- phenyl
- chloro
- inhibitors
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 512
- 230000000361 pesticidal effect Effects 0.000 title claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 453
- 230000000749 insecticidal effect Effects 0.000 claims abstract description 14
- 230000000855 fungicidal effect Effects 0.000 claims abstract description 11
- 241000589174 Bradyrhizobium japonicum Species 0.000 claims description 293
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 263
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 claims description 261
- 241000196324 Embryophyta Species 0.000 claims description 128
- -1 coumethoxystrobin Chemical compound 0.000 claims description 85
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 claims description 85
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 claims description 81
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical group CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 claims description 75
- 239000003112 inhibitor Substances 0.000 claims description 75
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 37
- 244000063299 Bacillus subtilis Species 0.000 claims description 36
- 239000002689 soil Substances 0.000 claims description 33
- 241000223260 Trichoderma harzianum Species 0.000 claims description 30
- 230000015572 biosynthetic process Effects 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 30
- 241000607479 Yersinia pestis Species 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 23
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 22
- 230000009471 action Effects 0.000 claims description 19
- 230000036541 health Effects 0.000 claims description 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 19
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 19
- 241000223261 Trichoderma viride Species 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Aalpha Natural products C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 claims description 15
- 238000003786 synthesis reaction Methods 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 12
- 229940125890 compound Ia Drugs 0.000 claims description 12
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 claims description 12
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 claims description 12
- 241000193747 Bacillus firmus Species 0.000 claims description 11
- 239000005781 Fludioxonil Substances 0.000 claims description 11
- 239000005783 Fluopyram Substances 0.000 claims description 11
- 239000005807 Metalaxyl Substances 0.000 claims description 11
- CCCGEKHKTPTUHJ-UHFFFAOYSA-N N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC2=C1C1CCC2C1=C(Cl)Cl CCCGEKHKTPTUHJ-UHFFFAOYSA-N 0.000 claims description 11
- 239000005818 Picoxystrobin Substances 0.000 claims description 11
- 239000005869 Pyraclostrobin Substances 0.000 claims description 11
- 229940005348 bacillus firmus Drugs 0.000 claims description 11
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 claims description 11
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 claims description 11
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical group COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 claims description 11
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 claims description 11
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 claims description 11
- 239000005737 Benzovindiflupyr Substances 0.000 claims description 10
- 241000221756 Cryphonectria parasitica Species 0.000 claims description 10
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical compound NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 claims description 9
- 239000005730 Azoxystrobin Substances 0.000 claims description 9
- 241000194103 Bacillus pumilus Species 0.000 claims description 9
- 239000005857 Trifloxystrobin Substances 0.000 claims description 9
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 claims description 9
- 239000000417 fungicide Substances 0.000 claims description 9
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 claims description 9
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 claims description 8
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 claims description 8
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 claims description 8
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Substances CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000005740 Boscalid Substances 0.000 claims description 8
- 241001149472 Clonostachys rosea Species 0.000 claims description 8
- 239000005761 Dimethomorph Substances 0.000 claims description 8
- 102000015782 Electron Transport Complex III Human genes 0.000 claims description 8
- 108010024882 Electron Transport Complex III Proteins 0.000 claims description 8
- 239000005868 Metconazole Substances 0.000 claims description 8
- 239000005816 Penthiopyrad Substances 0.000 claims description 8
- 239000005821 Propamocarb Substances 0.000 claims description 8
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 claims description 8
- 229940118790 boscalid Drugs 0.000 claims description 8
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 claims description 8
- NLKUPINTOLSSLD-UHFFFAOYSA-L calcium;4-(1-oxidopropylidene)-3,5-dioxocyclohexane-1-carboxylate Chemical compound [Ca+2].CCC([O-])=C1C(=O)CC(C([O-])=O)CC1=O NLKUPINTOLSSLD-UHFFFAOYSA-L 0.000 claims description 8
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 claims description 8
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 claims description 8
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 claims description 8
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims description 8
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 claims description 8
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 claims description 8
- 239000000018 receptor agonist Substances 0.000 claims description 8
- 229940044601 receptor agonist Drugs 0.000 claims description 8
- OXDDDHGGRFRLEE-UHFFFAOYSA-N 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]-n-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide Chemical compound C12=CC=CC=C2C(C(=O)NCC(=O)NCC(F)(F)F)=CC=C1C(C1)=NOC1(C(F)(F)F)C1=CC(Cl)=CC(C(F)(F)F)=C1 OXDDDHGGRFRLEE-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 230000002438 mitochondrial effect Effects 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 230000002195 synergetic effect Effects 0.000 claims description 7
- ZCVAOQKBXKSDMS-PVAVHDDUSA-N (+)-trans-(S)-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-PVAVHDDUSA-N 0.000 claims description 6
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 claims description 6
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 claims description 6
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 claims description 6
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 claims description 6
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 claims description 6
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 claims description 6
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 claims description 6
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 claims description 6
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 claims description 6
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 claims description 6
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 claims description 6
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 claims description 6
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 claims description 6
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 claims description 6
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical class O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 claims description 6
- 239000005660 Abamectin Substances 0.000 claims description 6
- 239000005875 Acetamiprid Substances 0.000 claims description 6
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 claims description 6
- 239000005877 Alpha-Cypermethrin Substances 0.000 claims description 6
- 239000005726 Ametoctradin Substances 0.000 claims description 6
- 239000005727 Amisulbrom Substances 0.000 claims description 6
- 241000228197 Aspergillus flavus Species 0.000 claims description 6
- 239000005738 Bixafen Substances 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 239000005886 Chlorantraniliprole Substances 0.000 claims description 6
- 239000005944 Chlorpyrifos Substances 0.000 claims description 6
- 239000005945 Chlorpyrifos-methyl Substances 0.000 claims description 6
- 239000005889 Cyantraniliprole Substances 0.000 claims description 6
- 239000005760 Difenoconazole Substances 0.000 claims description 6
- 239000005762 Dimoxystrobin Substances 0.000 claims description 6
- 239000005764 Dithianon Substances 0.000 claims description 6
- 239000005767 Epoxiconazole Substances 0.000 claims description 6
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 6
- 239000005778 Fenpropimorph Substances 0.000 claims description 6
- 239000005899 Fipronil Substances 0.000 claims description 6
- 239000005901 Flubendiamide Substances 0.000 claims description 6
- 239000005784 Fluoxastrobin Substances 0.000 claims description 6
- 239000005902 Flupyradifurone Substances 0.000 claims description 6
- 239000005785 Fluquinconazole Substances 0.000 claims description 6
- 239000005786 Flutolanil Substances 0.000 claims description 6
- 239000005788 Fluxapyroxad Substances 0.000 claims description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005906 Imidacloprid Substances 0.000 claims description 6
- 239000005867 Iprodione Substances 0.000 claims description 6
- 239000005799 Isopyrazam Substances 0.000 claims description 6
- 239000005800 Kresoxim-methyl Substances 0.000 claims description 6
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 6
- 239000005804 Mandipropamid Substances 0.000 claims description 6
- 239000005914 Metaflumizone Substances 0.000 claims description 6
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 claims description 6
- 239000005809 Metiram Substances 0.000 claims description 6
- 239000005810 Metrafenone Substances 0.000 claims description 6
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims description 6
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000005950 Oxamyl Substances 0.000 claims description 6
- 239000005815 Penflufen Substances 0.000 claims description 6
- 239000005923 Pirimicarb Substances 0.000 claims description 6
- 239000005820 Prochloraz Substances 0.000 claims description 6
- 239000005825 Prothioconazole Substances 0.000 claims description 6
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 claims description 6
- 241000131360 Pythium oligandrum Species 0.000 claims description 6
- 241000227654 Reynoutria Species 0.000 claims description 6
- 239000005834 Sedaxane Substances 0.000 claims description 6
- 239000005835 Silthiofam Substances 0.000 claims description 6
- 239000005839 Tebuconazole Substances 0.000 claims description 6
- 239000005938 Teflubenzuron Substances 0.000 claims description 6
- 239000005939 Tefluthrin Substances 0.000 claims description 6
- 239000005940 Thiacloprid Substances 0.000 claims description 6
- 239000005941 Thiamethoxam Substances 0.000 claims description 6
- 239000005842 Thiophanate-methyl Substances 0.000 claims description 6
- 239000005845 Tolclofos-methyl Substances 0.000 claims description 6
- 241000385222 Trichoderma stromaticum Species 0.000 claims description 6
- 241001149558 Trichoderma virens Species 0.000 claims description 6
- 239000005859 Triticonazole Substances 0.000 claims description 6
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 claims description 6
- 241000192351 [Candida] oleophila Species 0.000 claims description 6
- 241000192248 [Candida] saitoana Species 0.000 claims description 6
- 229950008167 abamectin Drugs 0.000 claims description 6
- LRZWFURXIMFONG-HRSIRGMGSA-N afidopyropen Chemical compound C([C@@]1(C)[C@H]2[C@]([C@H]3[C@@H](O)C=4C(=O)OC(=CC=4O[C@]3(C)[C@@H](O)C2)C=2C=NC=CC=2)(C)CC[C@@H]1OC(=O)C1CC1)OC(=O)C1CC1 LRZWFURXIMFONG-HRSIRGMGSA-N 0.000 claims description 6
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 claims description 6
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 claims description 6
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 claims description 6
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 claims description 6
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 claims description 6
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 claims description 6
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000032823 cell division Effects 0.000 claims description 6
- NDHXMRFNYMNBKO-PWSUYJOCSA-N chembl2227757 Chemical compound [O-][N+](=O)C([C@H]1CC[C@H](O1)N1CC2)=C1N2CC1=CC=C(Cl)N=C1 NDHXMRFNYMNBKO-PWSUYJOCSA-N 0.000 claims description 6
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 claims description 6
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 claims description 6
- 229950001327 dichlorvos Drugs 0.000 claims description 6
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 claims description 6
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 claims description 6
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 claims description 6
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 claims description 6
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical class [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 229940013764 fipronil Drugs 0.000 claims description 6
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 claims description 6
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 claims description 6
- MBHXIQDIVCJZTD-RVDMUPIBSA-N flufenoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=C(C(F)(F)F)C=C1Cl MBHXIQDIVCJZTD-RVDMUPIBSA-N 0.000 claims description 6
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 claims description 6
- QOIYTRGFOFZNKF-UHFFFAOYSA-N flupyradifurone Chemical compound C=1C(=O)OCC=1N(CC(F)F)CC1=CC=C(Cl)N=C1 QOIYTRGFOFZNKF-UHFFFAOYSA-N 0.000 claims description 6
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 claims description 6
- MLBZKOGAMRTSKP-UHFFFAOYSA-N fluralaner Chemical compound C1=C(C(=O)NCC(=O)NCC(F)(F)F)C(C)=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=C1 MLBZKOGAMRTSKP-UHFFFAOYSA-N 0.000 claims description 6
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 claims description 6
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 claims description 6
- 229940056881 imidacloprid Drugs 0.000 claims description 6
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 claims description 6
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 claims description 6
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 claims description 6
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims description 6
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 claims description 6
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 claims description 6
- 239000005910 lambda-Cyhalothrin Substances 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 229920000257 metiram Polymers 0.000 claims description 6
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 claims description 6
- DHQKLWKZSFCKTA-UHFFFAOYSA-N n-[1-[(6-chloropyridin-3-yl)methyl]pyridin-2-ylidene]-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)N=C1C=CC=CN1CC1=CC=C(Cl)N=C1 DHQKLWKZSFCKTA-UHFFFAOYSA-N 0.000 claims description 6
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 claims description 6
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 claims description 6
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 claims description 6
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 claims description 6
- 229960000490 permethrin Drugs 0.000 claims description 6
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 claims description 6
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 claims description 6
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 claims description 6
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 claims description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 6
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 claims description 6
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 claims description 6
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 claims description 6
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 claims description 6
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical group COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 claims description 6
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 claims description 6
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 claims description 6
- QFNFRZHOXWNWAQ-UHFFFAOYSA-N triclopyricarb Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NC(Cl)=C(Cl)C=C1Cl QFNFRZHOXWNWAQ-UHFFFAOYSA-N 0.000 claims description 6
- JARYYMUOCXVXNK-CSLFJTBJSA-N validamycin A Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-CSLFJTBJSA-N 0.000 claims description 6
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 claims description 5
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 claims description 5
- ZVXKYWHJBYIYNI-UHFFFAOYSA-N 1h-pyrazole-4-carboxamide Chemical compound NC(=O)C=1C=NNC=1 ZVXKYWHJBYIYNI-UHFFFAOYSA-N 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 239000005790 Fosetyl Substances 0.000 claims description 5
- 241000223221 Fusarium oxysporum Species 0.000 claims description 5
- 239000005984 Mepiquat Substances 0.000 claims description 5
- 239000005828 Pyrimethanil Substances 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- 241000228343 Talaromyces flavus Species 0.000 claims description 5
- 241000894120 Trichoderma atroviride Species 0.000 claims description 5
- 241000123975 Trichoderma polysporum Species 0.000 claims description 5
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 230000001419 dependent effect Effects 0.000 claims description 5
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 claims description 5
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 claims description 5
- VUERQRKTYBIULR-UHFFFAOYSA-N fosetyl Chemical compound CCOP(O)=O VUERQRKTYBIULR-UHFFFAOYSA-N 0.000 claims description 5
- NNCAWEWCFVZOGF-UHFFFAOYSA-N mepiquat Chemical compound C[N+]1(C)CCCCC1 NNCAWEWCFVZOGF-UHFFFAOYSA-N 0.000 claims description 5
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 5
- 229940079888 nitenpyram Drugs 0.000 claims description 5
- 239000005648 plant growth regulator Substances 0.000 claims description 5
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000011593 sulfur Substances 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- ROZUQUDEWZIBHV-UHFFFAOYSA-N tecloftalam Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C(=O)NC1=CC=CC(Cl)=C1Cl ROZUQUDEWZIBHV-UHFFFAOYSA-N 0.000 claims description 5
- ZOKXUAHZSKEQSS-UHFFFAOYSA-N tribufos Chemical compound CCCCSP(=O)(SCCCC)SCCCC ZOKXUAHZSKEQSS-UHFFFAOYSA-N 0.000 claims description 5
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 claims description 4
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 claims description 4
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 claims description 4
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 claims description 4
- BSMFIIDHYMHQLK-UHFFFAOYSA-N (6-tert-butyl-8-fluoro-2,3-dimethylquinolin-4-yl) 2-methoxyacetate Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)COC)=C(C)C(C)=NC2=C1F BSMFIIDHYMHQLK-UHFFFAOYSA-N 0.000 claims description 4
- VLOAPQGOKUJERV-UHFFFAOYSA-N 1-(5-ethylsulfinyl-2,4-dimethylphenyl)-3-methyl-1,2,4-triazole Chemical compound C1=C(C)C(S(=O)CC)=CC(N2N=C(C)N=C2)=C1C VLOAPQGOKUJERV-UHFFFAOYSA-N 0.000 claims description 4
- MOTGVPXRLDDMSK-UHFFFAOYSA-N 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2h-imidazo[1,2-a]pyridine Chemical compound C1CN2C(OCCC)CC(C)C([N+]([O-])=O)=C2N1CC1=CC=C(Cl)N=C1 MOTGVPXRLDDMSK-UHFFFAOYSA-N 0.000 claims description 4
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims description 4
- ZMZGFLUUZLELNE-UHFFFAOYSA-N 2,3,5-triiodobenzoic acid Chemical compound OC(=O)C1=CC(I)=CC(I)=C1I ZMZGFLUUZLELNE-UHFFFAOYSA-N 0.000 claims description 4
- DFPIGVDNBRPLIL-UHFFFAOYSA-N 2,3-dimethyl-5-(4-methylphenyl)-3-pyridin-3-yl-1,2-oxazolidine Chemical compound CN1OC(C=2C=CC(C)=CC=2)CC1(C)C1=CC=CN=C1 DFPIGVDNBRPLIL-UHFFFAOYSA-N 0.000 claims description 4
- QCODUEKLOOJCHF-UHFFFAOYSA-N 2-(5-ethylsulfinyl-2-fluoro-4-methylphenyl)-5-methyl-1,2,4-triazol-3-amine Chemical compound C1=C(C)C(S(=O)CC)=CC(N2C(=NC(C)=N2)N)=C1F QCODUEKLOOJCHF-UHFFFAOYSA-N 0.000 claims description 4
- VJLQEUIVLGVPSD-UHFFFAOYSA-N 2-(5-fluoropyridin-3-yl)-5-(6-pyrimidin-2-ylpyridin-2-yl)-1,3-thiazole;hydrofluoride Chemical compound F.FC1=CN=CC(C=2SC(=CN=2)C=2N=C(C=CC=2)C=2N=CC=CN=2)=C1 VJLQEUIVLGVPSD-UHFFFAOYSA-N 0.000 claims description 4
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 claims description 4
- ZQMRDENWZKMOTM-UHFFFAOYSA-N 2-butoxy-6-iodo-3-propylchromen-4-one Chemical compound C1=C(I)C=C2C(=O)C(CCC)=C(OCCCC)OC2=C1 ZQMRDENWZKMOTM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 4
- SWTPIYGGSMJRTB-UHFFFAOYSA-N 4,4-difluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 SWTPIYGGSMJRTB-UHFFFAOYSA-N 0.000 claims description 4
- HQAMEPONHQKVKQ-UHFFFAOYSA-N 4-cyclopropyl-n-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide Chemical compound COC1=CC(OC)=CC=C1NC(=O)C1=C(C2CC2)N=NS1 HQAMEPONHQKVKQ-UHFFFAOYSA-N 0.000 claims description 4
- PWVXXGRKLHYWKM-UHFFFAOYSA-N 5-[2-(benzenesulfonyl)ethyl]-3-[(1-methylpyrrolidin-2-yl)methyl]-1h-indole Chemical compound CN1CCCC1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 PWVXXGRKLHYWKM-UHFFFAOYSA-N 0.000 claims description 4
- ZGBKIRCRHOIXAN-UHFFFAOYSA-N 5-chloro-1-(4,6-dimethoxypyrimidin-2-yl)-2-methylbenzimidazole Chemical compound COC1=CC(OC)=NC(N2C3=CC=C(Cl)C=C3N=C2C)=N1 ZGBKIRCRHOIXAN-UHFFFAOYSA-N 0.000 claims description 4
- 241000471104 Alternaria oudemansii Species 0.000 claims description 4
- 241000501766 Ampelomyces quisqualis Species 0.000 claims description 4
- 241000223678 Aureobasidium pullulans Species 0.000 claims description 4
- 239000005734 Benalaxyl Substances 0.000 claims description 4
- 239000005735 Benalaxyl-M Substances 0.000 claims description 4
- 239000005884 Beta-Cyfluthrin Substances 0.000 claims description 4
- 239000005874 Bifenthrin Substances 0.000 claims description 4
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 claims description 4
- 239000005745 Captan Substances 0.000 claims description 4
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 4
- 239000005746 Carboxin Substances 0.000 claims description 4
- 239000005974 Chlormequat Substances 0.000 claims description 4
- 239000005747 Chlorothalonil Substances 0.000 claims description 4
- 235000019743 Choline chloride Nutrition 0.000 claims description 4
- 239000005754 Cyazofamid Substances 0.000 claims description 4
- 239000005946 Cypermethrin Substances 0.000 claims description 4
- 239000005758 Cyprodinil Substances 0.000 claims description 4
- 239000005892 Deltamethrin Substances 0.000 claims description 4
- 239000005893 Diflubenzuron Substances 0.000 claims description 4
- PHVNLLCAQHGNKU-UHFFFAOYSA-N Dimethipin Chemical compound CC1=C(C)S(=O)(=O)CCS1(=O)=O PHVNLLCAQHGNKU-UHFFFAOYSA-N 0.000 claims description 4
- 239000005947 Dimethoate Substances 0.000 claims description 4
- 239000005976 Ethephon Substances 0.000 claims description 4
- 239000005961 Ethoprophos Substances 0.000 claims description 4
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 claims description 4
- 239000005979 Forchlorfenuron Substances 0.000 claims description 4
- 239000005959 Fosthiazate Substances 0.000 claims description 4
- 241000577846 Fusarium dimerum Species 0.000 claims description 4
- 239000005980 Gibberellic acid Substances 0.000 claims description 4
- PPCUNNLZTNMXFO-ACCUITESSA-N Imicyafos Chemical compound CCCSP(=O)(OCC)N1CCN(CC)\C1=N/C#N PPCUNNLZTNMXFO-ACCUITESSA-N 0.000 claims description 4
- 239000005907 Indoxacarb Substances 0.000 claims description 4
- 239000005796 Ipconazole Substances 0.000 claims description 4
- 239000005983 Maleic hydrazide Substances 0.000 claims description 4
- BGRDGMRNKXEXQD-UHFFFAOYSA-N Maleic hydrazide Chemical compound OC1=CC=C(O)N=N1 BGRDGMRNKXEXQD-UHFFFAOYSA-N 0.000 claims description 4
- 239000005802 Mancozeb Substances 0.000 claims description 4
- 239000005956 Metaldehyde Substances 0.000 claims description 4
- 239000005951 Methiocarb Substances 0.000 claims description 4
- 239000005916 Methomyl Substances 0.000 claims description 4
- 241000775788 Metschnikowia fructicola Species 0.000 claims description 4
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 claims description 4
- 241001443590 Naganishia albida Species 0.000 claims description 4
- 241000887182 Paraphaeosphaeria minitans Species 0.000 claims description 4
- 241001634106 Phlebiopsis gigantea Species 0.000 claims description 4
- 239000005817 Phlebiopsis gigantea (several strains) Substances 0.000 claims description 4
- 239000005924 Pirimiphos-methyl Substances 0.000 claims description 4
- 239000005986 Prohexadione Substances 0.000 claims description 4
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 claims description 4
- 239000005929 Spinetoram Substances 0.000 claims description 4
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 claims description 4
- 239000005930 Spinosad Substances 0.000 claims description 4
- 239000005934 Sulfoxaflor Substances 0.000 claims description 4
- 239000005658 Tebufenpyrad Substances 0.000 claims description 4
- 239000005843 Thiram Substances 0.000 claims description 4
- 239000005847 Triazoxide Substances 0.000 claims description 4
- 241001460073 Trichoderma asperellum Species 0.000 claims description 4
- JARYYMUOCXVXNK-UHFFFAOYSA-N Validamycin A Natural products OC1C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)CC1NC1C=C(CO)C(O)C(O)C1O JARYYMUOCXVXNK-UHFFFAOYSA-N 0.000 claims description 4
- MLGCATYQZVMGBG-PBWVOLNLSA-N [(3s,6s,7r,8r)-8-benzyl-3-[(3-hydroxy-4-methoxypyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1O MLGCATYQZVMGBG-PBWVOLNLSA-N 0.000 claims description 4
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 claims description 4
- KAATUXNTWXVJKI-QPIRBTGLSA-N [(s)-cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-QPIRBTGLSA-N 0.000 claims description 4
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 claims description 4
- 229960001901 bioallethrin Drugs 0.000 claims description 4
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 claims description 4
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 claims description 4
- 229940117949 captan Drugs 0.000 claims description 4
- 229960005286 carbaryl Drugs 0.000 claims description 4
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical group C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 claims description 4
- 239000006013 carbendazim Substances 0.000 claims description 4
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 claims description 4
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 claims description 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims description 4
- XFDJMIHUAHSGKG-UHFFFAOYSA-N chlorethoxyfos Chemical compound CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl XFDJMIHUAHSGKG-UHFFFAOYSA-N 0.000 claims description 4
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 claims description 4
- JUZXDNPBRPUIOR-UHFFFAOYSA-N chlormequat Chemical compound C[N+](C)(C)CCCl JUZXDNPBRPUIOR-UHFFFAOYSA-N 0.000 claims description 4
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 claims description 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 4
- 229960003178 choline chloride Drugs 0.000 claims description 4
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 claims description 4
- GLWWLNJJJCTFMZ-UHFFFAOYSA-N cyclanilide Chemical compound C=1C=C(Cl)C=C(Cl)C=1NC(=O)C1(C(=O)O)CC1 GLWWLNJJJCTFMZ-UHFFFAOYSA-N 0.000 claims description 4
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 claims description 4
- 229960001591 cyfluthrin Drugs 0.000 claims description 4
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 claims description 4
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 claims description 4
- 229960005424 cypermethrin Drugs 0.000 claims description 4
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 claims description 4
- 229960002483 decamethrin Drugs 0.000 claims description 4
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 claims description 4
- 229940019503 diflubenzuron Drugs 0.000 claims description 4
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 claims description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 4
- FPKXBFWMIYHCID-UHFFFAOYSA-N dipymetitrone Chemical compound S1C=2C(=O)N(C)C(=O)C=2SC2=C1C(=O)N(C)C2=O FPKXBFWMIYHCID-UHFFFAOYSA-N 0.000 claims description 4
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 claims description 4
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 claims description 4
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical class C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 claims description 4
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 claims description 4
- GPXLRLUVLMHHIK-UHFFFAOYSA-N forchlorfenuron Chemical compound C1=NC(Cl)=CC(NC(=O)NC=2C=CC=CC=2)=C1 GPXLRLUVLMHHIK-UHFFFAOYSA-N 0.000 claims description 4
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 claims description 4
- 108700039708 galantide Proteins 0.000 claims description 4
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 claims description 4
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 claims description 4
- 239000003966 growth inhibitor Substances 0.000 claims description 4
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 claims description 4
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 claims description 4
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 claims description 4
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 claims description 4
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 claims description 4
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 claims description 4
- 229920000940 maneb Polymers 0.000 claims description 4
- GKKDCARASOJPNG-UHFFFAOYSA-N metaldehyde Chemical compound CC1OC(C)OC(C)OC(C)O1 GKKDCARASOJPNG-UHFFFAOYSA-N 0.000 claims description 4
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 claims description 4
- IXJOSTZEBSTPAG-UHFFFAOYSA-N methasulfocarb Chemical compound CNC(=O)SC1=CC=C(OS(C)(=O)=O)C=C1 IXJOSTZEBSTPAG-UHFFFAOYSA-N 0.000 claims description 4
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 claims description 4
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 claims description 4
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 claims description 4
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 claims description 4
- JPLCQHHISLYGRA-UHFFFAOYSA-N n-(6-methoxypyridin-3-yl)cyclopropanecarboxamide Chemical compound C1=NC(OC)=CC=C1NC(=O)C1CC1 JPLCQHHISLYGRA-UHFFFAOYSA-N 0.000 claims description 4
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 claims description 4
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 claims description 4
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 claims description 4
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 claims description 4
- BUCOQPHDYUOJSI-UHFFFAOYSA-N prohexadione Chemical compound CCC(=O)C1C(=O)CC(C(O)=O)CC1=O BUCOQPHDYUOJSI-UHFFFAOYSA-N 0.000 claims description 4
- DHTJFQWHCVTNRY-OEMAIJDKSA-N pyrisoxazole Chemical compound C1([C@@]2(C)CC(ON2C)C=2C=CC(Cl)=CC=2)=CC=CN=C1 DHTJFQWHCVTNRY-OEMAIJDKSA-N 0.000 claims description 4
- HPYNBECUCCGGPA-UHFFFAOYSA-N silafluofen Chemical compound C1=CC(OCC)=CC=C1[Si](C)(C)CCCC1=CC=C(F)C(OC=2C=CC=CC=2)=C1 HPYNBECUCCGGPA-UHFFFAOYSA-N 0.000 claims description 4
- 229940014213 spinosad Drugs 0.000 claims description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 4
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 claims description 4
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 claims description 4
- 239000004308 thiabendazole Substances 0.000 claims description 4
- 235000010296 thiabendazole Nutrition 0.000 claims description 4
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 4
- 229960004546 thiabendazole Drugs 0.000 claims description 4
- 229960002447 thiram Drugs 0.000 claims description 4
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 claims description 4
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 claims description 4
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 claims description 4
- RVKCCVTVZORVGD-UHFFFAOYSA-N trinexapac-ethyl Chemical group O=C1CC(C(=O)OCC)CC(=O)C1=C(O)C1CC1 RVKCCVTVZORVGD-UHFFFAOYSA-N 0.000 claims description 4
- 239000005943 zeta-Cypermethrin Substances 0.000 claims description 4
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 claims description 3
- SODPIMGUZLOIPE-UHFFFAOYSA-N (4-chlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1 SODPIMGUZLOIPE-UHFFFAOYSA-N 0.000 claims description 3
- GIWOBQLAIGEECV-UHFFFAOYSA-N (4-fluorophenyl) n-[1-[1-(4-cyanophenyl)ethylsulfonyl]butan-2-yl]carbamate Chemical compound C=1C=C(F)C=CC=1OC(=O)NC(CC)CS(=O)(=O)C(C)C1=CC=C(C#N)C=C1 GIWOBQLAIGEECV-UHFFFAOYSA-N 0.000 claims description 3
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 claims description 3
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 claims description 3
- DARPYRSDRJYGIF-PTNGSMBKSA-N (Z)-3-ethoxy-2-naphthalen-2-ylsulfonylprop-2-enenitrile Chemical compound C1=CC=CC2=CC(S(=O)(=O)C(\C#N)=C/OCC)=CC=C21 DARPYRSDRJYGIF-PTNGSMBKSA-N 0.000 claims description 3
- QYPFLRIVEVOAGA-UHFFFAOYSA-N 1,3-dimethyl-n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C QYPFLRIVEVOAGA-UHFFFAOYSA-N 0.000 claims description 3
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 claims description 3
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 claims description 3
- KMIVUNBKDYDWES-FRKPEAEDSA-N 1-[(6-chloropyridin-3-yl)methyl]-2-nitro-1-[(e)-pentylideneamino]guanidine Chemical compound CCCC\C=N\N(C(\N)=N\[N+]([O-])=O)CC1=CC=C(Cl)N=C1 KMIVUNBKDYDWES-FRKPEAEDSA-N 0.000 claims description 3
- JZWGZVIBYWRECK-RUMWWMSVSA-N 1-[(e)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea Chemical compound C1=CC(OC(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)/CC1=CC=C(C#N)C=C1 JZWGZVIBYWRECK-RUMWWMSVSA-N 0.000 claims description 3
- HVQHXBNMBZJPLK-UHFFFAOYSA-N 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound CC(=C)CNC1=C([S+]([O-])C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl HVQHXBNMBZJPLK-UHFFFAOYSA-N 0.000 claims description 3
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 claims description 3
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 claims description 3
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 claims description 3
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 claims description 3
- LRCCWFKSGWHDQR-UHFFFAOYSA-N 1-methyl-3-(trifluoromethyl)-n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C(F)(F)F LRCCWFKSGWHDQR-UHFFFAOYSA-N 0.000 claims description 3
- YIVXMZJTEQBPQO-UHFFFAOYSA-N 2,4-DB Chemical compound OC(=O)CCCOC1=CC=C(Cl)C=C1Cl YIVXMZJTEQBPQO-UHFFFAOYSA-N 0.000 claims description 3
- 239000002794 2,4-DB Substances 0.000 claims description 3
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 claims description 3
- IHASCEQSGGMLRB-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[4-(3,4-dimethoxyphenyl)-1,2-oxazol-5-yl]-2-prop-2-ynoxyacetamide Chemical compound C1=C(OC)C(OC)=CC=C1C1=C(NC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)ON=C1 IHASCEQSGGMLRB-UHFFFAOYSA-N 0.000 claims description 3
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 claims description 3
- XAYMVFWOJIOUTA-UHFFFAOYSA-N 2-[8-[8-(diaminomethylideneamino)octylamino]octyl]guanidine;2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O.NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N XAYMVFWOJIOUTA-UHFFFAOYSA-N 0.000 claims description 3
- XWHQQWVKDTVEEJ-UHFFFAOYSA-N 2-chloro-n-[1-[(6-chloropyridin-3-yl)methyl]pyridin-2-ylidene]-2,2-difluoroacetamide Chemical compound FC(F)(Cl)C(=O)N=C1C=CC=CN1CC1=CC=C(Cl)N=C1 XWHQQWVKDTVEEJ-UHFFFAOYSA-N 0.000 claims description 3
- ISJDMXYZNAEUBC-UHFFFAOYSA-N 2-n-(2-cyanopropan-2-yl)-1-n-(2,4-dimethylphenyl)-3-iodobenzene-1,2-dicarboxamide Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)C#N ISJDMXYZNAEUBC-UHFFFAOYSA-N 0.000 claims description 3
- NORUPDUSSAPDAJ-UHFFFAOYSA-N 2-n-[2-(3-chloropyridin-2-yl)-5-[(5-methyltetrazol-2-yl)methyl]pyrazol-3-yl]-5-cyano-1-n,3-dimethylbenzene-1,2-dicarboxamide Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1C(=O)NC1=CC(CN2N=C(C)N=N2)=NN1C1=NC=CC=C1Cl NORUPDUSSAPDAJ-UHFFFAOYSA-N 0.000 claims description 3
- KRYQDBFHAFVBSW-UHFFFAOYSA-N 2-pyridin-3-yl-5-(6-pyrimidin-2-ylpyridin-2-yl)-1,3-thiazole Chemical compound C=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=CC=1C1=NC=CC=N1 KRYQDBFHAFVBSW-UHFFFAOYSA-N 0.000 claims description 3
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Chemical class C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 3
- KNUJXXAPWWVVAG-UHFFFAOYSA-N 3-(difluoromethyl)-1,5-dimethyl-n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C1=C(C)N(C)N=C1C(F)F KNUJXXAPWWVVAG-UHFFFAOYSA-N 0.000 claims description 3
- UKPDFCZYKKAJTK-UHFFFAOYSA-N 3-[3-(4-fluorophenyl)-2,6-dimethylphenyl]-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one Chemical compound CC1=CC=C(C=2C=CC(F)=CC=2)C(C)=C1C(C(N1)=O)=C(O)C21CCOCC2 UKPDFCZYKKAJTK-UHFFFAOYSA-N 0.000 claims description 3
- DHTJFQWHCVTNRY-UHFFFAOYSA-N 3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine Chemical compound CN1OC(C=2C=CC(Cl)=CC=2)CC1(C)C1=CC=CN=C1 DHTJFQWHCVTNRY-UHFFFAOYSA-N 0.000 claims description 3
- RAMUASXTSSXCMB-UHFFFAOYSA-N 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide Chemical compound C1CC1C(C)NC(=O)C1=CC(Cl)=CC(Br)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl RAMUASXTSSXCMB-UHFFFAOYSA-N 0.000 claims description 3
- QZMQZUFFUNIGOE-GFCCVEGCSA-N 3-chloro-1-n-[4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-methylphenyl]-2-n-[(2r)-1-methylsulfonylpropan-2-yl]benzene-1,2-dicarboxamide Chemical compound CS(=O)(=O)C[C@@H](C)NC(=O)C1=C(Cl)C=CC=C1C(=O)NC1=CC=C(C(F)(C(F)(F)F)C(F)(F)F)C=C1C QZMQZUFFUNIGOE-GFCCVEGCSA-N 0.000 claims description 3
- QZMQZUFFUNIGOE-LBPRGKRZSA-N 3-chloro-1-n-[4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2-methylphenyl]-2-n-[(2s)-1-methylsulfonylpropan-2-yl]benzene-1,2-dicarboxamide Chemical compound CS(=O)(=O)C[C@H](C)NC(=O)C1=C(Cl)C=CC=C1C(=O)NC1=CC=C(C(F)(C(F)(F)F)C(F)(F)F)C=C1C QZMQZUFFUNIGOE-LBPRGKRZSA-N 0.000 claims description 3
- LHZOTJOOBRODLL-UHFFFAOYSA-N 4-oxo-1-(pyrimidin-5-ylmethyl)-3-[3-(trifluoromethyl)phenyl]pyrido[1,2-a]pyrimidin-5-ium-2-olate Chemical compound O=C1[N+]2=CC=CC=C2N(CC=2C=NC=NC=2)C([O-])=C1C1=CC=CC(C(F)(F)F)=C1 LHZOTJOOBRODLL-UHFFFAOYSA-N 0.000 claims description 3
- QGHKONZVJQXPBQ-UHFFFAOYSA-N 5,8-difluoro-n-[2-[2-fluoro-4-[4-(trifluoromethyl)pyridin-2-yl]oxyphenyl]ethyl]quinazolin-4-amine Chemical compound C=1C=C(CCNC=2C3=C(F)C=CC(F)=C3N=CN=2)C(F)=CC=1OC1=CC(C(F)(F)F)=CC=N1 QGHKONZVJQXPBQ-UHFFFAOYSA-N 0.000 claims description 3
- HQJIHVZTLDUUBP-UHFFFAOYSA-N 5-[6-(1,3-dioxan-2-yl)pyridin-2-yl]-2-pyridin-3-yl-1,3-thiazole Chemical compound O1CCCOC1C1=CC=CC(C=2SC(=NC=2)C=2C=NC=CC=2)=N1 HQJIHVZTLDUUBP-UHFFFAOYSA-N 0.000 claims description 3
- ZALZMUXMSIVXKA-UHFFFAOYSA-N 5-fluoro-2-[(4-fluorophenyl)methoxy]pyrimidin-4-amine Chemical compound C1=C(F)C(N)=NC(OCC=2C=CC(F)=CC=2)=N1 ZALZMUXMSIVXKA-UHFFFAOYSA-N 0.000 claims description 3
- CGRCPZUQMBYVPZ-UHFFFAOYSA-N 5-fluoro-2-[(4-methylphenyl)methoxy]pyrimidin-4-amine Chemical compound C1=CC(C)=CC=C1COC1=NC=C(F)C(N)=N1 CGRCPZUQMBYVPZ-UHFFFAOYSA-N 0.000 claims description 3
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 claims description 3
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical class O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 3
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 claims description 3
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 claims description 3
- 239000005964 Acibenzolar-S-methyl Substances 0.000 claims description 3
- 241001661349 Anthracocystis flocculosa Species 0.000 claims description 3
- 108010018763 Biotin carboxylase Proteins 0.000 claims description 3
- 239000005739 Bordeaux mixture Substances 0.000 claims description 3
- 239000005885 Buprofezin Substances 0.000 claims description 3
- 229940127437 Chloride Channel Antagonists Drugs 0.000 claims description 3
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 3
- 239000005750 Copper hydroxide Substances 0.000 claims description 3
- 239000005752 Copper oxychloride Substances 0.000 claims description 3
- 239000005756 Cymoxanil Substances 0.000 claims description 3
- 239000005766 Dodine Substances 0.000 claims description 3
- 239000005895 Esfenvalerate Substances 0.000 claims description 3
- 239000005896 Etofenprox Substances 0.000 claims description 3
- 239000005769 Etridiazole Substances 0.000 claims description 3
- 239000005772 Famoxadone Substances 0.000 claims description 3
- 239000005774 Fenamidone Substances 0.000 claims description 3
- 239000005780 Fluazinam Substances 0.000 claims description 3
- 239000005978 Flumetralin Substances 0.000 claims description 3
- PWNAWOCHVWERAR-UHFFFAOYSA-N Flumetralin Chemical compound [O-][N+](=O)C=1C=C(C(F)(F)F)C=C([N+]([O-])=O)C=1N(CC)CC1=C(F)C=CC=C1Cl PWNAWOCHVWERAR-UHFFFAOYSA-N 0.000 claims description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 3
- 239000005787 Flutriafol Substances 0.000 claims description 3
- 239000005789 Folpet Substances 0.000 claims description 3
- 239000005791 Fuberidazole Substances 0.000 claims description 3
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 claims description 3
- 239000005795 Imazalil Substances 0.000 claims description 3
- FKWDSATZSMJRLC-UHFFFAOYSA-N Iminoctadine acetate Chemical compound CC([O-])=O.CC([O-])=O.CC([O-])=O.NC([NH3+])=NCCCCCCCC[NH2+]CCCCCCCCN=C(N)[NH3+] FKWDSATZSMJRLC-UHFFFAOYSA-N 0.000 claims description 3
- PFDCOZXELJAUTR-UHFFFAOYSA-N Inabenfide Chemical compound C=1C(Cl)=CC=C(NC(=O)C=2C=CN=CC=2)C=1C(O)C1=CC=CC=C1 PFDCOZXELJAUTR-UHFFFAOYSA-N 0.000 claims description 3
- 239000005912 Lufenuron Substances 0.000 claims description 3
- 239000005917 Methoxyfenozide Substances 0.000 claims description 3
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 claims description 3
- 239000005918 Milbemectin Chemical class 0.000 claims description 3
- 239000005811 Myclobutanil Substances 0.000 claims description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 3
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 claims description 3
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 claims description 3
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 claims description 3
- 239000005985 Paclobutrazol Substances 0.000 claims description 3
- 239000005814 Pencycuron Substances 0.000 claims description 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 3
- IPDFPNNPBMREIF-CHWSQXEVSA-N Prohydrojasmon Chemical compound CCCCC[C@@H]1[C@@H](CC(=O)OCCC)CCC1=O IPDFPNNPBMREIF-CHWSQXEVSA-N 0.000 claims description 3
- 241001646398 Pseudomonas chlororaphis Species 0.000 claims description 3
- 241000893045 Pseudozyma Species 0.000 claims description 3
- 239000005925 Pymetrozine Substances 0.000 claims description 3
- 229930001406 Ryanodine Natural products 0.000 claims description 3
- 108010052164 Sodium Channels Proteins 0.000 claims description 3
- 102000018674 Sodium Channels Human genes 0.000 claims description 3
- 239000005664 Spirodiclofen Substances 0.000 claims description 3
- 239000005931 Spirotetramat Substances 0.000 claims description 3
- 239000005837 Spiroxamine Substances 0.000 claims description 3
- 229930182558 Sterol Natural products 0.000 claims description 3
- 239000005840 Tetraconazole Substances 0.000 claims description 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 3
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 claims description 3
- 239000005846 Triadimenol Substances 0.000 claims description 3
- CNFMJLVJDNGPHR-UKTHLTGXSA-N Triapenthenol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1CCCCC1 CNFMJLVJDNGPHR-UKTHLTGXSA-N 0.000 claims description 3
- 229930195482 Validamycin Natural products 0.000 claims description 3
- RVUZCGIVVZZREE-QELHCHSZSA-N [(3s,6s,7r,8r)-3-[[3-(acetyloxymethoxy)-4-methoxypyridine-2-carbonyl]amino]-8-benzyl-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1OCOC(C)=O RVUZCGIVVZZREE-QELHCHSZSA-N 0.000 claims description 3
- DRMJAYQZKNFLPL-RBODFLQRSA-N [(3s,6s,7r,8r)-8-benzyl-3-[[4-methoxy-3-(2-methylpropoxycarbonyloxy)pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1OC(=O)OCC(C)C DRMJAYQZKNFLPL-RBODFLQRSA-N 0.000 claims description 3
- DPJITPZADZSLBP-PIPQINALSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3r)-3-[(e)-2-cyanoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C(/C)C#N DPJITPZADZSLBP-PIPQINALSA-N 0.000 claims description 3
- 125000004442 acylamino group Chemical group 0.000 claims description 3
- 230000003281 allosteric effect Effects 0.000 claims description 3
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 claims description 3
- 230000000843 anti-fungal effect Effects 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 claims description 3
- 229960003168 bronopol Drugs 0.000 claims description 3
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 claims description 3
- 150000004657 carbamic acid derivatives Chemical class 0.000 claims description 3
- 210000000170 cell membrane Anatomy 0.000 claims description 3
- 210000002421 cell wall Anatomy 0.000 claims description 3
- 239000003467 chloride channel stimulating agent Substances 0.000 claims description 3
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 claims description 3
- 229910001956 copper hydroxide Inorganic materials 0.000 claims description 3
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 3
- CWVRPJSBNHNJSI-XQNSMLJCSA-N coumoxystrobin Chemical compound C1=C2OC(=O)C(CCCC)=C(C)C2=CC=C1OCC1=CC=CC=C1\C(=C/OC)C(=O)OC CWVRPJSBNHNJSI-XQNSMLJCSA-N 0.000 claims description 3
- 210000004292 cytoskeleton Anatomy 0.000 claims description 3
- 230000008021 deposition Effects 0.000 claims description 3
- 150000001470 diamides Chemical class 0.000 claims description 3
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 claims description 3
- FWCBATIDXGJRMF-UHFFFAOYSA-N dikegulac Natural products C12OC(C)(C)OCC2OC2(C(O)=O)C1OC(C)(C)O2 FWCBATIDXGJRMF-UHFFFAOYSA-N 0.000 claims description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012990 dithiocarbamate Substances 0.000 claims description 3
- 150000004659 dithiocarbamates Chemical class 0.000 claims description 3
- 229960002125 enilconazole Drugs 0.000 claims description 3
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 claims description 3
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 claims description 3
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 claims description 3
- 229950005085 etofenprox Drugs 0.000 claims description 3
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 claims description 3
- 125000005313 fatty acid group Chemical group 0.000 claims description 3
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 claims description 3
- RBWGTZRSEOIHFD-UHUFKFKFSA-N fenaminstrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C=C\C1=C(Cl)C=CC=C1Cl RBWGTZRSEOIHFD-UHUFKFKFSA-N 0.000 claims description 3
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 claims description 3
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 claims description 3
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 claims description 3
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 claims description 3
- XWROTTLWMHCFEC-LGMDPLHJSA-N fluthiacet Chemical compound C1=C(Cl)C(SCC(=O)O)=CC(\N=C/2N3CCCCN3C(=O)S\2)=C1F XWROTTLWMHCFEC-LGMDPLHJSA-N 0.000 claims description 3
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 claims description 3
- HICUREFSAIZXFQ-JOWPUVSESA-N i9z29i000j Chemical class C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\[C@H](OC(=O)C(=N/OC)\C=1C=CC=CC=1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 HICUREFSAIZXFQ-JOWPUVSESA-N 0.000 claims description 3
- 239000000411 inducer Substances 0.000 claims description 3
- 229960002418 ivermectin Drugs 0.000 claims description 3
- 229960000521 lufenuron Drugs 0.000 claims description 3
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 claims description 3
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 claims description 3
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 claims description 3
- FLZOYGGRUBRZKQ-UHFFFAOYSA-N n-[2-(4,4-dimethylpentan-2-yl)phenyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxamide Chemical compound CC(C)(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C FLZOYGGRUBRZKQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003865 nucleic acid synthesis inhibitor Substances 0.000 claims description 3
- 150000004045 organic chlorine compounds Chemical class 0.000 claims description 3
- 230000010627 oxidative phosphorylation Effects 0.000 claims description 3
- 229960000321 oxolinic acid Drugs 0.000 claims description 3
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 claims description 3
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 claims description 3
- 230000035699 permeability Effects 0.000 claims description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 3
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 claims description 3
- 229950001664 phoxim Drugs 0.000 claims description 3
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 claims description 3
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 claims description 3
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 3
- 238000001243 protein synthesis Methods 0.000 claims description 3
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 claims description 3
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 claims description 3
- DWTVBEZBWMDXIY-UHFFFAOYSA-N pyrametostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=C(C)C(C=2C=CC=CC=2)=NN1C DWTVBEZBWMDXIY-UHFFFAOYSA-N 0.000 claims description 3
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 claims description 3
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 claims description 3
- 108091006084 receptor activators Proteins 0.000 claims description 3
- JJSYXNQGLHBRRK-SFEDZAPPSA-N ryanodine Chemical compound O([C@@H]1[C@]([C@@]2([C@]3(O)[C@]45O[C@@]2(O)C[C@]([C@]4(CC[C@H](C)[C@H]5O)O)(C)[C@@]31O)C)(O)C(C)C)C(=O)C1=CC=CN1 JJSYXNQGLHBRRK-SFEDZAPPSA-N 0.000 claims description 3
- MSHXTAQSSIEBQS-UHFFFAOYSA-N s-[3-carbamoylsulfanyl-2-(dimethylamino)propyl] carbamothioate;hydron;chloride Chemical compound [Cl-].NC(=O)SCC([NH+](C)C)CSC(N)=O MSHXTAQSSIEBQS-UHFFFAOYSA-N 0.000 claims description 3
- 230000019491 signal transduction Effects 0.000 claims description 3
- 239000003195 sodium channel blocking agent Substances 0.000 claims description 3
- DEWVPZYHFVYXMZ-QCILGFJPSA-M sodium;(3ar,4as,8ar,8bs)-2,2,7,7-tetramethyl-4a,5,8a,8b-tetrahydro-[1,3]dioxolo[3,4]furo[1,3-d][1,3]dioxine-3a-carboxylate Chemical compound [Na+].O([C@H]12)C(C)(C)OC[C@@H]1O[C@]1(C([O-])=O)[C@H]2OC(C)(C)O1 DEWVPZYHFVYXMZ-QCILGFJPSA-M 0.000 claims description 3
- 229930185156 spinosyn Natural products 0.000 claims description 3
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 claims description 3
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 claims description 3
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 claims description 3
- 150000003432 sterols Chemical class 0.000 claims description 3
- 235000003702 sterols Nutrition 0.000 claims description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 3
- LITQZINTSYBKIU-UHFFFAOYSA-F tetracopper;hexahydroxide;sulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Cu+2].[Cu+2].[Cu+2].[Cu+2].[O-]S([O-])(=O)=O LITQZINTSYBKIU-UHFFFAOYSA-F 0.000 claims description 3
- 230000014616 translation Effects 0.000 claims description 3
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 claims description 3
- PIHCREFCPDWIPY-UHFFFAOYSA-N tris[2-(2,4-dichlorophenoxy)ethyl] phosphite Chemical compound ClC1=CC(Cl)=CC=C1OCCOP(OCCOC=1C(=CC(Cl)=CC=1)Cl)OCCOC1=CC=C(Cl)C=C1Cl PIHCREFCPDWIPY-UHFFFAOYSA-N 0.000 claims description 3
- 239000003744 tubulin modulator Substances 0.000 claims description 3
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 claims description 2
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 claims description 2
- KAATUXNTWXVJKI-GGPKGHCWSA-N (1R)-trans-(alphaS)-cypermethrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-GGPKGHCWSA-N 0.000 claims description 2
- FJDPATXIBIBRIM-QFMSAKRMSA-N (1R)-trans-cyphenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 FJDPATXIBIBRIM-QFMSAKRMSA-N 0.000 claims description 2
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 claims description 2
- GXEKYRXVRROBEV-FBXFSONDSA-N (1r,2s,3r,4s)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid Chemical compound C1C[C@@H]2[C@@H](C(O)=O)[C@@H](C(=O)O)[C@H]1O2 GXEKYRXVRROBEV-FBXFSONDSA-N 0.000 claims description 2
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 claims description 2
- SMYMJHWAQXWPDB-UHFFFAOYSA-N (2,4,5-trichlorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC(Cl)=C(Cl)C=C1Cl SMYMJHWAQXWPDB-UHFFFAOYSA-N 0.000 claims description 2
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 claims description 2
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 claims description 2
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 claims description 2
- FZRBKIRIBLNOAM-UHFFFAOYSA-N (E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate Chemical compound CC(C)CCCC(C)CC=CC(C)=CC(=O)OCC#C FZRBKIRIBLNOAM-UHFFFAOYSA-N 0.000 claims description 2
- IQVNEKKDSLOHHK-FNCQTZNRSA-N (E,E)-hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 claims description 2
- LJHFIVQEAFAURQ-ZPUQHVIOSA-N (NE)-N-[(2E)-2-hydroxyiminoethylidene]hydroxylamine Chemical compound O\N=C\C=N\O LJHFIVQEAFAURQ-ZPUQHVIOSA-N 0.000 claims description 2
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 claims description 2
- PCKNFPQPGUWFHO-SXBRIOAWSA-N (Z)-flucycloxuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1)=CC=C1CO\N=C(C=1C=CC(Cl)=CC=1)\C1CC1 PCKNFPQPGUWFHO-SXBRIOAWSA-N 0.000 claims description 2
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 claims description 2
- USGUVNUTPWXWBA-JRIXXDKMSA-N (e,2s)-2-amino-4-(2-aminoethoxy)but-3-enoic acid Chemical compound NCCO\C=C\[C@H](N)C(O)=O USGUVNUTPWXWBA-JRIXXDKMSA-N 0.000 claims description 2
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 claims description 2
- ZQMAFHIMPLLGDW-UHFFFAOYSA-N 1,1-dimethylpiperidin-1-ium (7-oxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonan-3-yl)oxy-oxoborane Chemical compound C[N+]1(C)CCCCC1.[O-]B1OB2OB(OB=O)OB(O1)O2 ZQMAFHIMPLLGDW-UHFFFAOYSA-N 0.000 claims description 2
- XQEMNBNCQVQXMO-UHFFFAOYSA-M 1,2-dimethyl-3,5-diphenylpyrazol-1-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C[N+]=1N(C)C(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 XQEMNBNCQVQXMO-UHFFFAOYSA-M 0.000 claims description 2
- MEUXXHGDZUDAAW-UHFFFAOYSA-N 1,3,5-trimethyl-n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1C MEUXXHGDZUDAAW-UHFFFAOYSA-N 0.000 claims description 2
- SBYGUIUIDOUGBU-UHFFFAOYSA-N 1,5-dimethyl-3-(trifluoromethyl)-n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C1=C(C)N(C)N=C1C(F)(F)F SBYGUIUIDOUGBU-UHFFFAOYSA-N 0.000 claims description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 claims description 2
- RKLCNSACPVMCDV-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-methyl-1-pyrimidin-5-ylpropan-1-ol Chemical compound C=1N=CN=CC=1C(O)(C(C)C)C1=CC=C(Cl)C=C1 RKLCNSACPVMCDV-UHFFFAOYSA-N 0.000 claims description 2
- RMOGWMIKYWRTKW-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)CC1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UHFFFAOYSA-N 0.000 claims description 2
- JDEKUYKSOCTBJT-UHFFFAOYSA-N 1-(4-chlorophenyl)-6-methyl-4-oxopyridazine-3-carboxylic acid Chemical compound CC1=CC(=O)C(C(O)=O)=NN1C1=CC=C(Cl)C=C1 JDEKUYKSOCTBJT-UHFFFAOYSA-N 0.000 claims description 2
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 claims description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 claims description 2
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 claims description 2
- HILAYQUKKYWPJW-UHFFFAOYSA-N 1-dodecylguanidine Chemical compound CCCCCCCCCCCCN=C(N)N HILAYQUKKYWPJW-UHFFFAOYSA-N 0.000 claims description 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims description 2
- XFNJVKMNNVCYEK-UHFFFAOYSA-N 1-naphthaleneacetamide Chemical compound C1=CC=C2C(CC(=O)N)=CC=CC2=C1 XFNJVKMNNVCYEK-UHFFFAOYSA-N 0.000 claims description 2
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 claims description 2
- ABFADXMVCUMADD-UHFFFAOYSA-N 2,2,2-trifluoro-n-[1-[(6-fluoropyridin-3-yl)methyl]pyridin-2-ylidene]acetamide Chemical compound C1=NC(F)=CC=C1CN1C(=NC(=O)C(F)(F)F)C=CC=C1 ABFADXMVCUMADD-UHFFFAOYSA-N 0.000 claims description 2
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 claims description 2
- VUIOHZGBOYTDSL-UHFFFAOYSA-N 2,7-dichloro-9-hydroxyfluorene-9-carboxylic acid Chemical compound C1=C(Cl)C=C2C(C(=O)O)(O)C3=CC(Cl)=CC=C3C2=C1 VUIOHZGBOYTDSL-UHFFFAOYSA-N 0.000 claims description 2
- MZHCENGPTKEIGP-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1Cl MZHCENGPTKEIGP-UHFFFAOYSA-N 0.000 claims description 2
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 claims description 2
- DNBMPXLFKQCOBV-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OCCOCCOCC)=NC2=C1 DNBMPXLFKQCOBV-UHFFFAOYSA-N 0.000 claims description 2
- 239000003315 2-(4-chlorophenoxy)-2-methylpropanoic acid Substances 0.000 claims description 2
- QKJJCZYFXJCKRX-HZHKWBLPSA-N 2-[(2s,3s,6r)-6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3,6-dihydro-2h-pyran-2-yl]-5-(diaminomethylideneamino)-2,4-dihydroxypentanoic acid Chemical compound O1[C@H](C(O)(CC(O)CN=C(N)N)C(O)=O)[C@@H](NC(=O)[C@H](CO)N)C=C[C@@H]1N1C(=O)N=C(N)C(CO)=C1 QKJJCZYFXJCKRX-HZHKWBLPSA-N 0.000 claims description 2
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 claims description 2
- ZJRUTGDCLVIVRD-UHFFFAOYSA-N 2-[4-chloro-2-(hydroxymethyl)phenoxy]acetic acid Chemical compound OCC1=CC(Cl)=CC=C1OCC(O)=O ZJRUTGDCLVIVRD-UHFFFAOYSA-N 0.000 claims description 2
- PVTHJAPFENJVNC-UHFFFAOYSA-N 2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid Chemical compound NC1CC(N=C(N)C(O)=O)C(C)OC1OC1C(O)C(O)C(O)C(O)C1O PVTHJAPFENJVNC-UHFFFAOYSA-N 0.000 claims description 2
- SVOAUHHKPGKPQK-UHFFFAOYSA-N 2-chloro-9-hydroxyfluorene-9-carboxylic acid Chemical compound C1=C(Cl)C=C2C(C(=O)O)(O)C3=CC=CC=C3C2=C1 SVOAUHHKPGKPQK-UHFFFAOYSA-N 0.000 claims description 2
- GJGFCWCPVQHXMF-UHFFFAOYSA-N 2-chloro-9h-fluorene-9-carboxylic acid Chemical compound C1=C(Cl)C=C2C(C(=O)O)C3=CC=CC=C3C2=C1 GJGFCWCPVQHXMF-UHFFFAOYSA-N 0.000 claims description 2
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 claims description 2
- RRSCOUPNURHZBJ-UHFFFAOYSA-N 2-chloroethanesulfinic acid Chemical compound OS(=O)CCCl RRSCOUPNURHZBJ-UHFFFAOYSA-N 0.000 claims description 2
- QKSRTQXCXWMMLG-UHFFFAOYSA-N 2-cyano-2-phenylbutanamide Chemical compound CCC(C#N)(C(N)=O)C1=CC=CC=C1 QKSRTQXCXWMMLG-UHFFFAOYSA-N 0.000 claims description 2
- AWSZRJQNBMEZOI-UHFFFAOYSA-N 2-methoxyethyl 2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate Chemical compound C=1C=C(C(C)(C)C)C=CC=1C(C#N)(C(=O)OCCOC)C(=O)C1=CC=CC=C1C(F)(F)F AWSZRJQNBMEZOI-UHFFFAOYSA-N 0.000 claims description 2
- 229940044120 2-n-octyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- RZCJYMOBWVJQGV-UHFFFAOYSA-N 2-naphthyloxyacetic acid Chemical compound C1=CC=CC2=CC(OCC(=O)O)=CC=C21 RZCJYMOBWVJQGV-UHFFFAOYSA-N 0.000 claims description 2
- AVGVFDSUDIUXEU-UHFFFAOYSA-N 2-octyl-1,2-thiazolidin-3-one Chemical compound CCCCCCCCN1SCCC1=O AVGVFDSUDIUXEU-UHFFFAOYSA-N 0.000 claims description 2
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical group CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 claims description 2
- AUQAUAIUNJIIEP-UHFFFAOYSA-N 3,4,5-trimethylphenyl methylcarbamate Chemical compound CNC(=O)OC1=CC(C)=C(C)C(C)=C1 AUQAUAIUNJIIEP-UHFFFAOYSA-N 0.000 claims description 2
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 claims description 2
- SWBHWUYHHJCADA-UHFFFAOYSA-N 3-(2-chlorophenyl)-6-(2,6-difluorophenyl)-1,2,4,5-tetrazine Chemical compound FC1=CC=CC(F)=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 SWBHWUYHHJCADA-UHFFFAOYSA-N 0.000 claims description 2
- BZGLBXYQOMFXAU-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=C(Cl)C(Cl)=C1 BZGLBXYQOMFXAU-UHFFFAOYSA-N 0.000 claims description 2
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 claims description 2
- YTCIYOXHHQLDEI-UHFFFAOYSA-N 3-(difluoromethyl)-1-methyl-n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C1=CN(C)N=C1C(F)F YTCIYOXHHQLDEI-UHFFFAOYSA-N 0.000 claims description 2
- HXKPOEOLTWELSY-UHFFFAOYSA-N 3-(difluoromethyl)-1-methyl-n-[2-[4-(trifluoromethylsulfanyl)phenyl]phenyl]pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC=C(SC(F)(F)F)C=C1 HXKPOEOLTWELSY-UHFFFAOYSA-N 0.000 claims description 2
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 claims description 2
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 claims description 2
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 claims description 2
- MVXMNHYVCLMLDD-UHFFFAOYSA-N 4-methoxynaphthalene-1-carbaldehyde Chemical compound C1=CC=C2C(OC)=CC=C(C=O)C2=C1 MVXMNHYVCLMLDD-UHFFFAOYSA-N 0.000 claims description 2
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 claims description 2
- ZCTRJEAOSGAHTA-UHFFFAOYSA-N 5-chloro-2-(3-chloropyridin-2-yl)-n-[2,4-dichloro-6-(2-cyanopropan-2-ylcarbamoyl)phenyl]pyrazole-3-carboxamide Chemical compound N#CC(C)(C)NC(=O)C1=CC(Cl)=CC(Cl)=C1NC(=O)C1=CC(Cl)=NN1C1=NC=CC=C1Cl ZCTRJEAOSGAHTA-UHFFFAOYSA-N 0.000 claims description 2
- ASMNSUBMNZQTTG-UHFFFAOYSA-N 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine Chemical compound C1CC(C)CCN1C1=C(C=2C(=CC(F)=CC=2F)F)C(Cl)=NC2=NC=NN12 ASMNSUBMNZQTTG-UHFFFAOYSA-N 0.000 claims description 2
- NEKULYKCZPJMMJ-UHFFFAOYSA-N 5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine Chemical compound C=1C=C(OC(F)F)C=CC=1C(CC)NC1=NC=NC(C)=C1Cl NEKULYKCZPJMMJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005651 Acequinocyl Substances 0.000 claims description 2
- 239000005652 Acrinathrin Substances 0.000 claims description 2
- 229930192334 Auxin Natural products 0.000 claims description 2
- 239000005736 Benthiavalicarb Substances 0.000 claims description 2
- IXVMHGVQKLDRKH-VRESXRICSA-N Brassinolide Natural products O=C1OC[C@@H]2[C@@H]3[C@@](C)([C@H]([C@@H]([C@@H](O)[C@H](O)[C@H](C(C)C)C)C)CC3)CC[C@@H]2[C@]2(C)[C@@H]1C[C@H](O)[C@H](O)C2 IXVMHGVQKLDRKH-VRESXRICSA-N 0.000 claims description 2
- 239000005741 Bromuconazole Substances 0.000 claims description 2
- 239000005742 Bupirimate Substances 0.000 claims description 2
- SPNQRCTZKIBOAX-UHFFFAOYSA-N Butralin Chemical compound CCC(C)NC1=C([N+]([O-])=O)C=C(C(C)(C)C)C=C1[N+]([O-])=O SPNQRCTZKIBOAX-UHFFFAOYSA-N 0.000 claims description 2
- 239000005973 Carvone Substances 0.000 claims description 2
- 229940123982 Cell wall synthesis inhibitor Drugs 0.000 claims description 2
- IVHVNMLJNASKHW-UHFFFAOYSA-M Chlorphonium chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CC1=CC=C(Cl)C=C1Cl IVHVNMLJNASKHW-UHFFFAOYSA-M 0.000 claims description 2
- 239000005647 Chlorpropham Substances 0.000 claims description 2
- 239000005887 Chromafenozide Substances 0.000 claims description 2
- 239000005654 Clofentezine Substances 0.000 claims description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 2
- 239000005755 Cyflufenamid Substances 0.000 claims description 2
- 239000005655 Cyflumetofen Substances 0.000 claims description 2
- 239000005891 Cyromazine Substances 0.000 claims description 2
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 claims description 2
- 239000005975 Daminozide Substances 0.000 claims description 2
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 claims description 2
- 239000005644 Dazomet Substances 0.000 claims description 2
- 208000006558 Dental Calculus Diseases 0.000 claims description 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 claims description 2
- 239000005759 Diethofencarb Substances 0.000 claims description 2
- LBGPXIPGGRQBJW-UHFFFAOYSA-N Difenzoquat Chemical compound C[N+]=1N(C)C(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 LBGPXIPGGRQBJW-UHFFFAOYSA-N 0.000 claims description 2
- HDWLUGYOLUHEMN-UHFFFAOYSA-N Dinobuton Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C HDWLUGYOLUHEMN-UHFFFAOYSA-N 0.000 claims description 2
- 239000005765 Dodemorph Substances 0.000 claims description 2
- AIGRXSNSLVJMEA-UHFFFAOYSA-N EPN Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 claims description 2
- YUGWDVYLFSETPE-JLHYYAGUSA-N Empenthrin Chemical compound CC\C=C(/C)C(C#C)OC(=O)C1C(C=C(C)C)C1(C)C YUGWDVYLFSETPE-JLHYYAGUSA-N 0.000 claims description 2
- SLZWEMYSYKOWCG-UHFFFAOYSA-N Etacelasil Chemical compound COCCO[Si](CCCl)(OCCOC)OCCOC SLZWEMYSYKOWCG-UHFFFAOYSA-N 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- GLPZEHFBLBYFHN-UHFFFAOYSA-N Ethychlozate Chemical compound C1=CC(Cl)=CC2=C(CC(=O)OCC)NN=C21 GLPZEHFBLBYFHN-UHFFFAOYSA-N 0.000 claims description 2
- 239000005897 Etoxazole Substances 0.000 claims description 2
- 239000005656 Fenazaquin Substances 0.000 claims description 2
- 239000005775 Fenbuconazole Substances 0.000 claims description 2
- 239000005776 Fenhexamid Substances 0.000 claims description 2
- ZLSWBLPERHFHIS-UHFFFAOYSA-N Fenoprop Chemical compound OC(=O)C(C)OC1=CC(Cl)=C(Cl)C=C1Cl ZLSWBLPERHFHIS-UHFFFAOYSA-N 0.000 claims description 2
- 239000005898 Fenoxycarb Substances 0.000 claims description 2
- 239000005777 Fenpropidin Substances 0.000 claims description 2
- 239000005779 Fenpyrazamine Substances 0.000 claims description 2
- 239000005657 Fenpyroximate Substances 0.000 claims description 2
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005900 Flonicamid Substances 0.000 claims description 2
- 239000005782 Fluopicolide Substances 0.000 claims description 2
- GXAMYUGOODKVRM-UHFFFAOYSA-N Flurecol Chemical compound C1=CC=C2C(C(=O)O)(O)C3=CC=CC=C3C2=C1 GXAMYUGOODKVRM-UHFFFAOYSA-N 0.000 claims description 2
- VEVZCONIUDBCDC-UHFFFAOYSA-N Flurprimidol Chemical compound C=1N=CN=CC=1C(O)(C(C)C)C1=CC=C(OC(F)(F)F)C=C1 VEVZCONIUDBCDC-UHFFFAOYSA-N 0.000 claims description 2
- 239000005948 Formetanate Substances 0.000 claims description 2
- 239000005903 Gamma-cyhalothrin Substances 0.000 claims description 2
- 229930191978 Gibberellin Natural products 0.000 claims description 2
- MXCOJKLBLFWFNI-VBFYFJBNSA-N Gibberellin A15 Natural products O=C(O)[C@H]1[C@@H]2[C@@]3(C)C(=O)OC[C@]2([C@H]2[C@@]41CC(=C)[C@H](C4)CC2)CCC3 MXCOJKLBLFWFNI-VBFYFJBNSA-N 0.000 claims description 2
- BKBYHSYZKIAJDA-UHFFFAOYSA-N Gibberellin A29 Natural products C12CCC(C3)(O)C(=C)CC23C(C(O)=O)C2C3(C)C(=O)OC21CC(O)C3 BKBYHSYZKIAJDA-UHFFFAOYSA-N 0.000 claims description 2
- NYLKJADFYRJQOI-DMQYUYNFSA-N Gibberellin A35 Natural products C([C@@H]1C[C@]2(CC1=C)[C@H]1C(O)=O)[C@H](O)[C@H]2[C@@]2(OC3=O)[C@H]1[C@@]3(C)[C@@H](O)CC2 NYLKJADFYRJQOI-DMQYUYNFSA-N 0.000 claims description 2
- KSBJAONOPKRVRR-UHFFFAOYSA-N Gibberellin A44 Natural products C12CCC(C3)(O)C(=C)CC23C(C(O)=O)C2C3(C)C(=O)OCC21CCC3 KSBJAONOPKRVRR-UHFFFAOYSA-N 0.000 claims description 2
- FKMJLJSSQHSAEF-WQODXWHISA-N Gibberellin A50 Natural products O=C(O)[C@H]1[C@@H]2[C@@]3(C)[C@@H](O)[C@@H](O)C[C@@]2(OC3=O)[C@@H]2[C@@H](O)C[C@H]3C(=C)C[C@@]12C3 FKMJLJSSQHSAEF-WQODXWHISA-N 0.000 claims description 2
- JKQCGVABHHQYKQ-YZVDRFENSA-N Gibberellin A61 Natural products O=C(O)[C@H]1[C@@H]2[C@]3(C)C(=O)O[C@]2([C@H](O)CC3)[C@H]2[C@]31CC(=C)[C@@H](C3)CC2 JKQCGVABHHQYKQ-YZVDRFENSA-N 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- RYOCQKYEVIJALB-SDNWHVSQSA-N Heptopargil Chemical compound C1CC2(C)\C(=N\OCC#C)CC1C2(C)C RYOCQKYEVIJALB-SDNWHVSQSA-N 0.000 claims description 2
- 239000005661 Hexythiazox Substances 0.000 claims description 2
- 108010072039 Histidine kinase Proteins 0.000 claims description 2
- 239000005794 Hymexazol Substances 0.000 claims description 2
- 239000005797 Iprovalicarb Substances 0.000 claims description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 claims description 2
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 claims description 2
- 108091054455 MAP kinase family Proteins 0.000 claims description 2
- 239000005949 Malathion Substances 0.000 claims description 2
- OKIBNKKYNPBDRS-UHFFFAOYSA-N Mefluidide Chemical compound CC(=O)NC1=CC(NS(=O)(=O)C(F)(F)F)=C(C)C=C1C OKIBNKKYNPBDRS-UHFFFAOYSA-N 0.000 claims description 2
- 229940127408 Melanin Synthesis Inhibitors Drugs 0.000 claims description 2
- 239000005805 Mepanipyrim Substances 0.000 claims description 2
- 239000002169 Metam Substances 0.000 claims description 2
- 102000013379 Mitochondrial Proton-Translocating ATPases Human genes 0.000 claims description 2
- 108010026155 Mitochondrial Proton-Translocating ATPases Proteins 0.000 claims description 2
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 claims description 2
- XFOXDUJCOHBXRC-UHFFFAOYSA-N N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide Chemical compound CCN(C)C(=O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C(OC)C(OC)=C1 XFOXDUJCOHBXRC-UHFFFAOYSA-N 0.000 claims description 2
- VJAWBEFMCIINFU-UHFFFAOYSA-N Nitrothal-isopropyl Chemical compound CC(C)OC(=O)C1=CC(C(=O)OC(C)C)=CC([N+]([O-])=O)=C1 VJAWBEFMCIINFU-UHFFFAOYSA-N 0.000 claims description 2
- 239000005813 Penconazole Substances 0.000 claims description 2
- 239000005921 Phosmet Substances 0.000 claims description 2
- NTHCPJMKRGXODE-UHFFFAOYSA-N Piproctanyl Chemical group CC(C)CCCC(C)CC[N+]1(CC=C)CCCCC1 NTHCPJMKRGXODE-UHFFFAOYSA-N 0.000 claims description 2
- 229930182764 Polyoxin Natural products 0.000 claims description 2
- 239000005823 Propineb Substances 0.000 claims description 2
- 239000005824 Proquinazid Substances 0.000 claims description 2
- 229940123573 Protein synthesis inhibitor Drugs 0.000 claims description 2
- BKVRQJSQZDTXCG-UHFFFAOYSA-N Pydanon Chemical compound OC(=O)CC1(O)CC(=O)NNC1=O BKVRQJSQZDTXCG-UHFFFAOYSA-N 0.000 claims description 2
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 claims description 2
- 239000005663 Pyridaben Substances 0.000 claims description 2
- 239000005829 Pyriofenone Substances 0.000 claims description 2
- 239000005927 Pyriproxyfen Substances 0.000 claims description 2
- 239000005831 Quinoxyfen Substances 0.000 claims description 2
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005989 Sintofen Substances 0.000 claims description 2
- 239000005665 Spiromesifen Substances 0.000 claims description 2
- 239000005935 Sulfuryl fluoride Substances 0.000 claims description 2
- 240000004460 Tanacetum coccineum Species 0.000 claims description 2
- 239000005937 Tebufenozide Substances 0.000 claims description 2
- 239000005942 Triflumuron Substances 0.000 claims description 2
- 239000005994 Trinexapac Substances 0.000 claims description 2
- 239000005860 Valifenalate Substances 0.000 claims description 2
- 101710175177 Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 claims description 2
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 claims description 2
- 239000005870 Ziram Substances 0.000 claims description 2
- 239000005863 Zoxamide Substances 0.000 claims description 2
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 claims description 2
- FHOXQLTVOMNIOR-QZPAGEHASA-N [(1S,2R,4R,5S,7S,11S,12S,15R,16S)-2,16-dimethyl-15-[(1S)-1-[(2R,3R)-3-[(3S)-2-methylpentan-3-yl]oxiran-2-yl]ethyl]-8-oxo-4-propanoyloxy-9-oxatetracyclo[9.7.0.02,7.012,16]octadecan-5-yl] propanoate Chemical compound CC[C@@H](C(C)C)[C@H]1O[C@@H]1[C@@H](C)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C[C@@H](OC(=O)CC)[C@@H](OC(=O)CC)C[C@@H]4C(=O)OC[C@H]3[C@@H]2CC1 FHOXQLTVOMNIOR-QZPAGEHASA-N 0.000 claims description 2
- TTZOASGYLRKMAN-BOWONNERSA-N [(3s,6s,7r,8r)-3-[(3-acetyloxy-4-methoxypyridine-2-carbonyl)amino]-8-benzyl-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate Chemical compound COC1=CC=NC(C(=O)N[C@@H]2C(O[C@@H](C)[C@H](OC(=O)C(C)C)[C@@H](CC=3C=CC=CC=3)C(=O)OC2)=O)=C1OC(C)=O TTZOASGYLRKMAN-BOWONNERSA-N 0.000 claims description 2
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(e)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 claims description 2
- CTJBHIROCMPUKL-WEVVVXLNSA-N [(e)-3-methylsulfonylbutan-2-ylideneamino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(/C)C(C)S(C)(=O)=O CTJBHIROCMPUKL-WEVVVXLNSA-N 0.000 claims description 2
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 claims description 2
- KVIZNNVXXNFLMU-AIIUZBJTSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3r)-2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C\C KVIZNNVXXNFLMU-AIIUZBJTSA-N 0.000 claims description 2
- MWFQAAWRPDRKDG-KOLCDFICSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1C=C(Cl)Cl MWFQAAWRPDRKDG-KOLCDFICSA-N 0.000 claims description 2
- APEPLROGLDYWBS-UHFFFAOYSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2,3,3-tetramethylcyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1(C)C APEPLROGLDYWBS-UHFFFAOYSA-N 0.000 claims description 2
- FMPFURNXXAKYNE-UHFFFAOYSA-N [2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]quinolin-4-yl] methyl carbonate Chemical compound C1=C2C(OC(=O)OC)=C(C)C(CC)=NC2=CC(C)=C1OC1=CC=C(OC(F)(F)F)C=C1 FMPFURNXXAKYNE-UHFFFAOYSA-N 0.000 claims description 2
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 claims description 2
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 claims description 2
- QDRXWCAVUNHOGA-UHFFFAOYSA-N acequinocyl Chemical group C1=CC=C2C(=O)C(CCCCCCCCCCCC)=C(OC(C)=O)C(=O)C2=C1 QDRXWCAVUNHOGA-UHFFFAOYSA-N 0.000 claims description 2
- YLJLLELGHSWIDU-OKZTUQRJSA-N acetic acid;(2s,6r)-4-cyclododecyl-2,6-dimethylmorpholine Chemical compound CC(O)=O.C1[C@@H](C)O[C@@H](C)CN1C1CCCCCCCCCCC1 YLJLLELGHSWIDU-OKZTUQRJSA-N 0.000 claims description 2
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 claims description 2
- GMAUQNJOSOMMHI-JXAWBTAJSA-N alanycarb Chemical compound CSC(\C)=N/OC(=O)N(C)SN(CCC(=O)OCC)CC1=CC=CC=C1 GMAUQNJOSOMMHI-JXAWBTAJSA-N 0.000 claims description 2
- 150000001350 alkyl halides Chemical class 0.000 claims description 2
- 239000011717 all-trans-retinol Substances 0.000 claims description 2
- 235000019169 all-trans-retinol Nutrition 0.000 claims description 2
- ZCVAOQKBXKSDMS-UHFFFAOYSA-N allethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-UHFFFAOYSA-N 0.000 claims description 2
- 229940024113 allethrin Drugs 0.000 claims description 2
- 229960002587 amitraz Drugs 0.000 claims description 2
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 claims description 2
- HUTDUHSNJYTCAR-UHFFFAOYSA-N ancymidol Chemical compound C1=CC(OC)=CC=C1C(O)(C=1C=NC=NC=1)C1CC1 HUTDUHSNJYTCAR-UHFFFAOYSA-N 0.000 claims description 2
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002363 auxin Substances 0.000 claims description 2
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 claims description 2
- 229950000294 azaconazole Drugs 0.000 claims description 2
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 claims description 2
- OTSAMNSACVKIOJ-UHFFFAOYSA-N azane;carbamoyl(ethoxy)phosphinic acid Chemical compound [NH4+].CCOP([O-])(=O)C(N)=O OTSAMNSACVKIOJ-UHFFFAOYSA-N 0.000 claims description 2
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 claims description 2
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 claims description 2
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 claims description 2
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 claims description 2
- LJOZMWRYMKECFF-UHFFFAOYSA-N benodanil Chemical compound IC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LJOZMWRYMKECFF-UHFFFAOYSA-N 0.000 claims description 2
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 claims description 2
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 claims description 2
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 claims description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims description 2
- IXORZMNAPKEEDV-OHSBXDGMSA-N berelex Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)C1[C@@]3(C)C(=O)O2 IXORZMNAPKEEDV-OHSBXDGMSA-N 0.000 claims description 2
- 229950002373 bioresmethrin Drugs 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910021538 borax Inorganic materials 0.000 claims description 2
- IXVMHGVQKLDRKH-KNBKMWSGSA-N brassinolide Chemical compound C1OC(=O)[C@H]2C[C@H](O)[C@H](O)C[C@]2(C)[C@H]2CC[C@]3(C)[C@@H]([C@H](C)[C@@H](O)[C@H](O)[C@@H](C)C(C)C)CC[C@H]3[C@@H]21 IXVMHGVQKLDRKH-KNBKMWSGSA-N 0.000 claims description 2
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 claims description 2
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 claims description 2
- SFNPDDSJBGRXLW-UITAMQMPSA-N butocarboxim Chemical compound CNC(=O)O\N=C(\C)C(C)SC SFNPDDSJBGRXLW-UITAMQMPSA-N 0.000 claims description 2
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 claims description 2
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 claims description 2
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 claims description 2
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 claims description 2
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 claims description 2
- CWJSHJJYOPWUGX-UHFFFAOYSA-N chlorpropham Chemical compound CC(C)OC(=O)NC1=CC=CC(Cl)=C1 CWJSHJJYOPWUGX-UHFFFAOYSA-N 0.000 claims description 2
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 claims description 2
- PIZCXVUFSNPNON-UHFFFAOYSA-N clofencet Chemical compound CCC1=C(C(O)=O)C(=O)C=NN1C1=CC=C(Cl)C=C1 PIZCXVUFSNPNON-UHFFFAOYSA-N 0.000 claims description 2
- UXADOQPNKNTIHB-UHFFFAOYSA-N clofentezine Chemical compound ClC1=CC=CC=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 UXADOQPNKNTIHB-UHFFFAOYSA-N 0.000 claims description 2
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 claims description 2
- 229950008441 clofibric acid Drugs 0.000 claims description 2
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 claims description 2
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 claims description 2
- LSFUGNKKPMBOMG-UHFFFAOYSA-N cycloprothrin Chemical compound ClC1(Cl)CC1(C=1C=CC=CC=1)C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 LSFUGNKKPMBOMG-UHFFFAOYSA-N 0.000 claims description 2
- APJLTUBHYCOZJI-VZCXRCSSSA-N cyenopyrafen Chemical compound CC1=NN(C)C(\C(OC(=O)C(C)(C)C)=C(/C#N)C=2C=CC(=CC=2)C(C)(C)C)=C1C APJLTUBHYCOZJI-VZCXRCSSSA-N 0.000 claims description 2
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 claims description 2
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 claims description 2
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 claims description 2
- OAWUUPVZMNKZRY-UHFFFAOYSA-N cyprosulfamide Chemical compound COC1=CC=CC=C1C(=O)NS(=O)(=O)C1=CC=C(C(=O)NC2CC2)C=C1 OAWUUPVZMNKZRY-UHFFFAOYSA-N 0.000 claims description 2
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 claims description 2
- 229950000775 cyromazine Drugs 0.000 claims description 2
- 239000004062 cytokinin Substances 0.000 claims description 2
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims description 2
- 229940008203 d-transallethrin Drugs 0.000 claims description 2
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 claims description 2
- 239000002837 defoliant Substances 0.000 claims description 2
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 claims description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 claims description 2
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 claims description 2
- WURGXGVFSMYFCG-UHFFFAOYSA-N dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 claims description 2
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960003887 dichlorophen Drugs 0.000 claims description 2
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 claims description 2
- 229940004812 dicloran Drugs 0.000 claims description 2
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 claims description 2
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 claims description 2
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 claims description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 claims description 2
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 claims description 2
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 claims description 2
- 239000002895 emetic Substances 0.000 claims description 2
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 claims description 2
- HEZNVIYQEUHLNI-UHFFFAOYSA-N ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 claims description 2
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 claims description 2
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 claims description 2
- JISACBWYRJHSMG-UHFFFAOYSA-N famphur Chemical compound COP(=S)(OC)OC1=CC=C(S(=O)(=O)N(C)C)C=C1 JISACBWYRJHSMG-UHFFFAOYSA-N 0.000 claims description 2
- 239000003940 fatty acid amidase inhibitor Substances 0.000 claims description 2
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 claims description 2
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 claims description 2
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 claims description 2
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 claims description 2
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 claims description 2
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 claims description 2
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 claims description 2
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 claims description 2
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 claims description 2
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 claims description 2
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 claims description 2
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 claims description 2
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 claims description 2
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 claims description 2
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 claims description 2
- 229960004413 flucytosine Drugs 0.000 claims description 2
- GJEREQYJIQASAW-UHFFFAOYSA-N flufenerim Chemical compound CC(F)C1=NC=NC(NCCC=2C=CC(OC(F)(F)F)=CC=2)=C1Cl GJEREQYJIQASAW-UHFFFAOYSA-N 0.000 claims description 2
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 claims description 2
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 claims description 2
- RMFNNCGOSPBBAD-MDWZMJQESA-N formetanate Chemical compound CNC(=O)OC1=CC=CC(\N=C\N(C)C)=C1 RMFNNCGOSPBBAD-MDWZMJQESA-N 0.000 claims description 2
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 claims description 2
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 claims description 2
- 239000003448 gibberellin Substances 0.000 claims description 2
- GFEIVLLXVCBXOQ-UHFFFAOYSA-N gibberelline Natural products CC12CCCC3(C(O)OC1=O)C4CCC5(O)CC4(CC5=C)C(C23)C(=O)O GFEIVLLXVCBXOQ-UHFFFAOYSA-N 0.000 claims description 2
- OXHDYFKENBXUEM-UHFFFAOYSA-N glyphosine Chemical compound OC(=O)CN(CP(O)(O)=O)CP(O)(O)=O OXHDYFKENBXUEM-UHFFFAOYSA-N 0.000 claims description 2
- 239000003324 growth hormone secretagogue Substances 0.000 claims description 2
- 239000007954 growth retardant Substances 0.000 claims description 2
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 claims description 2
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 claims description 2
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 claims description 2
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 claims description 2
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 claims description 2
- 229930000073 hydroprene Natural products 0.000 claims description 2
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 claims description 2
- 150000002460 imidazoles Chemical class 0.000 claims description 2
- VPRAQYXPZIFIOH-UHFFFAOYSA-N imiprothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCN1C(=O)N(CC#C)CC1=O VPRAQYXPZIFIOH-UHFFFAOYSA-N 0.000 claims description 2
- YFVOXLJXJBQDEF-UHFFFAOYSA-N isocarbophos Chemical compound COP(N)(=S)OC1=CC=CC=C1C(=O)OC(C)C YFVOXLJXJBQDEF-UHFFFAOYSA-N 0.000 claims description 2
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 claims description 2
- 229930014550 juvenile hormone Natural products 0.000 claims description 2
- 239000002949 juvenile hormone Substances 0.000 claims description 2
- GQFJDWYHPRLNHR-UHFFFAOYSA-N karetazan Chemical compound CCN1C(C)=CC(=O)C(C(O)=O)=C1C1=CC=C(Cl)C=C1 GQFJDWYHPRLNHR-UHFFFAOYSA-N 0.000 claims description 2
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 claims description 2
- 229940043355 kinase inhibitor Drugs 0.000 claims description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 claims description 2
- 229960001669 kinetin Drugs 0.000 claims description 2
- 229930001540 kinoprene Natural products 0.000 claims description 2
- UWRBYRMOUPAKLM-UHFFFAOYSA-L lead arsenate Chemical compound [Pb+2].O[As]([O-])([O-])=O UWRBYRMOUPAKLM-UHFFFAOYSA-L 0.000 claims description 2
- 230000003859 lipid peroxidation Effects 0.000 claims description 2
- 229960000453 malathion Drugs 0.000 claims description 2
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 claims description 2
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 claims description 2
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 claims description 2
- HYVVJDQGXFXBRZ-UHFFFAOYSA-N metam Chemical compound CNC(S)=S HYVVJDQGXFXBRZ-UHFFFAOYSA-N 0.000 claims description 2
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 229930002897 methoprene Natural products 0.000 claims description 2
- 229950003442 methoprene Drugs 0.000 claims description 2
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 claims description 2
- 229940102396 methyl bromide Drugs 0.000 claims description 2
- DSRNRYQBBJQVCW-UHFFFAOYSA-N metoxuron Chemical compound COC1=CC=C(NC(=O)N(C)C)C=C1Cl DSRNRYQBBJQVCW-UHFFFAOYSA-N 0.000 claims description 2
- 229960001952 metrifonate Drugs 0.000 claims description 2
- KCIRYJNISRMYFI-UHFFFAOYSA-N mildiomycin Natural products NC(CO)C(=O)NC1C=CC(OC1C(O)(CC(O)CNC(=N)N)C(=O)O)N2CN=C(N)C(=C2)CO KCIRYJNISRMYFI-UHFFFAOYSA-N 0.000 claims description 2
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 claims description 2
- RXFQELGMJUSBGP-UHFFFAOYSA-N n'-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-n-ethyl-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 RXFQELGMJUSBGP-UHFFFAOYSA-N 0.000 claims description 2
- SURYGMYUVAMSRO-UHFFFAOYSA-N n'-[5-(difluoromethyl)-2-methyl-4-(3-trimethylsilylpropoxy)phenyl]-n-ethyl-n-methylmethanimidamide Chemical compound CCN(C)C=NC1=CC(C(F)F)=C(OCCC[Si](C)(C)C)C=C1C SURYGMYUVAMSRO-UHFFFAOYSA-N 0.000 claims description 2
- TUCSJFNYZJYLHE-UHFFFAOYSA-N n'-tert-butyl-n'-(3,5-dimethylbenzoyl)-2,7-dimethyl-2,3-dihydro-1-benzofuran-6-carbohydrazide Chemical compound CC1=C2OC(C)CC2=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 TUCSJFNYZJYLHE-UHFFFAOYSA-N 0.000 claims description 2
- APDZUEJJUCDJTL-UHFFFAOYSA-N n-(4-chloro-2-nitrophenyl)-n-ethyl-4-methylbenzenesulfonamide Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)N(CC)C1=CC=C(Cl)C=C1[N+]([O-])=O APDZUEJJUCDJTL-UHFFFAOYSA-N 0.000 claims description 2
- QTGVGIVRLSGTJJ-UHFFFAOYSA-N n-(acetamidomethyl)-2-chloro-n-(2,6-diethylphenyl)acetamide Chemical compound CCC1=CC=CC(CC)=C1N(CNC(C)=O)C(=O)CCl QTGVGIVRLSGTJJ-UHFFFAOYSA-N 0.000 claims description 2
- YYELCPZJQRYUSB-UHFFFAOYSA-N n-[1-[(6-bromopyridin-3-yl)methyl]pyridin-2-ylidene]-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)N=C1C=CC=CN1CC1=CC=C(Br)N=C1 YYELCPZJQRYUSB-UHFFFAOYSA-N 0.000 claims description 2
- NWOFWGTYDVCXRD-UHFFFAOYSA-N n-[1-[(6-chloropyridin-3-yl)methyl]pyridin-2-ylidene]-2,2,3,3,3-pentafluoropropanamide Chemical compound FC(F)(F)C(F)(F)C(=O)N=C1C=CC=CN1CC1=CC=C(Cl)N=C1 NWOFWGTYDVCXRD-UHFFFAOYSA-N 0.000 claims description 2
- DOYIIGHUVNZMAL-UHFFFAOYSA-N n-[1-[(6-chloropyridin-3-yl)methyl]pyridin-2-ylidene]-2,2-difluoroacetamide Chemical compound FC(F)C(=O)N=C1C=CC=CN1CC1=CC=C(Cl)N=C1 DOYIIGHUVNZMAL-UHFFFAOYSA-N 0.000 claims description 2
- IDFXUDGCYIGBDC-UHFFFAOYSA-N n-[4-ethylsulfanyl-2-(trifluoromethyl)phenyl]methanesulfonamide Chemical compound CCSC1=CC=C(NS(C)(=O)=O)C(C(F)(F)F)=C1 IDFXUDGCYIGBDC-UHFFFAOYSA-N 0.000 claims description 2
- CUYDUAXYJJPSRK-UHFFFAOYSA-N n-[4-methyl-3-(trifluoromethylsulfonylamino)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(C)C(NS(=O)(=O)C(F)(F)F)=C1 CUYDUAXYJJPSRK-UHFFFAOYSA-N 0.000 claims description 2
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 claims description 2
- NMBXMBCZBXUXAM-UHFFFAOYSA-N n-butyl-1-dibutoxyphosphorylcyclohexan-1-amine Chemical compound CCCCOP(=O)(OCCCC)C1(NCCCC)CCCCC1 NMBXMBCZBXUXAM-UHFFFAOYSA-N 0.000 claims description 2
- SACHJKZWHBFWEL-UHFFFAOYSA-N n-ethyl-n-methyl-n'-[2-methyl-5-(trifluoromethyl)-4-(3-trimethylsilylpropoxy)phenyl]methanimidamide Chemical compound CCN(C)C=NC1=CC(C(F)(F)F)=C(OCCC[Si](C)(C)C)C=C1C SACHJKZWHBFWEL-UHFFFAOYSA-N 0.000 claims description 2
- BUYMVQAILCEWRR-UHFFFAOYSA-N naled Chemical compound COP(=O)(OC)OC(Br)C(Cl)(Cl)Br BUYMVQAILCEWRR-UHFFFAOYSA-N 0.000 claims description 2
- DCUJJWWUNKIJPH-UHFFFAOYSA-N nitrapyrin Chemical compound ClC1=CC=CC(C(Cl)(Cl)Cl)=N1 DCUJJWWUNKIJPH-UHFFFAOYSA-N 0.000 claims description 2
- 125000006501 nitrophenyl group Chemical group 0.000 claims description 2
- YTYGAJLZOJPJGH-UHFFFAOYSA-N noviflumuron Chemical compound FC1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F YTYGAJLZOJPJGH-UHFFFAOYSA-N 0.000 claims description 2
- QHGUCRYDKWKLMG-UHFFFAOYSA-N octopamine Chemical compound NCC(O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-UHFFFAOYSA-N 0.000 claims description 2
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 claims description 2
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 claims description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 2
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 claims description 2
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 claims description 2
- 229960003536 phenothrin Drugs 0.000 claims description 2
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 claims description 2
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 claims description 2
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 claims description 2
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 claims description 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims description 2
- URHWNXDZOULUHC-ULJHMMPZSA-N picarbutrazox Chemical compound CN1N=NN=C1\C(C=1C=CC=CC=1)=N/OCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-ULJHMMPZSA-N 0.000 claims description 2
- 150000004885 piperazines Chemical class 0.000 claims description 2
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 claims description 2
- ZVUVJTQITHFYHV-UHFFFAOYSA-M potassium;naphthalene-1-carboxylate Chemical compound [K+].C1=CC=C2C(C(=O)[O-])=CC=CC2=C1 ZVUVJTQITHFYHV-UHFFFAOYSA-M 0.000 claims description 2
- SMKRKQBMYOFFMU-UHFFFAOYSA-N prallethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC#C)C(=O)C1 SMKRKQBMYOFFMU-UHFFFAOYSA-N 0.000 claims description 2
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 claims description 2
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 claims description 2
- BZNDWPRGXNILMS-VQHVLOKHSA-N propetamphos Chemical compound CCNP(=S)(OC)O\C(C)=C\C(=O)OC(C)C BZNDWPRGXNILMS-VQHVLOKHSA-N 0.000 claims description 2
- VXPLXMJHHKHSOA-UHFFFAOYSA-N propham Chemical compound CC(C)OC(=O)NC1=CC=CC=C1 VXPLXMJHHKHSOA-UHFFFAOYSA-N 0.000 claims description 2
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 claims description 2
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 claims description 2
- 229940121649 protein inhibitor Drugs 0.000 claims description 2
- 239000012268 protein inhibitor Substances 0.000 claims description 2
- 239000000007 protein synthesis inhibitor Substances 0.000 claims description 2
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 claims description 2
- DZVWKNFPXMUIFA-UHFFFAOYSA-N pyflubumide Chemical compound C1=C(CC(C)C)C(C(OC)(C(F)(F)F)C(F)(F)F)=CC=C1N(C(=O)C(C)C)C(=O)C1=C(C)N(C)N=C1C DZVWKNFPXMUIFA-UHFFFAOYSA-N 0.000 claims description 2
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 claims description 2
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 claims description 2
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 claims description 2
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 claims description 2
- 229940015367 pyrethrum Drugs 0.000 claims description 2
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 claims description 2
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 claims description 2
- 150000003222 pyridines Chemical class 0.000 claims description 2
- 150000003230 pyrimidines Chemical class 0.000 claims description 2
- YYXSCUSVVALMNW-FOWTUZBSSA-N pyriminostrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(NC=2C(=CC(Cl)=CC=2)Cl)=N1 YYXSCUSVVALMNW-FOWTUZBSSA-N 0.000 claims description 2
- BAUQXSYUDSNRHL-UHFFFAOYSA-N pyrimorph Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C=1C=NC(Cl)=CC=1)=CC(=O)N1CCOCC1 BAUQXSYUDSNRHL-UHFFFAOYSA-N 0.000 claims description 2
- NMVCBWZLCXANER-UHFFFAOYSA-N pyriofenone Chemical compound COC1=C(OC)C(OC)=CC(C)=C1C(=O)C1=C(C)C(Cl)=CN=C1OC NMVCBWZLCXANER-UHFFFAOYSA-N 0.000 claims description 2
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 claims description 2
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 claims description 2
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 claims description 2
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 claims description 2
- 229940108410 resmethrin Drugs 0.000 claims description 2
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 claims description 2
- 229940080817 rotenone Drugs 0.000 claims description 2
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 claims description 2
- QLMNCUHSDAGQGT-UHFFFAOYSA-N sintofen Chemical compound N1=C(C(O)=O)C(=O)C=2C(OCCOC)=CC=CC=2N1C1=CC=C(Cl)C=C1 QLMNCUHSDAGQGT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004328 sodium tetraborate Substances 0.000 claims description 2
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 2
- KQSJSRIUULBTSE-UHFFFAOYSA-M sodium;3-(3-ethylcyclopentyl)propanoate Chemical compound [Na+].CCC1CCC(CCC([O-])=O)C1 KQSJSRIUULBTSE-UHFFFAOYSA-M 0.000 claims description 2
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 claims description 2
- 229960005322 streptomycin Drugs 0.000 claims description 2
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical compound CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 claims description 2
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 claims description 2
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 claims description 2
- 239000005936 tau-Fluvalinate Substances 0.000 claims description 2
- INISTDXBRIBGOC-XMMISQBUSA-N tau-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 claims description 2
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 claims description 2
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 claims description 2
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 claims description 2
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 claims description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims description 2
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 claims description 2
- DPOWHSMECVNHAT-YERPJTIDSA-N tetcyclacis Chemical compound C1=CC(Cl)=CC=C1N1[C@H]2[C@H]([C@@H]3[C@H]4N=N3)C[C@H]4[C@H]2N=N1 DPOWHSMECVNHAT-YERPJTIDSA-N 0.000 claims description 2
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 claims description 2
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 claims description 2
- 229960005199 tetramethrin Drugs 0.000 claims description 2
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 claims description 2
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 claims description 2
- OPASCBHCTNRLRM-UHFFFAOYSA-N thiometon Chemical compound CCSCCSP(=S)(OC)OC OPASCBHCTNRLRM-UHFFFAOYSA-N 0.000 claims description 2
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 claims description 2
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 claims description 2
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 claims description 2
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 claims description 2
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 claims description 2
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 claims description 2
- DDVNRFNDOPPVQJ-HQJQHLMTSA-N transfluthrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F DDVNRFNDOPPVQJ-HQJQHLMTSA-N 0.000 claims description 2
- 150000003852 triazoles Chemical class 0.000 claims description 2
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 claims description 2
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 claims description 2
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 claims description 2
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 claims description 2
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 claims description 2
- DFFWZNDCNBOKDI-UHFFFAOYSA-N trinexapac Chemical compound O=C1CC(C(=O)O)CC(=O)C1=C(O)C1CC1 DFFWZNDCNBOKDI-UHFFFAOYSA-N 0.000 claims description 2
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 claims description 2
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 claims description 2
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 claims description 2
- 229940023877 zeatin Drugs 0.000 claims description 2
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 claims description 2
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 claims description 2
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 claims 7
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims 4
- ANJYDSPMBISEHY-UHFFFAOYSA-N (4-fluorophenyl) carbamate Chemical compound NC(=O)OC1=CC=C(F)C=C1 ANJYDSPMBISEHY-UHFFFAOYSA-N 0.000 claims 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 claims 1
- 241000168022 Elaphurus davidianus Species 0.000 claims 1
- 108091006027 G proteins Proteins 0.000 claims 1
- 102000030782 GTP binding Human genes 0.000 claims 1
- 108091000058 GTP-Binding Proteins 0.000 claims 1
- 241000228341 Talaromyces Species 0.000 claims 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 claims 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 claims 1
- NJQMOZPWNXUSIL-UHFFFAOYSA-N methyl n-[[3,5-dibromo-2-[[5-bromo-2-(3-chloropyridin-2-yl)pyrazole-3-carbonyl]amino]benzoyl]-methylamino]-n-methylcarbamate Chemical compound COC(=O)N(C)N(C)C(=O)C1=CC(Br)=CC(Br)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl NJQMOZPWNXUSIL-UHFFFAOYSA-N 0.000 claims 1
- UWKQSUQMFIRFMM-UHFFFAOYSA-N n-[2-(tert-butylcarbamoyl)-4-chloro-6-methylphenyl]-2-(3-chloropyridin-2-yl)-5-(fluoromethoxy)pyrazole-3-carboxamide Chemical compound CC1=CC(Cl)=CC(C(=O)NC(C)(C)C)=C1NC(=O)C1=CC(OCF)=NN1C1=NC=CC=C1Cl UWKQSUQMFIRFMM-UHFFFAOYSA-N 0.000 claims 1
- OKQXFDSPKIACRT-UHFFFAOYSA-N n-ethyl-n'-[4-[4-fluoro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1OC1=CC=C(F)C(C(F)(F)F)=C1 OKQXFDSPKIACRT-UHFFFAOYSA-N 0.000 claims 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 claims 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 claims 1
- KNDVJPKNBVIKML-UHFFFAOYSA-N tetraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(CN2N=C(N=N2)C(F)(F)F)=NN1C1=NC=CC=C1Cl KNDVJPKNBVIKML-UHFFFAOYSA-N 0.000 claims 1
- 230000008635 plant growth Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- OBTZDIRUQWFRFZ-UHFFFAOYSA-N 2-(5-methylfuran-2-yl)-n-(4-methylphenyl)quinoline-4-carboxamide Chemical compound O1C(C)=CC=C1C1=CC(C(=O)NC=2C=CC(C)=CC=2)=C(C=CC=C2)C2=N1 OBTZDIRUQWFRFZ-UHFFFAOYSA-N 0.000 description 248
- 241001000605 Semia Species 0.000 description 73
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 70
- 229910052700 potassium Inorganic materials 0.000 description 70
- 239000011591 potassium Chemical class 0.000 description 70
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 68
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 65
- 229910052744 lithium Inorganic materials 0.000 description 65
- 229960001078 lithium Drugs 0.000 description 65
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 62
- 241001148114 Bradyrhizobium elkanii Species 0.000 description 48
- 230000001965 increasing effect Effects 0.000 description 45
- 235000010469 Glycine max Nutrition 0.000 description 28
- 244000068988 Glycine max Species 0.000 description 28
- 238000009472 formulation Methods 0.000 description 25
- 241001551803 Bradyrhizobium japonicum SEMIA 5079 Species 0.000 description 21
- 229930195729 fatty acid Natural products 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 230000004790 biotic stress Effects 0.000 description 18
- 235000013399 edible fruits Nutrition 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 235000013339 cereals Nutrition 0.000 description 16
- 239000008187 granular material Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000036579 abiotic stress Effects 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 240000007594 Oryza sativa Species 0.000 description 12
- 235000007164 Oryza sativa Nutrition 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 12
- 244000005700 microbiome Species 0.000 description 12
- 235000009566 rice Nutrition 0.000 description 12
- 239000004094 surface-active agent Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 description 11
- 244000105624 Arachis hypogaea Species 0.000 description 10
- 239000000575 pesticide Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 150000003871 sulfonates Chemical class 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 235000013311 vegetables Nutrition 0.000 description 10
- 240000008042 Zea mays Species 0.000 description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 235000005822 corn Nutrition 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 9
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 241000209140 Triticum Species 0.000 description 8
- 235000021307 Triticum Nutrition 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 241000233866 Fungi Species 0.000 description 7
- 241000219745 Lupinus Species 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000009931 harmful effect Effects 0.000 description 7
- 239000002054 inoculum Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- NAYYNDKKHOIIOD-UHFFFAOYSA-N phthalamide Chemical compound NC(=O)C1=CC=CC=C1C(N)=O NAYYNDKKHOIIOD-UHFFFAOYSA-N 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 241000223218 Fusarium Species 0.000 description 6
- 240000005979 Hordeum vulgare Species 0.000 description 6
- 235000007340 Hordeum vulgare Nutrition 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000003899 bactericide agent Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 239000002270 dispersing agent Substances 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Chemical class 0.000 description 6
- 235000003911 Arachis Nutrition 0.000 description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 description 5
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 5
- 241000589171 Bradyrhizobium sp. Species 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 235000021536 Sugar beet Nutrition 0.000 description 5
- 241000219977 Vigna Species 0.000 description 5
- 235000010726 Vigna sinensis Nutrition 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 229940000425 combination drug Drugs 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000008821 health effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 4
- 235000017060 Arachis glabrata Nutrition 0.000 description 4
- 235000018262 Arachis monticola Nutrition 0.000 description 4
- 241000959699 Bradyrhizobium lupini Species 0.000 description 4
- 240000007124 Brassica oleracea Species 0.000 description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 241000896542 Clonostachys rosea f. catenulata Species 0.000 description 4
- 241001133184 Colletotrichum agaves Species 0.000 description 4
- 241000371644 Curvularia ravenelii Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000228453 Pyrenophora Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 241000223259 Trichoderma Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 239000002518 antifoaming agent Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000006072 paste Substances 0.000 description 4
- 235000020232 peanut Nutrition 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 229920005552 sodium lignosulfonate Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 241000563903 Bacillus velezensis Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001450781 Bipolaris oryzae Species 0.000 description 3
- 241000228437 Cochliobolus Species 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 239000005757 Cyproconazole Substances 0.000 description 3
- 241000221785 Erysiphales Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000223247 Gloeocercospora Species 0.000 description 3
- 241000219146 Gossypium Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 241000757048 Libertella blepharis Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 241001532588 Mesorhizobium ciceri Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 241000233629 Phytophthora parasitica Species 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000589180 Rhizobium Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241000246091 Thermopsis Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 240000000359 Triticum dicoccon Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- KQNPFQTWMSNSAP-UHFFFAOYSA-M isobutyrate Chemical compound CC(C)C([O-])=O KQNPFQTWMSNSAP-UHFFFAOYSA-M 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000002790 naphthalenes Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 235000012015 potatoes Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 2
- YLZYSVYZMDJYOT-UHFFFAOYSA-N 2-methoxypyrimidine Chemical compound COC1=NC=CC=N1 YLZYSVYZMDJYOT-UHFFFAOYSA-N 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- BMTZEAOGFDXDAD-UHFFFAOYSA-M 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 BMTZEAOGFDXDAD-UHFFFAOYSA-M 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- ATCHXZDKOPPPST-UHFFFAOYSA-N 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]-2-methyl-n-(1-oxothietan-3-yl)benzamide Chemical compound CC1=CC(C=2CC(ON=2)(C=2C=C(Cl)C=C(Cl)C=2)C(F)(F)F)=CC=C1C(=O)NC1CS(=O)C1 ATCHXZDKOPPPST-UHFFFAOYSA-N 0.000 description 2
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 2
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241000213004 Alternaria solani Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 2
- 241000501812 Ampelomyces Species 0.000 description 2
- 206010002368 Anger Diseases 0.000 description 2
- 241000223651 Aureobasidium Species 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 241001465178 Bipolaris Species 0.000 description 2
- 241000190150 Bipolaris sorokiniana Species 0.000 description 2
- 241000228439 Bipolaris zeicola Species 0.000 description 2
- 241000123650 Botrytis cinerea Species 0.000 description 2
- 241000159535 Bradyrhizobium liaoningense Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241001157813 Cercospora Species 0.000 description 2
- 241001466031 Colletotrichum gossypii Species 0.000 description 2
- 241001312183 Coniothyrium Species 0.000 description 2
- 241000221755 Cryphonectria Species 0.000 description 2
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 2
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 208000035859 Drug effect increased Diseases 0.000 description 2
- 241000221787 Erysiphe Species 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241000223195 Fusarium graminearum Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000208818 Helianthus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 241000803621 Ilyonectria liriodendri Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000228457 Leptosphaeria maculans Species 0.000 description 2
- 241000294754 Macroptilium atropurpureum Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001135320 Mesorhizobium huakuii Species 0.000 description 2
- 241001123674 Metschnikowia Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- HRYILSDLIGTCOP-UHFFFAOYSA-N N-benzoylurea Chemical class NC(=O)NC(=O)C1=CC=CC=C1 HRYILSDLIGTCOP-UHFFFAOYSA-N 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000233679 Peronosporaceae Species 0.000 description 2
- 241000047853 Phaeomoniella chlamydospora Species 0.000 description 2
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 2
- 241001634117 Phlebiopsis Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 241000386899 Pseudocercospora vitis Species 0.000 description 2
- 244000044425 Quisqualis indica Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241000266300 Ulocladium Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 241001360088 Zymoseptoria tritici Species 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
- 235000019289 ammonium phosphates Nutrition 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 150000008059 anilinopyrimidines Chemical class 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000021015 bananas Nutrition 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 150000001556 benzimidazoles Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000003857 carboxamides Chemical class 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- UYJUZNLFJAWNEZ-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2NC3=CC=CC=C3N=2)=C1 UYJUZNLFJAWNEZ-UHFFFAOYSA-N 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000003197 gene knockdown Methods 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- FVRDNLIUSWSBCT-VOJRNIOYSA-N harzianum a Chemical compound C([C@@]12[C@@]3([C@H](OC(=O)\C=C/C=C/C=C/C(O)=O)C[C@H]1O[C@@H]1C=C(CC[C@@]13C)C)C)O2 FVRDNLIUSWSBCT-VOJRNIOYSA-N 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 125000004285 isoxazolidin-3-yl group Chemical group [H]N1OC([H])([H])C([H])([H])C1([H])* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- DYFHTHIEAZGGDF-UHFFFAOYSA-N methyl 2-[2-[(2,5-dimethylphenoxy)methyl]phenyl]-3-methoxyprop-2-enoate Chemical compound COC=C(C(=O)OC)C1=CC=CC=C1COC1=CC(C)=CC=C1C DYFHTHIEAZGGDF-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 2
- 230000024121 nodulation Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000010603 pastilles Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229960004838 phosphoric acid Drugs 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 125000005543 phthalimide group Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- SRJQTHAZUNRMPR-SFGMUSMWSA-N spinosyn-a Chemical compound C([C@@H](OC(=O)C[C@H]1[C@@H]2C=C[C@@H]3C[C@H](C[C@H]3[C@@H]2C=C1C(=O)[C@@H]1C)O[C@H]2[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O2)OC)CC)CCC1O[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 SRJQTHAZUNRMPR-SFGMUSMWSA-N 0.000 description 2
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004546 suspension concentrate Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 239000001974 tryptic soy broth Substances 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PMTMAFAPLCGXGK-JMTMCXQRSA-N (15Z)-12-oxophyto-10,15-dienoic acid Chemical compound CC\C=C/C[C@H]1[C@@H](CCCCCCCC(O)=O)C=CC1=O PMTMAFAPLCGXGK-JMTMCXQRSA-N 0.000 description 1
- BAZVSMNPJJMILC-STQMWFEESA-N (1s,2r)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound O([C@@H]([C@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-STQMWFEESA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-M (R)-pantothenate Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GHOKWGTUZJEAQD-ZETCQYMHSA-M 0.000 description 1
- KANAPVJGZDNSCZ-UHFFFAOYSA-N 1,2-benzothiazole 1-oxide Chemical class C1=CC=C2S(=O)N=CC2=C1 KANAPVJGZDNSCZ-UHFFFAOYSA-N 0.000 description 1
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 1
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 1
- 239000005969 1-Methyl-cyclopropene Substances 0.000 description 1
- SHDPRTQPPWIEJG-UHFFFAOYSA-N 1-methylcyclopropene Chemical compound CC1=CC1 SHDPRTQPPWIEJG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OYVYISSVIAMCJD-UHFFFAOYSA-N 1h-1,2,4-triazol-5-yl thiocyanate Chemical compound N#CSC1=NC=NN1 OYVYISSVIAMCJD-UHFFFAOYSA-N 0.000 description 1
- HWGJWYNMDPTGTD-UHFFFAOYSA-N 1h-azonine Chemical compound C=1C=CC=CNC=CC=1 HWGJWYNMDPTGTD-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LMBOBAWFGUTZRU-UHFFFAOYSA-N 2-(5-fluoropyridin-3-yl)-5-(6-pyrimidin-2-ylpyridin-2-yl)-1,3-thiazole Chemical compound FC1=CN=CC(C=2SC(=CN=2)C=2N=C(C=CC=2)C=2N=CC=CN=2)=C1 LMBOBAWFGUTZRU-UHFFFAOYSA-N 0.000 description 1
- IRJQWZWMQCVOLA-ZBKNUEDVSA-N 2-[(z)-n-[(3,5-difluorophenyl)carbamoylamino]-c-methylcarbonimidoyl]pyridine-3-carboxylic acid Chemical compound N=1C=CC=C(C(O)=O)C=1C(/C)=N\NC(=O)NC1=CC(F)=CC(F)=C1 IRJQWZWMQCVOLA-ZBKNUEDVSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- IWTFOFMTUOBLHG-UHFFFAOYSA-N 2-methoxypyridine Chemical compound COC1=CC=CC=N1 IWTFOFMTUOBLHG-UHFFFAOYSA-N 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- ILZMHOGEJDCHHH-UHFFFAOYSA-N 3-chloro-2-n-(2-cyanopropan-2-yl)-1-n-(2,4-dimethylphenyl)benzene-1,2-dicarboxamide Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC=CC(Cl)=C1C(=O)NC(C)(C)C#N ILZMHOGEJDCHHH-UHFFFAOYSA-N 0.000 description 1
- GWRSATNRNFYMDI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C)CC1 GWRSATNRNFYMDI-UHFFFAOYSA-N 0.000 description 1
- BCFOOQRXUXKJCL-UHFFFAOYSA-N 4-amino-4-oxo-2-sulfobutanoic acid Chemical class NC(=O)CC(C(O)=O)S(O)(=O)=O BCFOOQRXUXKJCL-UHFFFAOYSA-N 0.000 description 1
- YUXBNNVWBUTOQZ-UHFFFAOYSA-N 4-phenyltriazine Chemical class C1=CC=CC=C1C1=CC=NN=N1 YUXBNNVWBUTOQZ-UHFFFAOYSA-N 0.000 description 1
- RXDDBNBVULNXNI-UHFFFAOYSA-N 5-[[5-(trifluoromethyl)tetrazol-2-yl]methyl]-1h-pyrazole-3-carboxamide Chemical compound N1N=C(C(=O)N)C=C1CN1N=C(C(F)(F)F)N=N1 RXDDBNBVULNXNI-UHFFFAOYSA-N 0.000 description 1
- BRFZHKHWPSROPX-UHFFFAOYSA-N 5-cyano-1-n,3-dimethylbenzene-1,2-dicarboxamide Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1C(N)=O BRFZHKHWPSROPX-UHFFFAOYSA-N 0.000 description 1
- VNHBYKHXBCYPBJ-UHFFFAOYSA-N 5-ethynylimidazo[1,2-a]pyridine Chemical compound C#CC1=CC=CC2=NC=CN12 VNHBYKHXBCYPBJ-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 241000919511 Albugo Species 0.000 description 1
- 241000919507 Albugo candida Species 0.000 description 1
- 241001163841 Albugo ipomoeae-panduratae Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000399940 Anguina tritici Species 0.000 description 1
- 241001444083 Aphanomyces Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000239223 Arachnida Species 0.000 description 1
- 241000222195 Ascochyta Species 0.000 description 1
- 241000887188 Ascochyta hordei Species 0.000 description 1
- 241000228438 Bipolaris maydis Species 0.000 description 1
- 241001480060 Blumeria Species 0.000 description 1
- 241000310268 Brachycaudus tragopogonis Species 0.000 description 1
- 241000233685 Bremia lactucae Species 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 241000498608 Cadophora gregata Species 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000221866 Ceratocystis Species 0.000 description 1
- 241000530549 Cercospora beticola Species 0.000 description 1
- 241001658057 Cercospora kikuchii Species 0.000 description 1
- 241000113401 Cercospora sojina Species 0.000 description 1
- 241000437818 Cercospora vignicola Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241001149956 Cladosporium herbarum Species 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241001123534 Colletotrichum coccodes Species 0.000 description 1
- 241001429695 Colletotrichum graminicola Species 0.000 description 1
- 241001120669 Colletotrichum lindemuthianum Species 0.000 description 1
- 241000222239 Colletotrichum truncatum Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FMGBNISRFNDECK-CZSBRECXSA-N Coronatine Chemical compound CC[C@H]1C[C@]1(C(O)=O)NC(=O)C1=C[C@H](CC)C[C@@H]2C(=O)CC[C@H]12 FMGBNISRFNDECK-CZSBRECXSA-N 0.000 description 1
- 241001529717 Corticium <basidiomycota> Species 0.000 description 1
- 235000005987 Crotalaria longirostrata Nutrition 0.000 description 1
- 240000000287 Crotalaria longirostrata Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 241000723247 Cylindrocarpon Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 241001508802 Diaporthe Species 0.000 description 1
- 241001508801 Diaporthe phaseolorum Species 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000591358 Eballistra oryzae Species 0.000 description 1
- 241000125117 Elsinoe Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001492222 Epicoccum Species 0.000 description 1
- 241000984019 Erysiphe cruciferarum Species 0.000 description 1
- 241001337814 Erysiphe glycines Species 0.000 description 1
- 241001489205 Erysiphe pisi Species 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical class OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 241000378864 Eutypa Species 0.000 description 1
- 241000306559 Exserohilum Species 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000221778 Fusarium fujikuroi Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 241000233732 Fusarium verticillioides Species 0.000 description 1
- 241000590686 Fuscopannaria mediterranea Species 0.000 description 1
- 241001149475 Gaeumannomyces graminis Species 0.000 description 1
- 241001620302 Glomerella <beetle> Species 0.000 description 1
- 241000896246 Golovinomyces cichoracearum Species 0.000 description 1
- 241000221557 Gymnosporangium Species 0.000 description 1
- 241001409809 Gymnosporangium sabinae Species 0.000 description 1
- 241001181537 Hemileia Species 0.000 description 1
- 241001181532 Hemileia vastatrix Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 241001293495 Lactuca virosa Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 108010033104 M-81 Proteins 0.000 description 1
- 241001495426 Macrophomina phaseolina Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007679 Mandevilla laxa Species 0.000 description 1
- 241001422926 Mayetiola hordei Species 0.000 description 1
- 241000970829 Mesorhizobium Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical class [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241001518729 Monilinia Species 0.000 description 1
- 241001518731 Monilinia fructicola Species 0.000 description 1
- 241001518836 Monilinia fructigena Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 241000131448 Mycosphaerella Species 0.000 description 1
- HYVABZIGRDEKCD-UHFFFAOYSA-N N(6)-dimethylallyladenine Chemical compound CC(C)=CCNC1=NC=NC2=C1N=CN2 HYVABZIGRDEKCD-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241001226034 Nectria <echinoderm> Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 241001231450 Neonectria Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- PMTMAFAPLCGXGK-UHFFFAOYSA-N OPDA Natural products CCC=CCC1C(CCCCCCCC(O)=O)C=CC1=O PMTMAFAPLCGXGK-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 241000221871 Ophiostoma Species 0.000 description 1
- 241000221671 Ophiostoma ulmi Species 0.000 description 1
- 241000673120 Ornithopus pinnatus Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000222291 Passalora fulva Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241001670203 Peronospora manshurica Species 0.000 description 1
- 241000582441 Peronospora tabacina Species 0.000 description 1
- 241000263269 Phaeoacremonium minimum Species 0.000 description 1
- 241000440445 Phakopsora meibomiae Species 0.000 description 1
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
- 244000100170 Phaseolus lunatus Species 0.000 description 1
- 241000123107 Phellinus Species 0.000 description 1
- 241000222831 Phialophora <Chaetothyriales> Species 0.000 description 1
- 241000975369 Phoma betae Species 0.000 description 1
- 241001480007 Phomopsis Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000210649 Phyllosticta ampelicida Species 0.000 description 1
- 241000932914 Physalospora obtusa Species 0.000 description 1
- 241000471406 Physoderma maydis Species 0.000 description 1
- 241001281803 Plasmopara viticola Species 0.000 description 1
- 241000782724 Plenodomus tracheiphilus Species 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000087479 Pseudocercospora fijiensis Species 0.000 description 1
- 241001008026 Pseudopezicula tetraspora Species 0.000 description 1
- 241000520648 Pyrenophora teres Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000589157 Rhizobiales Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241001299709 Rosellinia Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001533598 Septoria Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000332749 Setosphaeria turcica Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000011575 Spilocaea Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 241000218220 Ulmaceae Species 0.000 description 1
- 241001286670 Ulmus x hollandica Species 0.000 description 1
- 241000221577 Uromyces appendiculatus Species 0.000 description 1
- 241000905623 Venturia oleaginea Species 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010725 Vigna aconitifolia Nutrition 0.000 description 1
- 244000042325 Vigna aconitifolia Species 0.000 description 1
- 244000207951 Vigna marina Species 0.000 description 1
- 235000010716 Vigna mungo Nutrition 0.000 description 1
- 241001098704 Vigna parkeri Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 235000010722 Vigna unguiculata Nutrition 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000004490 capsule suspension Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Chemical class 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical class [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000008645 cold stress Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- FMGBNISRFNDECK-UHFFFAOYSA-N coronatine Natural products CCC1CC1(C(O)=O)NC(=O)C1=CC(CC)CC2C(=O)CCC12 FMGBNISRFNDECK-UHFFFAOYSA-N 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 230000008641 drought stress Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 108010023700 galanin-(1-13)-bradykinin-(2-9)-amide Proteins 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000001034 iron oxide pigment Substances 0.000 description 1
- VRWKTAYJTKRVCU-UHFFFAOYSA-N iron(6+);hexacyanide Chemical compound [Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] VRWKTAYJTKRVCU-UHFFFAOYSA-N 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-O isopropylaminium Chemical compound CC(C)[NH3+] JJWLVOIRVHMVIS-UHFFFAOYSA-O 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical class [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940063559 methacrylic acid Drugs 0.000 description 1
- GECUYSIOMPPGPL-UHFFFAOYSA-N methyl 2-[(6-ethyl-1-oxo-2,3-dihydroindene-4-carbonyl)amino]-3-methylpentanoate Chemical compound CCC(C)C(C(=O)OC)NC(=O)C1=CC(CC)=CC2=C1CCC2=O GECUYSIOMPPGPL-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000011733 molybdenum Chemical class 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- GBKQJFJTRJJJML-UHFFFAOYSA-N n-(1,1,3-trimethyl-2,3-dihydroinden-4-yl)-1h-pyrazole-4-carboxamide Chemical compound C=12C(C)CC(C)(C)C2=CC=CC=1NC(=O)C=1C=NNC=1 GBKQJFJTRJJJML-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- YFSUKTJZKJIUTM-UHFFFAOYSA-N n-[1-[(2-chloropyrimidin-5-yl)methyl]pyridin-2-ylidene]-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)N=C1C=CC=CN1CC1=CN=C(Cl)N=C1 YFSUKTJZKJIUTM-UHFFFAOYSA-N 0.000 description 1
- YMDDUFGMFWBOIM-UHFFFAOYSA-N n-[1-[(6-chloro-5-fluoropyridin-3-yl)methyl]pyridin-2-ylidene]-2,2,2-trifluoroacetamide Chemical compound N1=C(Cl)C(F)=CC(CN2C(C=CC=C2)=NC(=O)C(F)(F)F)=C1 YMDDUFGMFWBOIM-UHFFFAOYSA-N 0.000 description 1
- FMDLTPBLTVHTIM-UHFFFAOYSA-N n-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-5-bromo-2-(3-chloropyridin-2-yl)pyrazole-3-carboxamide Chemical compound C=1C(Br)=NN(C=2C(=CC=CN=2)Cl)C=1C(=O)NC=1C(C)=CC(Cl)=CC=1C1=NN=C(N)S1 FMDLTPBLTVHTIM-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- PMCVMORKVPSKHZ-UHFFFAOYSA-N oxydemeton-methyl Chemical compound CCS(=O)CCSP(=O)(OC)OC PMCVMORKVPSKHZ-UHFFFAOYSA-N 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000004477 pesticide formulation type Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 150000008048 phenylpyrazoles Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008659 phytopathology Effects 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical class OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000009367 silviculture Methods 0.000 description 1
- 239000004550 soluble concentrate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229940061368 sonata Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004548 suspo-emulsion Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000759 toxicological effect Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- MCVUKOYZUCWLQQ-UHFFFAOYSA-N tridecylbenzene Chemical class CCCCCCCCCCCCCC1=CC=CC=C1 MCVUKOYZUCWLQQ-UHFFFAOYSA-N 0.000 description 1
- 239000006150 trypticase soy agar Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940117958 vinyl acetate Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/22—Bacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the present invention relates to synergistic mixtures comprising as active components
- -Inhibitors of complex III at Qo site azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrameto- strobin, pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-meth- oxy-acrylic acid methyl ester and 2(2-(3-(2,6-di-chlorophenyl)-1 -methyl-allylideneamino- oxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlo- rodincarb,
- -inhibitors of complex II benodanil, bixafen, boscalid, carboxin, fen-furam, fluopyram, flutolanil, fluxapyroxad, furametpyr, isopyrazam, mepronil, oxycarboxin, penflufen, penthio- pyrad, sedaxane, tecloftalam, thifluzamide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-diflu- oromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-di- methyl-5-fluoro-1 H-pyrazole-4-carboxamide, N-[9-(dichloromethylene)-1 ,2,3,4-tetrahydro- 1 ,4-methanonaphthalen-5-yl]-3-(diflu
- respiration inhibitors e.g. complex I, uncouplers: diflumetorim, (5,8-difluoro-quin- azolin-4-yl)- ⁇ 2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl ⁇ -amine; nitro- phenyl derivates: binapacryl, dinobuton, dinocap, fluazinam; ferimzone; organometal com- pounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctra- din; and silthiofam;
- complex I uncouplers
- DMI fungicides triazoles: azaconazole, bitertanol, bromu- conazole, cyproconazole, difenoconazole,diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ip- conazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, pro- thioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triti— conazole, uniconazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4
- -Delta14-reductase inhibitors aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;
- -phenylamides or acyl amino acid fungicides benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, ofurace, oxadixyl;
- -tubulin inhibitors such as benzimidazoles, thiophanates: benomyl, carbendazim, fuber- idazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro-7-(4-methyl- piperidin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]triazolo[1 ,5-a]pyrimidine;
- -methionine synthesis inhibitors anilino-pyrimidines: cyprodinil, mepanipyrim, pyrimethan- il;
- blasticidin-S blasticidin-S, kasugamycin, kasugamycin hydrochloride- hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;
- -MAP / histidine kinase inhibitors fluoroimid, iprodione, procymidone, vinclozolin, fen- piclonil, fludioxonil;
- -G protein inhibitors quinoxyfen
- -Phospholipid biosynthesis inhibitors edifenphos, iprobenfos, pyrazophos, isoprothiolane;
- -lipid peroxidation dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
- -fatty acid amide hydrolase inhibitors 1 -[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro- 3-isoxazolyl]-2-thiazolyl]-1 -piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol- 1 -yl]ethanone;
- -organochlorine compounds e.g. phthalimides, sulfamides, chloronitriles: anilazine, chlo- rothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pen- tachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl- 4-methyl-benzenesulfonamide;
- phthalimides e.g. phthalimides, sulfamides, chloronitriles
- guanidines and others guanidine, dodine, dodine free base, guazatine, guazatine- acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6- dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;
- glucan synthesis validamycin, polyoxin B; melanin synthesis inhibitors: py- roquilon, carpropamid, dicyclomet, fenoxanil;
- Ampelomyces quisqualis e.g. AQ 10® from Intrachem Bio GmbH & Co. KG, Germany
- Aspergillus flavus e.g. AFLAGUARD® from Syngenta, CH
- Aureobasidium pullulans e.g.
- BOTECTOR® from bio-ferm GmbH, Germany
- Bacillus pumilus e.g. NRRL B-30087 in SONA-TA® and BALLAD® Plus from AgraQuest Inc., USA
- Bacillus subtilis e.g. isolate NRRL B-21661 in RHAPSODY®, SERENADE® MAX and SERENADE® ASO from AgraQuest Inc., USA
- Bacillus subtilis var. amylolique-faciens FZB24 e.g. TAEGRO® from Novozyme Biologicals, Inc., USA
- Candida oleophila 1-82 e.g. ASPIRE® from Ecogen Inc., USA
- Candida saitoana e.g.
- BIOCURE® in mixture with lysozyme
- BIO-COAT® from Micro Flo Company, USA (BASF SE) and Arysta
- Chitosan e.g. ARMOUR-ZEN from BotriZen Ltd., NZ
- Clonostachys rosea f. catenulata also named Glio- cladium catenulatum (e.g. isolate J 1446: PRESTOP® from Verdera, Finland), Coni- othyrium minitans (e.g. CONTANS® from Prophyta, Germany), Cryphonectria parasitica (e.g. Endothia parasitica from CNICM, France), Cryptococcus albidus (e.g.
- Fusarium oxysporum e.g. BIOFOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France
- Metschnikowia fructicola e.g. SHEMER® from Agrogreen, Israel
- Microdochium dimerum e.g. ANTI- BOT® from Agrauxine, France
- Phlebiopsis gigantea e.g. ROTSOP® from Verdera, Finland
- Pseudozyma flocculosa e.g. SPORODEX® from Plant Products Co. Ltd., Canada
- Pythium oligandrum DV74 e.g.
- harzianum TH 35 e.g. ROOT PRO® from Mycontrol Ltd., Israel
- T. harzianum T-39 e.g. TRICHODEX® and TRICHODERMA 2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel
- T. harzianum and T. viride e.g. TRICHOPEL from Agrimm Technologies Ltd, NZ
- T. harzianum ICC012 and T. viride ICC080 e.g. REMEDIER® WP from Isagro Ricerca, Italy
- T. polysporum and T. harzianum e.g. BINAB® from BINAB Bio-Innovation AB, Sweden
- T. virens GL-21 e.g. SOILGARD® from Certis LLC, USA
- T. viride e.g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIOCURE® F from T. Stanes & Co. Ltd., Indien
- T. viride TV1 e.g. T. viride TV1 from Agribi- otec srl, Italy
- Ulocladium oudemansii HRU3 e.g. BOTRY-ZEN® from Botry-Zen Ltd, NZ
- BOTRY-ZEN® from Botry-Zen Ltd, NZ
- insecticidal compound IB selected from the group consisting of
- aldicarb aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, tri- methacarb, XMC, xylylcarb, and triazamate;
- M-2.B fiproles ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
- M-3 sodium channel modulators from the class of pyrethroids M-3 sodium channel modulators from the class of pyrethroids:
- abamectin emamectin benzoate, ivermectin, lepimectin or milbemectin;
- hydroprene hydroprene, kinoprene, methoprene, fenoxycarb or pyriproxyfen;
- M-8 non-specific multi-site inhibitors methyl bromide and other alkyl halides, chloropicrin, sulfuryl fluoride, borax or tartar emetic;
- M-9 selective homopteran feeding blockers pymetrozine, flonicamid, pyrifluquinazon, 2-(5- fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride;
- M-10 mite growth inhibitors clofentezine, hexythiazox, diflovidazin or etoxazole;
- M-1 1 inhibitors of mitochondrial ATP synthase diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, or tetradifon;
- M-12 uncouplers of oxidative phosphorylation chlorfenapyr, DNOC or sulfluramid;
- M-14 inhibitors of the chitin biosynthesis type 0 (benzoylurea class):
- M-15 inhibitors of the chitin biosynthesis type 1 buprofezin;
- M-16 moulting disruptors cyromazine
- M-17 Ecdyson receptor agonists methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide;
- Mitochondrial complex III electron transport inhibitors hydramethylnon, acequinocyl, flometoquin, fluacrypyrim or pyriminostrobin;
- M-20 Mitochondrial complex I electron transport inhibitors fenazaquin, fenpyroximate, py- rimidifen, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim, or rotenone;
- 5-cyano-N1 ,3-dimethyl-phthalamide (known from WO 2007/144100), N2-(1 -cyano-1 -meth- yl-ethyl)-N1 -(2,4-dimethylphenyl)-3-iodo-phthalamide (known from CN102613183), 3-chlo- ro-N2-(1 -cyano-1 -methyl-ethyl)-N1 -(2,4-dimethylphenyl)phthalamide (known from
- M-26 Bacillus firmus (e.g. Bacillus firmus CNCM 1-1582; WO 09/126473 and
- one compound IC having plant growth regulator activity selected from the group consisting of:
- Antiauxins clofibric acid, 2,3,5-tri-iodobenzoic acid;
- 4-CPA ((4-chlorophenoxy)acetic acid), 2,4-D ((2,4-dichlorophenoxy)acetic acid), 2,4-DB (4-(2,4-dichlorophenoxy)butyric acid), 2,4-DEP (tris[2-(2,4-dichlorophenoxy)ethyl] phosphite), dichlorprop, fenoprop, IAA (1 H-indol-3-ylacetic acid), IBA (4-(1 H-indol-3- yl)butyric acid), naphthaleneacetamide, onaphthaleneacetic acid, 1 -naphthol, naphthox- yacetic acid, potassium naphthenate, sodium naphthenate, 2,4,5-T ((2,4,5-trichloro- phenoxy)acetic acid);
- Ethylene modulators aviglycine, 1 -methylcyclopropene (1 -MCP), prohexadione, prohex- adione calcium, trinexapac, trinexapac-ethyl;
- Ethylene releasers 1 -aminocyclopropane-1 -carboxylic acid (ACC), et messagingl, ethephon, glyoxime;
- Gibberellins gibberelline, gibberellic acid
- Growth inhibitors abscisic acid, ancymidol, butralin, carbaryl, chlorphonium, chlorprop- ham, dikegulac, flumetralin, fluoridamid, fosamine, glyphosine, isopyrimol, jasmonic acid, maleic hydrazide, mepiquat, mepiquat chloride, mepiquat pentaborate, piproctanyl, pro- hydrojasmon, propham, 2,3,5-tri-iodobenzoic acid;
- chlormequat chlormequat chloride, daminozide, flurprimidol, mefluid- ide, paclobutrazol, tetcyclacis, uniconazole, metconazole;
- Unclassified plant growth regulators / classification unknown amidochlor, benzofluor, buminafos, carvone, choline chloride, ciobutide, clofencet, cloxyfonac, cyanamide, cyclanilide, cycloheximide, cyprosulfamide, epocholeone, ethychlozate, ethylene, fen- ridazon, fluprimidol, fluthiacet, heptopargil, holosulf, inabenfide, karetazan, lead arsenate, methasulfocarb, pydanon, sintofen, triapenthenol; and
- Bacillus subtilis MBI600 as compound II having the accession number NRRL B-50595.
- Bacillus subtilis MBI600 (defined herein as compound II) having the accession number NRRL B- 50595 is deposited with the United States Department of Agriculture on Nov. 10, 201 1 under the strain designation Bacillus subtilis 1430. It has also been deposited at The National Collections of Industrial and Marine Bacteria Ltd. (NCIB), Torry Research Station, P.O. Box 31 , 135 Abbey Road, Aberdeen, AB9 8DG, Scotland. under accession number 1237 on December 22, 1986. Bacillus subtilis MBI600 is known as plant growth-promoting rice seed treatment from Int. J. Microbiol. Res. ISSN 0975-5276, 3(2) (201 1 ), 120-130 and further described e.g. in US
- strain MBI600 is commercially available as liquid formulation product Integral® (Becker-Underwood Inc., USA).
- Bacillus amyloliquefaciens Several plant-associated strains of the genus Bacillus described as belonging to the species Bacillus amyloliquefaciens or Bacillus subtilis are used commercially to promote the growth and improve the health of crop plants (Phytopathology 96, 145-154, 2006). Recently, the strain MBI600 has been re-classified as Bacillus amyloliquefaciens subsp. plantarum based on poly- phasic testing which combines classical microbiological methods relying on a mixture of traditional tools (such as culture-based methods) and molecular tools (such as genotyping and fatty acids analysis).
- Bacillus subtilis MBI600 (or MBI 600 or MBI-600) is identical to Bacillus amyloliquefaciens subsp. plantarum MBI600, formerly Bacillus subtilis MBI600.
- Bacillus subitilis MBI600 shall mean Bacillus amyloliquefaciens subsp. plantarum MBI600, formerly Bacillus subtilis MBI600.
- Bacillus amyloliquefaciens and/or Bacillus subitlis are naturally occurring spore- forming bacteria found e.g. in soils or on plant surfaces all over the world.
- the Bacillus subtilis strain MBI600 was isolated from a faba bean plant leaf surface growing at Nottingham University School of Agriculture, Sutton Boningham, United Kingdom.
- Bacillus subtilis MBI600 were cultivated using media and fermentation techniques known in the art, e.g. in Tryptic Soy Broth (TSB) at 27°C for 24-72 hrs.
- the bacterial cells (vegatitive cells and spores) were washed and concentrated (e.g. by centrifugation at room temperature for 15 min at 7000 x g).
- bacterial cells preferably spores were suspended in a suitable dry carrier (e.g. clay).
- a suitable liquid formulation cells, preferably spores, were re-suspended in a suitable liquid carrier (e.g. water-based) to the desired spore density.
- the spore density number of spores per ml. was determined by identifying the number of heat- resistant colony-forming units (70°C for 10 min) on Trypticase Soy Agar after incubation for 18- 24 hrs at 37°C.
- Bacillus subtilis MBI600 is active in temperatures between 7°C and 52°C (Holtmann, G. & Bremer, E. (2004), J. Bacteriol. 186, 1683-1693).
- the present invention relates to synergistic mixtures comprising Bacillus subtilis MBI600 as compound II having the accession number NRRL B-50595 and one compound IA.
- the present invention furthermore relates to synergistic mixtures comprising Bacillus subtilis MBI600 as compound II having the accession number NRRL B-50595 and one compound IB.
- pests embrace animal pests, and harmful fungi.
- Another difficulty in relation to the use of pesticides is that the repeated and exclusive application of an individual pesticidal compound leads in many cases to a rapid selection of pests, that means animal pests, and harmful fungi, which have developed natural or adapted resistance against the active compound in question. Therefore there is a need for pest control agents that help prevent or overcome resistance.
- Another problem underlying the present invention is the desire for compositions that improve plants, a process which is commonly and hereinafter referred to as "plant health”.
- insecticidal also denotes not only action against (or attack by) insects, but also against (by) arachnids and nematodes.
- the present invention relates to the inventive mixtures having synergistically enhanced action of controlling harmful fungi.
- the invention relates to a method for controlling pest, using the inventive mixtures having synergistically enhanced action for controlling pests and to the use of compound I and compound II for preparing such mixtures, and also to compositions comprising such mixtures, wherein such methods relate to soil application.
- simultaneous, that is joint or separate, application of the compound I and the compound II or successive application of the compound I and compound II provides enhanced plant health effects compared to the plant health effects that are possible with the individual compounds (synergistic mixtures).
- the present invention relates to inventive mixtures having synergistically enhanced action of increasing the health of plants.
- the invention relates to a method for improving the health of plants, using the inventive mixtures having synergistically enhanced action for improving the health of plants and to the use of compound I and compound II for preparing such mixtures, and also to compositions comprising such mixtures, wherein such methods relate to soil application.
- the present invention relates to a method for protection of plant propagation material from pests and/or improving the health of plants grown from said plant propagation material, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
- the present invention relates to a method for protection of plant propagation material from pests, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
- the present invention relates to a method for protection of plant propagation material from harmful fungi, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
- the present invention relates to a method for protection of plant propagation material from animal pests (insects, acarids or nematodes), wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
- the present invention relates to a method for improving the health of plants grown from plant propagation material, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
- the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession.
- plant propagation material is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.
- the term propagation material denotes seeds.
- pesticidally effective amount means the amount of the inventive mixtures or of compositions comprising the mixtures needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism.
- the pesticidally effective amount can vary for the various mixtures / compositions used in the invention.
- a pesticidally effective amount of the mixtures / compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like.
- plant health effective amount denotes an amount of the inventive mixtures, which is sufficient for achieving plant health effects as defined herein below.
- Healthier plants are desirable since they result among others in better yields and/or a better quality of the plants or crops, specifically better quality of the harvested plant parts. Healthier plants also better resist to biotic and/or abiotic stress. A high resistance against biotic stresses in turn allows the person skilled in the art to reduce the quantity of pesticides applied and consequently to slow down the development of resistances against the respective pesticides. It was therefore an object of the present invention to provide a pesticidal composition which solves the problems outlined above, and which should, in particular, improve the health of plants, in particular the yield of plants.
- health of a plant or “plant health” is defined as a condition of the plant and/or its products which is determined by several aspects alone or in combination with each other such as increased yield, plant vigor, quality of harvested plant parts and tolerance to abiotic and/or biotic stress.
- Each plant health indicator listed below which is selected from the groups consisting of yield, plant vigor, quality and tolerance of the plant to abiotic and/or biotic stress, is to be understood as a preferred embodiment of the present invention either each on its own or preferably in combination with each other.
- increased yield of a plant means that the yield of a product of the respective plant is increased by a measurable amount over the yield of the same product of the plant produced under the same conditions, but without the application of the inventive mixture.
- increased yield can be characterized, among others, by the following improved properties of the plant:
- Gram and “fruit” are to be understood as any plant product which is further utilized after harvesting, e.g. fruits in the proper sense, vegetables, nuts, grains, seeds, wood (e.g. in the case of silviculture plants), flowers (e.g. in the case of gardening plants, ornamentals) etc., that is any- thing of economic value that is produced by the plant.
- the yield is increased by at least 4%.
- the yield increase may even be higher, for example 5 to 10 %, more preferable by 10 to 20 %, or even 20 to 30 %
- the yield - if measured in the absence of pest pressure - is increased by at least 2 %
- the yield increase may even be higher, for example until 4%-5% or even more.
- the plant vigor becomes mani- fest in several aspects such as the general visual appearance.
- improved plant vigor can be characterized, among others, by the following improved properties of the plant: improved vitality of the plant; and/or improved plant growth; and/or improved plant development; and/or improved visual appearance; and/or im- proved plant stand (less plant verse/lodging); and/or improved emergence; and/or enhanced root growth and/or more developed root system; and/or enhanced nodulation, in particular rhi- zobial nodulation;-and/or increased plant height; and/or increased tiller number; and/or increased number of side shoots; and/or increased number of flowers per plant; and/or increased shoot growth;-and/or less non-productive tillersand/or less input needed (such as fertilizers or water); and/or less seeds neededf and/or stronger and/or more productive tillersand/or improved quality of seeds (for being seeded in the following seasons for seed production);-and/or field establishment.
- Another indicator for the condition of the plant is the "quality" of a plant and/or its products.
- quality means that certain plant characteristics such as the content or composition of certain ingredients are increased or improved by a measurable or noticeable amount over the same factor of the plant produced under the same conditions, but without the application of the mixtures of the present invention.
- Enhanced quality can be char- acterized, among others, by following improved properties of the plant or its product: increased nutrient content; and/or increased protein content; and/or increased oil content; and/or increased starch content; and/or increased content of fatty acids; and/or increased metabolite content; and/or increased carotenoid content; and/or increased sugar content; and/or increased amount of essential amino acids; and/or improved nutrient composition; and/or improved protein composition; and/or improved composition of fatty acids; and/or improved metabolite composition; and/or improved carotenoid composition; and/or improved sugar composition; and/or improved amino acids composition ; and/or improved or optimal fruit color; and/or improved leaf color; and/or higher storage capacity; and/or better processability of the harvested products.
- Another indicator for the condition of the plant is the plant's tolerance or resistance to biotic and/or abiotic stress factors.
- Biotic and abiotic stress can have harmful effects on plants. Biotic stress is caused by living organisms while abiotic stress is caused for example by environmental extremes.
- "enhanced tolerance or resistance to biotic and/or abiotic stress factors” means (1 .) that certain negative factors caused by biotic and/or abiotic stress are diminished in a measurable or noticeable amount as compared to plants exposed to the same conditions, but without being treated with an inventive mixture and (2.) that the negative effects are not diminished by a direct action of the inventive mixture on the stress factors, e.g.
- Negative factors caused by biotic stress such as pathogens and pests are widely known and are caused by living organisms, such as competing plants (for example weeds), microorganisms (such as phythopathogenic fungi and/or bacteria) and/or viruses.
- Negative factors caused by abiotic stress are also well-known and can often be observed as reduced plant vigor (see above), for example:
- Abiotic stress can be caused for example by: extremes in temperature such as heat or cold (heat stress / cold stress); and/or strong variations in temperature; and/or temperatures unusual for the specific season; and/or drought (drought stress); and/or extreme wetness; and/or high salinity (salt stress); and/or radiation (for example by increased UV radiation due to the decreasing ozone layer); and/or increased ozone levels (ozone stress); and/or organic pollution (for example by phythotoxic amounts of pesticides); and/or inorganic pollution (for example by heavy metal contaminants).
- extremes in temperature such as heat or cold (heat stress / cold stress); and/or strong variations in temperature; and/or temperatures unusual for the specific season; and/or drought (drought stress); and/or extreme wetness; and/or high salinity (salt stress); and/or radiation (for example by increased UV radiation due to the decreasing ozone layer); and/or increased ozone levels (ozone stress); and/or organic pollution (for example by
- the above identified indicators for the health condition of a plant may be interdependent and may result from each other.
- an increased resistance to biotic and/or abiotic stress may lead to a better plant vigor, e.g. to better and bigger crops, and thus to an increased yield.
- a more developed root system may result in an increased resistance to biotic and/or abiotic stress.
- these interdependencies and interactions are neither all known nor fully understood and therefore the different indicators are described separately.
- the inventive mixtures effectuate an increased yield of a plant or its product.
- inventive mixtures effectuate an increased vigor of a plant or its product. In another embodiment the inventive mixtures effectuate in an increased quality of a plant or its product.
- inventive mixtures effectuate an increased tolerance and/or resistance of a plant or its product against biotic stress.
- inventive mixtures effectuate an increased tolerance and/or resistance of a plant or its product against abiotic stress.
- the inventive mixtures effect an increase in the yield.
- the inventive mixtures effect an improvement of the plant vigor.
- the plant health effects of the inventive mixtures effect increased resistance of plant against biotic stress.
- the plant health effects of the inventive mixtures effect increased resistance of plant against abiotic stress.
- the inventive mixtures effect an increase in the yield. In a more preferred embodiment of the invention, the inventive mixtures effect an increase in the vigor.
- the mass ratio of any two ingredients in each combination is selected to give the desired, for example, synergistic action. In general, the mass ratio would vary depending on the specific compound I. Generally, the ratio by weight between any two ingredients in any combination of the present invention (compound I: compound II / compound ll:lll) [in the ternary mixtures ratios between any of the compounds I, II and III or compounds I, II and IV, or compounds I, III and IV or in the quaternary mixtures the ratios between any of the compounds I, II, III and IV], inde- pendently of one another, is from 1000:1 to 1 :1000, preferably from 500:1 to 1 :500, more preferably the ratios from 100:1 to 1 :100 (for example ratios from 99:1 , 98:2, 97:3, 96:4, 95:5, 94:6, 93:7, 92:8, 91 :9, 90:10, 89:1 1 , 88:12, 87:13, 86:14
- preferred mass ratios are those between any two components of present invention are from 75:1 to 1 :75, more preferably, 50:1 to 1.50, especially 25:1 to 1 :25, advantageously 10:1 to 1 :10, such as 5:1 to 1 :5.
- ratios are suitable for inventive mixtures applied by soil treatment.
- all of these ratios refer to a preparation with at least 10 6 CFU/g ("colony forming units per gram").
- compound II may be supplied in any physiological state such as active or dormant.
- Dormant compound II may be supplied for example frozen, dried, or lyophilized or partly desiccated (procedures to produce these partly desiccated organisms are given in WO2008/002371 ) or for compound II in form of spores.
- Organisms in an active state can be delivered in a growth medium without any additional additives or materials or in combination with suitable nutrient mixtures.
- the compound II is preferably delivered and formulated in a dormant stage.
- the microorganisms as used according to the invention can be cultivated continuously or discontinuously in the batch process or in the fed batch or repeated fed batch process.
- a review of known methods of cultivation will be found in the textbook by Chmiel (Bioreaktoren und periphere bamboo (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).
- the culture medium that is to be used must satisfy the requirements of the particular strains in an appropriate manner.
- culture media for various microorganisms are given in the handbook "Manual of Methods for General Bacteriology” of the American Society for Bacte- riology (Washington D. C, USA, 1981 ).
- These culture media that can be used according to the invention generally comprise one or more sources of carbon, sources of nitrogen, inorganic salts, vitamins and/or trace elements.
- Preferred sources of carbon are sugars, such as mono-, di- or polysaccharides.
- Very good sources of carbon are for example glucose, fructose, man- nose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch or cellulose.
- Sugars can also be added to the media via complex compounds, such as molasses, or other by-products from sugar refining. It may also be advantageous to add mixtures of various sources of carbon.
- Other possible sources of carbon are oils and fats such as soybean oil, sunflower oil, peanut oil and coconut oil, fatty acids such as palmitic acid, stearic acid or linoleic acid, alcohols such as glycerol, methanol or ethanol and organic acids such as acetic acid or lactic acid.
- Sources of nitrogen are usually organic or inorganic nitrogen compounds or materials containing these compounds.
- sources of nitrogen include ammonia gas or ammonium salts, such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates, urea, amino acids or complex sources of ni- trogen, such as corn-steep liquor, soybean flour, soybean protein, yeast extract, meat extract and others.
- the sources of nitrogen can be used separately or as a mixture.
- Inorganic salt compounds that may be present in the media comprise the chloride, phosphate or sulfate salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron.
- Inorganic sulfur-containing compounds for example sulfates, sulfites, dithionites, tetrathi- onates, thiosulfates, sulfides, but also organic sulfur compounds, such as mercaptans and thiols, can be used as sources of sulfur.
- Phosphoric acid, potassium dihydrogenphosphate or dipotassium hydrogenphosphate or the corresponding sodium-containing salts can be used as sources of phosphorus.
- Chelating agents can be added to the medium, in order to keep the metal ions in solution.
- Especially suitable chelating agents comprise dihydroxyphenols, such as catechol or protocatechuate, or organic acids, such as citric acid.
- the culture media used may also contain other growth factors, such as vitamins or growth promoters, which include for example biotin, riboflavin, thiamine, folic acid, nicotinic acid, pantothenate and pyridoxine. Growth factors and salts often come from complex components of the media, such as yeast extract, molasses, corn-steep liquor and the like. In addition, suitable precursors can be added to the culture medium. The precise composition of the compounds in the medium is strongly dependent on the particular experiment and must be decided individually for each specific case. Information on media optimization can be found in the textbook "Applied Microbiol. Physiology, A Practical Approach" (Publ. P.M. Rhodes, P.F. Stanbury, IRL Press (1997) p.
- Growing media can also be obtained from commercial suppliers, such as Standard 1 (Merck) or BHI (Brain heart infusion, DIFCO) etc. All components of the medium are sterilized, either by heating (20 min at 2.0 bar and 121 °C) or by sterile filtration. The components can be sterilized either together, or if necessary separately. All the components of the medium can be present at the start of growing, or optionally can be added continuously or by batch feed.
- the temperature of the culture of the respective microorganism is normally between 15°C and 45°C, preferably 25°C to 40°C and can be kept constant or can be varied during the experiment.
- the pH value of the medium should be in the range from 5 to 8.5, preferably around 7.0.
- the pH value for growing can be controlled during growing by adding basic compounds such as sodium hydroxide, potassium hydroxide, ammonia or ammonia water or acid compounds such as phos- phoric acid or sulfuric acid.
- Antifoaming agents e.g. fatty acid polyglycol esters, can be used for controlling foaming.
- suitable substances with selective action e.g. antibiotics
- Oxygen or oxygen-containing gas mixtures e.g. the ambient air, are fed into the culture in order to maintain aerobic conditions.
- the temperature of the culture is normally from 20°C to 45°C. Culture is continued until a maximum of the desired product has formed. This is normally achieved within 10 hours to 160 hours.
- the cells can be disrupted optionally by high-frequency ultrasound, by high pressure, e.g. in a French pressure cell, by osmolysis, by the action of detergents, lytic enzymes or organic solvents, by means of homogenizers or by a combination of several of the methods listed.
- the methodology of the present invention can further include a step of recovering individual compositions such as cell-free extracts, supernatants, metabolites or alike.
- the term "recovering" includes extracting, harvesting, isolating or purifying of an extract, supernatant or metabolite e.g. from whole culture broth.
- Recovering can be performed according to any conventional isolation or purification methodology known in the art including, but not limited to, treatment with a conventional resin (e.g., anion or cation exchange resin, non-ionic adsorption resin, etc.), treatment with a conventional adsorbent (e.g., activated charcoal, silicic acid, silica gel, cellulose, alumina, etc.), alteration of pH, solvent extraction (e.g., with a conventional solvent such as an alcohol, ethyl acetate, hexane and the like), distillation, dialysis, filtration, concentration, crystallization, recrystallization, pH adjustment, lyophilization and the like.
- a conventional resin e.g., anion or cation exchange resin, non-ionic adsorption resin, etc.
- a conventional adsorbent e.g., activated charcoal, silicic acid, silica gel, cellulose, alumina, etc.
- solvent extraction e.g.
- the agent can be recovered from culture media by first removing the microorganisms. The remaining broth is then passed through or over a cation exchange resin to remove unwanted cations and then through or over an anion exchange resin to remove unwanted inorganic anions and organic acids.
- Preferred inventive mixtures are those comprising compound II and fungicidal compound I A selected from the group consisting of
- Inhibitors of complex III at Qo site coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester, 2-(2-(3-(2,6-di- chlorophenyl)-1 -methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acet- amide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;
- inhibitors of complex III at Qi site cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl- 3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine- 2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl]-2-methylpropanoate, [(3S,6S,7R,8R)- 8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo
- inhibitors of complex II bixafen, boscalid, carboxin, fluopyram, flutolanil, fluxapyroxad, isopyrazam, penflufen, penthiopyrad, sedaxane, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-di- fluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-di- methyl-5-fluoro-1 H-pyrazole-4-carboxamide, benzovindiflupyr, 3-(difluoromethyl)-1 -methyl- N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 -methyl-N-(1 ,1 ,3-tri- methylindan-4-yl)pyrazole-4-carboxamide, 1
- respiration inhibitors (5,8-difluoroquinazolin-4-yl)- ⁇ 2-[2-fluoro-4-(4-trifluoromethyl- pyridin-2-yloxy)-phenyl]-ethyl ⁇ -amine, fluazinam; ametoctradin; and silthiofam;
- C14 demethylase inhibitors (DMI fungicides): bitertanol, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fluquinconazole, flusilazole, flutriafol, ipconazole, metconazole, myclobutanil, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadi- menol, triticonazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-
- Delta14-reductase inhibitors fenpropimorph, spiroxamine
- phenylamides or acyl amino acid fungicides benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, oxadixyl;
- tubulin inhibitors such as benzimidazoles, thiophanates: fuberidazole, thiabendazole, thiophanate-methyl;
- cell division inhibitors ethaboxam, pencycuron, metrafenone;
- methionine synthesis inhibitors anilino-pyrimidines: cyprodinil, pyrimethanil;
- Phospholipid biosynthesis inhibitors iprobenfos
- lipid peroxidation quintozene, tolclofos-methyl, etridiazole;
- phospholipid biosynthesis and cell wall deposition dimethomorph, mandipropamid, N-(1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;
- inorganic active substances Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
- thio- and dithiocarbamates ferbam, maneb, metiram, thiram;
- organochlorine compounds e.g. phthalimides, sulfamides, chloronitriles: chlorothalonil, captan, folpet; guanidines and others: guanidine, dodine, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1 H,5H- [1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;
- organochlorine compounds e.g. phthalimides, sulfamides, chloronitriles
- guanidines and others guanidine, dodine, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine
- Ampelomyces quisqualis e.g. AQ 10® from Intrachem Bio GmbH & Co. KG, Germany
- Aspergillus flavus e.g. AFLAGUARD® from Syngenta, CH
- Aureobasidium pullulans e.g. BO- T ECTOR® from bio-ferm GmbH, Germany
- Bacillus pumilus e.g. NRRL B-30087 in SONATA® and BALLAD® Plus from AgraQuest Inc., USA
- Bacillus subtilis e.g. isolate NRRL B-21661 in RHAPSODY®, SERENADE® MAX and SERENADE® ASO from AgraQuest Inc., USA
- Bacillus subtilis var Bacillus subtilis var.
- amyloliquefaciens FZB24 e.g. TAEGRO® from Novozyme Biologi- cals, Inc., USA
- Candida oleophila I-82 e.g. ASPIRE® from Ecogen Inc., USA
- Candida sai- toana e.g. BIOCURE® (in mixture with lysozyme) and BIO-COAT® from Micro Flo Company, USA (BASF SE) and Arysta
- Chitosan e.g. ARMOUR-ZEN from BotriZen Ltd., NZ
- Clonosta- chys rosea f. catenulata also named Gliocladium catenulatum (e.g.
- isolate J 1446 PRESTOP® from Verdera, Finland), Coniothyrium minitans (e.g. CONTANS® from Prophyta, Germany), Cryphonectria parasitica (e.g. Endothia parasitica from CNICM, France), Cryptococcus albidus (e.g. YIELD PLUS® from Anchor Bio-Technologies, South Africa), Fusarium oxysporum (e.g. BIOFOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France),
- Metschnikowia fructicola e.g. SHEMER® from Agrogreen, Israel
- Microdochium dimerum e.g. ANTIBOT® from Agrauxine, France
- Phlebiopsis gigantea e.g. ROTSOP® from Verdera, Finland
- Pseudozyma flocculosa e.g. SPORODEX® from Plant Products Co. Ltd., Canada
- Pythium oligandrum DV74 e.g. POLYVERSUM® from Remeslo SSRO, Biopreparaty, Czech Rep.
- Reynoutria sachlinensis e.g.
- T. harzianum and T. viride e.g. TRICHOPEL from Agrimm Technologies Ltd, NZ
- T. harzianum ICC012 and T. viride ICC080 e.g. REMEDIER® WP from Isa- gro Ricerca, Italy
- T. polysporum and T. harzianum e.g. BINAB® from BINAB Bio-Innovation AB, Sweden
- T. stromaticum e.g. TRICOVAB® from C.E.P.L.A.C., Brazil
- T. virens GL-21 e.g.
- T. viride e.g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO-CURE® F from T. Stanes & Co. Ltd., Indien
- T. viride TV1 e.g. T. viride TV1 from Agribiotec srl, Italy
- Ulocladium oudemansii HRU3 e.g. BOTRY-ZEN® from Botry- Zen Ltd, NZ.
- Preferred inventive mixtures especially useful for soil treatment are those comprising compound II and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl, Fludioxonil, Oryzastro- bin, Boscalid, Penthiopyrad, Iprodione, Dimethomorph and Mandipropamid; more preferably selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl and Fludioxonil.
- compound II and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metala
- Equally preferred inventive mixtures are those comprising compound II and insecticidal compound IA selected from the group consisting of
- M-1 A acetylcholine esterase inhibitors from the class of carbamates: aldicarb, benfuracarb, carbofuran, carbosulfan, isoprocarb, methiocarb, methomyl, oxamyl, pirimicarb, thiodicarb, triazamate;
- fiproles phenylpyrazoles: ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
- M-3 sodium channel modulators from the class of pyrethroids bifenthrin, cyfluthrin, beta-cyflu- thrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenvalerate, flucythrinate, permethrin, silafluofen, tefluthrin;
- M-9 selective homopteran feeding blockers pymetrozine, pyrifluquinazon, 2-(5-fluoro-3-pyridyl)- 5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride;
- M-13 nicotinic acetylcholine receptor channel blockers cartap hydrochloride; M-14 inhibitors of the chitin biosynthesis type 0 (benzoylurea class): diflubenzuron, flufenox- uron, lufenuron, novaluron, teflubenzuron;
- M-15 inhibitors of the chitin biosynthesis type 1 buprofezin;
- M-17 Ecdyson receptor agonists methoxyfenozide
- M-26 Bacillus firmus (e.g. Bacillus firmus CNCM 1-1582).
- More preferred inventive mixtures are those comprising compound II and fungicidal compound IA displayed in Table 1A:
- Table 1A the following abbreviations are used:
- Bacillus subtilis MBI600 having the accession number NRRL B-50595 A
- Phlebiopsis gig an tea A 2-yl)-2-methyl-1 H-
- Preferred inventive mixtures especially useful for soil treatment are those comprising compound I I and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl, Fludioxonil, Oryzastro- bin, Boscalid, Penthiopyrad, Iprodione, Dimethomorph and Mandipropamid, more preferably selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl and Fludioxonil.
- compound I I and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr,
- Equally more preferred inventive mixtures are those comprising compound II and insecticidal compound I B displayed in Table 1 B:
- Bacillus subtilis MBI600 having the accession number NRRL B-50595
- More preferred inventive mixtures especially useful for soil treatment are those comprising compound II and insecticidal compound IB selected from momfluorothrin; 1 -[(6-chloro-3-pyridyl)- methyl]-2-nitro-1 -[(E)-pentylideneamino]guanidine; 1 -[(E)-[2-(4-cyanophenyl)-1 -[3-(trifluoro- methyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea; N2-(1 -cyano-1 -methyl- ethyl)-N1 -(2,4-dimethylphenyl)-3-iodo-phthalamide, 3-chloro-N2-(1 -cyano-1 -methyl-ethyl)- N1 -(2,4-dimethylphenyl)phthalamide, 2-(3-chloro-2-pyridyl)-
- Bacillus subtilis MBI600 having the accession number NRRL B-50595 A
- More preferred inventive mixtures especially useful for soil treatment are those comprising compound II and compound IC having plant growth regulating activity selected from 6- benzylaminopurine, chlormequat, chlormequat chloride, choline chloride, cyclanilide, dikegulac, diflufenzopyr, dimethipin, ethephon, flumetralin, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, maleic hydrazide, mepiquat, mepiquat chloride, 1 -MCP, paclobutrazol, prohexadione, prohexadione calcium, prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, trinexapac-ethyl and uniconazole.
- plant growth regulating activity selected from 6- benzylaminopurine, chlormequat, chlormequat chloride, choline chloride
- inventive mixtures especially useful for soil treatment are those comprising compound II and compound IC having plant growth regulating activity selected from chlormequat, chlormequat chloride, choline chloride, cyclanilide, dimethipin, ethephon, forchlorfenuron, gibberellic acid, maleic hydrazide, mepiquat, mepiquat chlorid, 1 -MCP, prohex- adione, prohexadione calcium, pthidiazuron and trinexapac-ethyl.
- plant growth regulating activity selected from chlormequat, chlormequat chloride, choline chloride, cyclanilide, dimethipin, ethephon, forchlorfenuron, gibberellic acid, maleic hydrazide, mepiquat, mepiquat chlorid, 1 -MCP, prohex- adione, prohexadione calcium, pthidiazuron and
- Most preferred inventive mixtures are those comprising compound II and fungicidal compound
- Bacillus subtilis MBI600 having the accession number NRRL B-50595 A
- Bacillus subtilis A quinolyl)isoquinoline C-88. Bacillus subtilis A
- Phlebiopsis gig an tea A C-1 14. T. harzianum A
- Bacillus subtilis MBI600 having the accession number NRRL B-50595 A
- the present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Bradyrhizobium japonicum (B. japonicum).
- B. japonicum is not one of the strains TA-1 1 or 532c.
- B. japonicum strains were cultivated using media and fermentation tech- niques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days. These mixtures are particularly suitable in soybean.
- B. japonicum is not one of the strains TA-1 1 or 532c.
- B. japonicum strains were cultivated using media and fermentation tech- niques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days. These mixtures are particularly suitable in soybean.
- YEM yeast extract-mannitol broth
- japonicum is not one of the strains TA-1 1 or 532c.
- B. japonicum strains were cultivated using media and fermentation techniques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days. References for various B. japonicum strains are given e.g. in US 7,262,151 (B.
- USDA refers to United States Department of Agriculture Culture Collection, Beltsville, Md., USA (see e.g. Belts- ville Rhizobium Culture Collection Catalog March 1987 ARS-30).
- B. japonicum strain G49 (INRA, Angers, France) is described in Fernandez-Flouret, D. & Cleyet-Marel, J. C. (1987) C R Acad Agric Fr 73, 163-171 ), especially for soybean grown in Europe, in particular in France.
- B. japonicum strain TA-1 1 (TA1 1 NOD + ) (NRRL B-18466) is i.a. described in US 5,021 ,076; AppI Environ Microbiol (1990) 56, 2399-2403 and commercially avail- able as liquid inoculant for soybean (VAULT® NP, Becker Underwood, USA). Further B.
- japonicum strains as example for compound III are described in US2012/0252672A. Further suitable and especially in Canada commercially available strain 532c (The Nitragin Company, Milwaukee, Wisconsin, USA, field isolate from Wisconsin; Nitragin strain collection No. 61A152; Can J Plant Sci 70 (1990), 661 -666).
- strains have been re-classified as a novel species Bradyrhizobium elkanii, e.g. strain USDA 76 (Can. J. Microbiol., 1992, 38, 501 - 505).
- the present invention also relates to mixtures consisting of as active ingredients compound II and comprising compound III, wherein compound III is selected from Bradyrhizobium japonicum (B. japonicum), provided that compound III is not B. japonicum TA-1 1 or 532c.
- the present invention also relates to mixtures comprising compound II and comprising com- pound III and compound IV, wherein compound III is selected from Bradyrhizobium japonicum (B. japonicum) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- compound III is selected from Bradyrhizobium japonicum (B. japonicum) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- the present invention also relates to mixtures comprising compound II and comprising com- pound III, wherein compound III is selected from Bradyrhizobium elkanii and Bradyrhizobium liaoningense (B. elkanii and B. liaoningense), more preferably from B. elkanii.
- compound III is selected from Bradyrhizobium elkanii and Bradyrhizobium liaoningense (B. elkanii and B. liaoningense), more preferably from B. elkanii.
- B. elkanii and liaoningense were cultivated using media and fermentation techniques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days.
- the present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Bradyrhizobium elkanii and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- the present invention also relates to mixtures comprising compound II and comprising com- pound III, wherein compound III is selected from Bradyrhizobium sp. (Arachis) (B. sp. Arachis) which shall describe the cowpea miscellany cross-inoculation group which includes inter alia indigenous cowpea bradyrhizobia on cowpea (Vigna unguiculata), siratro (Macroptilium atropur- pureum), lima bean (Phaseolus lunatus), and peanut (Arachis hypogaea).
- This mixture comprising compound II and B. sp. Arachis is especially suitable for use in peanut, Cowpea, Mung bean, Moth bean, Dune bean, Rice bean, Snake bean and Creeping vigna, in particular peanut.
- the present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Bradyrhizobium sp. (Ara- chis) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- the present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Bradyrhizobium sp. (Lupine) (also called B. lupini). This mixture is especially suitable for use in dry beans and lupins.
- B. lupini strain is LL13 (INRA, Angers, France;
- B. lupini strains WU245 isolated in Esperance, Western Australia from a non-Australian legume Ornthopus compressus
- WSM4024 isolated from lupins in Australia by CRS during a 2005 survey
- WSM471 isolated from Ornithopus pinnatus in Oyster Harbour, Western Australia
- the present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Bradyrhizobium sp. (Lupine) (B. lupini) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- compound III is selected from Bradyrhizobium sp. (Lupine) (B. lupini) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- the present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Mesorhizobium spp., more preferably Mesorhi- zobium ciceri. These mixtures are particularly suitable in cowpea.
- the present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Mesorhizobium ciceri and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- the present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Mesorhizobium huakuii, also referred to as Rhizobium huakii (see e.g.
- the present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Mesorhizobium huakuii and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- Salts of jasmonic acid or derivatives include without limitation the jasmonate salts potassium jasmonate, sodium jasmonate, lithium jasmonate, ammonium jasmonate, dimethylammonium jasmonate, isopropylammonium jasmonate, diolammonium jasmonate, diethtriethanolammoni- um jasmonate, jasmonic acid methyl ester, jasmonic acid amide, jasmonic acid methylamide, jasmonic acid-L-amino acid (amide-linked) conjugates (e.g., conjugates with L- isoleucine, L- valine, L-leucine, or L-phenylalanine), 12-oxo-phytodienoic acid, coronatine, coronafacoyl- L- serine, coronafacoyl-L-threonine, methyl esters of 1 - oxo-indanoyl-isoleucine, methyl esters of 1
- jasmonic acid Preferred amongst the group of salts of jasmonic acid or derivatives are jasmonic acid, methyl jasmonate, sodium jasmonate, potassium jasmonate, lithium jasmonate and ammonium jasmonate. More preferred is jasmonic acid methyl ester.
- the present invention also relates to mixtures comprising compound II and comprising compound III and compound II, compound III and compound IV as set forth in Table 3 below:
- Bacillus subtilis MBI600 having the accession number NRRL B-50595
- the present invention also relates to mixtures comprising compound I, compound II and com- pound I I I as third component, wherein compound I II is selected from Bradyrhizobium japonicum (B. japonicum).
- the present invention furthermore relates to ternary mixtures, wherein compound I I I is B. japonicum and the combination of compounds I and I I in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound I II is B. japonicum strain USDA 1 10 and the combination of compounds I and I I in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound I II is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corre- sponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corre- sponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corre- sponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corre- sponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corre- sponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corre- sponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corre- sponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corre- sponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corre- sponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention also relates to ternary mixtures comprising compound IV as third component, wherein compound IV is selected from jasmonates or salts or derivatives thereof.
- compound IV is selected from jasmonates or salts or derivatives thereof.
- Preferred amongst the group of salts of jasmonic acid or derivatives are jasmonic acid, methyl jasmonate, sodium jasmonate, potassium jasmonate, lithium jasmonate and ammonium jasmonate. More preferred is jasmonic acid methyl ester.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of com- pounds I and II in each case corresponds to a row of Table 1 A.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B..
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtuers comprising compound I, pound II, compound III and compound IV.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of com- pounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of com- pounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain USDA 1 10
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- com- pound III is B. japonicum USDA31
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain USDA76
- compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain USDA3
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain E-109
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain G49
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammo- nium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain 532c
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammo- nium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or am- monium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain TA-1 1
- compound IV is a jasmonate salt (e.g. potassium, lithium or am- monium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. japonicum strain SEMIA 5079
- compound IV is B. japonicum strain SEMIA 5080
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- compound III is B. elkanii strain SEMIA 587
- compound IV is B. elkanii strain SEMIA 5019
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- com- pound III is B. japonicum USDA31
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- a jasmonate salt e.g. potassium, lith- ium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- compound III is B. japonicum strain USDA3
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- compound III is B. japonicum strain 532c
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- japonicum strain TA-1 1 compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- compound III is B. japonicum strain SEMIA 5079
- compound IV is B. japonicum strain SEMIA 5080
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- compound III is B. elkanii strain SEMIA 587
- compound IV is B. elkanii strain SEMIA 5019
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is Bradyrhizobium japonicum
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium)
- the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain USDA 1 10
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- com- pound III is B. japonicum USDA31
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain USDA76
- compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain USDA121
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain USDA3
- compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain E-109
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain G49
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain 532c
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain TA-1 1
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. japonicum strain SEMIA 5079
- compound IV is B. japonicum strain SEMIA 5080
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- compound III is B. elkanii strain SEMIA 587
- compound IV is B. elkanii strain SEMIA 5019
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum USDA31
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain USDA76
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- com- pound III is B. japonicum strain USDA121
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain USDA3
- compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain E-109
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain G49
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain 532c
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain TA-1 1
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. japonicum strain SEMIA 5079
- compound IV is B. japonicum strain SEMIA 5080
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- compound III is B. elkanii strain SEMIA 587
- compound IV is B. elkanii strain SEMIA 5019
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- a jasmonate salt e.g. potassium, lithi- um or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum USDA31
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain USDA76
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- com- pound III is B. japonicum strain USDA121
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain USDA3
- compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain E-109
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain G49
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain 532c
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain TA-1 1
- compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. japonicum strain SEMIA 5079
- compound IV is B. japonicum strain SEMIA 5080
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- a jasmonate salt e.g. potassium, lithium or ammonium
- the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- compound III is B. elkanii strain SEMIA 587
- compound IV is B. elkanii strain SEMIA 5019
- compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
- the inventive mixtures can further contain one or more insecticides, fungicides, plant growth regulators and/or herbicides.
- the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession.
- inventive mixtures can further contain one or more insecticides, fungicides and/or, herbi- cides.
- the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession.
- the mixtures according to the present invention can be converted jointly with formulation auxiliaries into individual formulations (compositions) or can be converted jointly with formulation auxiliaries into customary formulations (co-formulation).
- compound I and compound II are naturally be formulated separately.
- the compounds of the inventive mixtures can be present in a kit of parts comprising as part one formulated compound I as defined above; and as second component one formulated compound II as defined above.
- individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e.g seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate.
- a spray tank or any other kind of vessel used for applications e.g seed treater drums, seed pelleting machinery, knapsack sprayer
- further auxiliaries may be added, if appropriate.
- living microorganisms, such as compound II, form part of such kit it must be taken care that choice and amounts of the other parts of the kit (e.g.
- chemcial pesticidal agents and of the further auxiliaries should not influence the viability of the microbial pesticides in the composition mixed by the user. Especially for bactericides and solvents, compatibility with the respective microbial pesticide has to be taken into account.
- one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit compring a) a composition comprising component 1 ) as defined herein and at least one auxiliary; or b) a composition comprising component 2) as defined herein and at least one auxiliary; or c) a composition comprising component 3) as defined herein and at least one auxiliary; and d) a composition comprising component 4) as defined herein and at least one auxiliary; and optionally e) a composition comprising at least one auxiliary and o further active ingedrients such as compound III and/or compound IV as defined herein.
- the present invention therefore also relates to a kit of parts comprising as part one formulated compound I as defined above; and as second component one formulated compound II as defined above. This applies also to combinations of compound II and III.
- kit of part may also optionally additionally comprise additional components III (and/ or IV) as outlined above, which can be also be provided separately packed, or, alternatively be present in combination with compound I or compound II.
- composition types for compound I and/or compound II are suspensions (e.g. SC, OD, FS), emulsifiable concentrates, capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g.
- compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.
- compositions are prepared in a known manner, such as described by Mollet and Grube- mann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.
- soil formulation types for pre-mix compositions are:
- WP wettable powders
- WG water dispersable granules (powders)
- OD oil-based suspension concentrate
- SE aqueous suspo-emulsion
- auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective col- loids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, stabilizers or nutrients, UV protectants, tackifiers and binders.
- Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, al- kylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g.
- mineral oil fractions of medium to high boiling point e.g. kerosene, diesel oil
- oils of vegetable or animal origin oils of vegetable or animal origin
- aliphatic, cyclic and aromatic hydrocarbons e. g. toluene, paraffin, tetrahydronaphthalene, al-
- lactates carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.
- amides e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.
- Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. ce- real meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
- mineral earths e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide
- polysaccharides e.g. cellulose, starch
- Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective col- loid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
- Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof.
- sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates.
- Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters.
- Examples of phosphates are phosphate esters.
- Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.
- Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof.
- alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents.
- Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide.
- N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides.
- esters are fatty acid esters, glycerol esters or monoglycerides.
- sugar- based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or al- kylpolyglucosides.
- polymeric surfactants are home- or copolymers of vinylpyrroli- done, vinylalcohols, or vinylacetate.
- Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines.
- Suitable amphoteric surfactants are alkylbetains and imidazolines.
- Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide.
- Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or pol- yethyleneamines.
- Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the inventive mixtures on the target.
- examples are surfactants, mineral or vegetable oils, and other auxilaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
- Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.
- Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.
- Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
- Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
- Suitable colorants are pigments of low water solubility and water- soluble dyes.
- examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanofer- rate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).
- Suitable tackifiers or binders are polyvinylpyrrolidone, polyvinylacetates, polyvinyl alcohols, pol- yacrylates, biological or synthetic waxes, and cellulose ethers.
- compo- sitions can be prepared as compositions comprising besides the active ingredients at least one auxiliary (inert ingredient) by usual means (see e.g. H.D. Burges: Formulation of Micobial Bi- opestcides, Springer, 1998).
- auxiliary inert ingredient
- Suitable customary types of such compositions are suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof.
- composition types are suspensions (e.g. SC, OD, FS), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g.
- WP WP
- SP WS
- DP DS
- pressings e.g. BR, TB, DT
- granules e.g. WG, SG, GR, FG, GG, MG
- insecticidal articles e.g. LN
- gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF).
- Suitable formulations are e.g. mentioned in WO 2008/002371 , US 6955,912, US 5,422,107.
- auxiliaries examples are those mentioned earlier herein, wherein it must be taken care that choice and amounts of such auxiliaries should not influence the viability of the microbial pesticides in the composition.
- auxiliaries Especially for bactericides and solvents, compatibility with the respective microorganism of the respective microbial pesticide has to be taken into account.
- compositions with microbial pesticides may further contain stabilizers or nutrients and UV protectants.
- Suitable stabilizers or nutrients are e.g. alpha-tocopherol, trehalose, glutamate, potassium sorbate, various sugars like glucose, sucrose, lactose, maltodextrine.
- Suitable UV protectants are e.g. inorganic compounds like titan dioxide, zinc oxide and iron oxide pigments or organic compounds like benzophenones, benzotriazoles, phenyltriazines.
- compositions may in addition to auxiliaries mentioned for compositions comprising compounds I herein optionally comprise 0.1 - 80% stabilizers or nutrients and 0.1 -10% UV protect- ants.
- CS formulations are particularly useful for compound I, less for compound II.
- granules, powders or suspensions are preferred formulation type.
- agitated vessel 1 -60 wt% of compound I or II or an inventive mixture are comminuted with addition of 2-10 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0.1 -2 wt% thickener (e.g. xanthan gum) and up to 100 wt% water or an suitable oil to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance.
- dispersants and wetting agents e.g. sodium lignosulfonate and alcohol ethoxylate
- 0.1 -2 wt% thickener e.g. xanthan gum
- up to 100 wt% water or an suitable oil to give a fine active substance suspension.
- Dilution with water gives a stable suspension of the active substance.
- binder e.g. polyvinylalcohol
- Water-dispersible granules and water-soluble granules (WG) 1 -80 wt% of compound I or II or an inventive mixture are are mixed to 100 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) and prepared as water- dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray- drying, fluidized bed). Dilution with water gives a stable dispersion or solution of the active sub- stance.
- dispersants and wetting agents e.g. sodium lignosulfonate and alcohol ethoxylate
- 1 -80 wt% a of compound I or II or an inventive mixture are are mixed with addition of 1 -5 wt% dispersants (e.g. sodium lignosulfonate), 1 -3 wt% wetting agents (e.g. alcohol ethoxylate) and up to 100 wt% solid carrier, e.g. silica gel. Dilution with water gives a stable dispersion or solution of the active substance.
- dispersants e.g. sodium lignosulfonate
- 1 -3 wt% wetting agents e.g. alcohol ethoxylate
- solid carrier e.g. silica gel
- compound I or II or an inventive mixture are comminuted with addition of 3-10 wt% dispersants (e.g. sodium lignosulfonate), 1 -5 wt% thickener (e.g. carboxy- methylcellulose) and up to 100 wt% water to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.
- dispersants e.g. sodium lignosulfonate
- 1 -5 wt% thickener e.g. carboxy- methylcellulose
- An oil phase comprising 5-50 wt% of a compound I, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e.g. methylmethacrylate, meth- acrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules.
- an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g.
- diphenylmethene-4,4'-diisocyanatae are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol).
- a protective colloid e.g. polyvinyl alcohol.
- the addition of a polyamine results in the formation of polyurea microcapsules.
- the monomers amount to 1 -10 wt%.
- the wt% relate to the total CS composition.
- 1 -10 wt% of compound I or II or an inventive mixture are mixed intimately with up to 100 wt% solid carrier, e.g. finely divided kaolin.
- compositions types i) to xi) may optionally comprise further auxiliaries, such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
- auxiliaries such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
- the soil treatment combinations and compositions comprising the inventive mixtures can also comprise or may be applied together and/or sequentially with further active compounds.
- further useful active compounds can be fertilizers or micronutrient donors (such as Mo, Zn and / or Co).
- the resulting agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active substance.
- the active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
- a tank-mix formulation for soil application comprises 0.1 to 20 percent, especially 0.1 to 15 percent, of the desired ingredients, and 99.9 to 80 percent, especially 99.9 to 85 percent, of a solid or liquid auxiliaries (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 20 percent, especially 0.1 to 15 percent, based on the tank-mix formulation.
- auxiliaries including, for example, a solvent such as water
- a pre-mix formulation for soil application comprises 0.1 to 99.9 percent, especially 1 to 95 percent, of the desired ingredients, and 99.9 to 0.1 percent, especially 99 to 5 percent, of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 50 percent, especially 0.5 to 40 percent, based on the pre-mix formulation.
- a solid or liquid adjuvant including, for example, a solvent such as water
- the auxiliaries can be a surfactant in an amount of 0 to 50 percent, especially 0.5 to 40 percent, based on the pre-mix formulation.
- granules can be directetly been added to the soil.
- soil application or “soil treatment” includes methods of applying to the soil can be via any suitable method, which ensures that the combination penetrates the soil, for example, nursery tray application, in furrow application, soil drenching, soil injection, drip irrigation, appli- cation through sprinklers or central pivot, incorporation into soil (broad cast or in band) are such methods.
- either individual compounds of the inventive mixtures formulated as composition or partially premixed components e. g. components set forth in the inventive mix- tures may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate (tank mix).
- either individual components of the inventive mixture or partially premixed components e. g. components comprising the compound I and II (or the compounds in- ventive ternary and quaternary mixtures), can be applied jointly (e. g. after tankmix) or consecutively.
- the rates of application (use) of a combination vary, for example, according to type of use, type of crop, the compound (I) in the combination with I, type of plant propagation material (if appro- priate), but is such that the active ingredients in the combination is an effective amount to provide the desired synergistically enhanced action (such as disease or pest control and plant heath effects) and can be determined by trials and routine experimentation known to one of ordinary skill in the art.
- the amounts of active substances (compound I, IV, if present) applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.01 to 1.0 kg per ha, and in particular from 0.05 to 0.75 kg per ha.
- the application rates preferably range from about 1 x 10 6 to 5 x 10 15 (or more) CFU/ha.
- the spore concentration is about 1 x 10 7 to about 1 x 10 11 CFU/ha.
- inventive mixtures are suitable for controlling the following fungal plant diseases:
- Albugo spp. white rust on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis); Altemaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassi- cae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A.retemata), tomatoes (e. g. A. solani or A.retemata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici (anthracnose) on wheat and A.
- Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicola) on corn, e. g. spot blotch (B. sorokiniana) on cereals and e.g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) gram- inis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botry- otinia fuckeliana: grey mold) on fruits and berries (e.
- strawberries vegetables
- vegetables e. g. lettuce, carrots, celery and cabbages
- rape flowers, vines, forestry plants and wheat
- Bremia lactucae downy mildew
- Ceratocystis syn. Ophiostoma
- Cercospora spp. rot or wilt
- corn e.g. Gray leaf spot: C. zeae-maydis
- sugar beets e. g. C.
Abstract
The present invention relates to pesticidal mixtures comprising one biological compound and at least one fungicidal, insecticidal or plant growth regulating compound and respective agricultural uses thereof as defined herein.
Description
Pesticidal mixtures
Description The present invention relates to synergistic mixtures comprising as active components,
1 ) one fungicidal compound IA selected from the group consisting of
A) Respiration inhibitors
-Inhibitors of complex III at Qo site: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrameto- strobin, pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-meth- oxy-acrylic acid methyl ester and 2(2-(3-(2,6-di-chlorophenyl)-1 -methyl-allylideneamino- oxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlo- rodincarb, famoxadone, fenamidone;
-inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-
3- [(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine- 2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate,
[(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)- amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-ben- zyl-3-[[3-(1 ,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-car-bonyl]amino]-6-methyl- 4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, (3S,6S,7R,8R)-3-[[(3-hydroxy-4-meth- oxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1 ,5-dioxonan-7-yl 2-methylpropanoate;
-inhibitors of complex II: benodanil, bixafen, boscalid, carboxin, fen-furam, fluopyram, flutolanil, fluxapyroxad, furametpyr, isopyrazam, mepronil, oxycarboxin, penflufen, penthio- pyrad, sedaxane, tecloftalam, thifluzamide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-diflu- oromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-di- methyl-5-fluoro-1 H-pyrazole-4-carboxamide, N-[9-(dichloromethylene)-1 ,2,3,4-tetrahydro- 1 ,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1 -methyl-1 H-pyrazole-4-carboxamide
(benzovindiflupyr), 3-(difluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-
4- carboxamide, 3-(trifluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-car- boxamide, 1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoro- methyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluorome- thyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1 ,3,5-trimethyl-
N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide;
-other respiration inhibitors (e.g. complex I, uncouplers): diflumetorim, (5,8-difluoro-quin- azolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; nitro- phenyl derivates: binapacryl, dinobuton, dinocap, fluazinam; ferimzone; organometal com- pounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctra- din; and silthiofam;
B) Sterol biosynthesis inhibitors (SBI fungicides)
-C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole, bitertanol, bromu-
conazole, cyproconazole, difenoconazole,diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ip- conazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, pro- thioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triti— conazole, uniconazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranyl- methyl]-5-thiocyanato-1 H-[1 ,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluoro- phenyl)-oxiranylmethyl]-2H-[1 ,2,4]triazole-3-thiol; imidazoles: imazalil, pefurazoate, pro- chloraz, triflumizol; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine;
-Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;
-Inhibitors of 3-keto reductase: fenhexamid;
C) Nucleic acid synthesis inhibitors
-phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, ofurace, oxadixyl;
-others: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2- (p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;
D) Inhibitors of cell division and cytoskeleton
-tubulin inhibitors, such as benzimidazoles, thiophanates: benomyl, carbendazim, fuber- idazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro-7-(4-methyl- piperidin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]triazolo[1 ,5-a]pyrimidine;
-other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zox- amide, metrafenone, pyriofenone;
E) Inhibitors of amino acid and protein synthesis
-methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, mepanipyrim, pyrimethan- il;
-protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride- hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;
F) Signal transduction inhibitors
-MAP / histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fen- piclonil, fludioxonil;
-G protein inhibitors: quinoxyfen;
G) Lipid and membrane synthesis inhibitors
-Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isoprothiolane; -lipid peroxidation: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
-phospholipid biosynthesis and cell wall deposition: dimethomorph, flumorph, mandipro- pamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate and N-(1 -(1 -(4-cyano-phenyl)- ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;
-compounds affecting cell membrane permeability and fatty acides: propamocarb, pro- pamocarb-hydrochloride;
-fatty acid amide hydrolase inhibitors: 1 -[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro- 3-isoxazolyl]-2-thiazolyl]-1 -piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol-
1 -yl]ethanone;
H) Inhibitors with Multi Site Action
-inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
-thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, thiram, zineb, ziram;
-organochlorine compounds (e.g. phthalimides, sulfamides, chloronitriles): anilazine, chlo- rothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pen- tachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl- 4-methyl-benzenesulfonamide;
-guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine- acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6- dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;
I) Cell wall synthesis inhibitors
-inhibitors of glucan synthesis: validamycin, polyoxin B; melanin synthesis inhibitors: py- roquilon, carpropamid, dicyclomet, fenoxanil;
J) Plant defence inducers
-acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; 4-cyclopropyl- N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide; phosphonates: fosetyl, fosetyl-alu- minum, phosphorous acid and its salts;
K) Unknown mode of action
-bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, dif- enzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfa- mide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxine-copper, picarbutrazox, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one,
N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl ac- etamide, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N' (4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-me- thyl formamidine, N'-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)- N-ethyl-N-methyl formamidine, N'-(5-difluoromethyl-2-methyl-4-(3-tri-methylsilanyl-prop- oxy)-phenyl)-N-ethyl-N-methyl formamidine, 2-methoxy-acetic acid 6-tert-butyl-8-fluoro- 2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]- pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1 -(4,6-di-methoxy- pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy- phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide, 4,4-difluoro-3,3-dimethyl-1 -(3-quinolyl)- isoquinoline;
L) Antifungal biological Control Agents:
Ampelomyces quisqualis (e.g. AQ 10® from Intrachem Bio GmbH & Co. KG, Germany), Aspergillus flavus (e.g. AFLAGUARD® from Syngenta, CH), Aureobasidium pullulans (e.g.
BOTECTOR® from bio-ferm GmbH, Germany), Bacillus pumilus (e.g. NRRL B-30087 in SONA-TA® and BALLAD® Plus from AgraQuest Inc., USA), Bacillus subtilis (e.g. isolate NRRL B-21661 in RHAPSODY®, SERENADE® MAX and SERENADE® ASO from
AgraQuest Inc., USA), Bacillus subtilis var. amylolique-faciens FZB24 (e.g. TAEGRO® from Novozyme Biologicals, Inc., USA), Candida oleophila 1-82 (e.g. ASPIRE® from Ecogen Inc., USA), Candida saitoana (e.g. BIOCURE® (in mixture with lysozyme) and BIO-COAT® from Micro Flo Company, USA (BASF SE) and Arysta), Chitosan (e.g. ARMOUR-ZEN from BotriZen Ltd., NZ), Clonostachys rosea f. catenulata, also named Glio- cladium catenulatum (e.g. isolate J 1446: PRESTOP® from Verdera, Finland), Coni- othyrium minitans (e.g. CONTANS® from Prophyta, Germany), Cryphonectria parasitica (e.g. Endothia parasitica from CNICM, France), Cryptococcus albidus (e.g. YIELD PLUS® from Anchor Bio-Technologies, South Africa), Fusarium oxysporum (e.g. BIOFOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France), Metschnikowia fructicola (e.g. SHEMER® from Agrogreen, Israel), Microdochium dimerum (e.g. ANTI- BOT® from Agrauxine, France), Phlebiopsis gigantea (e.g. ROTSOP® from Verdera, Finland), Pseudozyma flocculosa (e.g. SPORODEX® from Plant Products Co. Ltd., Canada), Pythium oligandrum DV74 (e.g. POLYVERSUM® from Remeslo SSRO, Biopreparaty, Czech Rep.), Reynoutria sachlinensis (e.g. REGALIA® from Marrone Biolnnovations, USA), Talaromyces flavus V1 17b (e.g. PROTUS® from Prophyta, Germany), Trichoderma asperellum SKT-1 (e.g. ECO-HOPE® from Kumiai Chemical Industry Co., Ltd., Japan), T. atroviride LC52 (e.g. SENTINEL® from Agrimm Technologies Ltd, NZ), T. harzianum T-22 (e.g. PLANTSHIELD® der Firma BioWorks Inc., USA), T. harzianum TH 35 (e.g. ROOT PRO® from Mycontrol Ltd., Israel), T. harzianum T-39 (e.g. TRICHODEX® and TRICHODERMA 2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel), T. harzianum and T. viride (e.g. TRICHOPEL from Agrimm Technologies Ltd, NZ), T. harzianum ICC012 and T. viride ICC080 (e.g. REMEDIER® WP from Isagro Ricerca, Italy), T. polysporum and T. harzianum (e.g. BINAB® from BINAB Bio-Innovation AB, Sweden), T. stromaticum (e.g. TRICOVAB® from C.E.P.L.A.C., Brazil), T. virens GL-21 (e.g. SOILGARD® from Certis LLC, USA), T. viride (e.g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIOCURE® F from T. Stanes & Co. Ltd., Indien), T. viride TV1 (e.g. T. viride TV1 from Agribi- otec srl, Italy), Ulocladium oudemansii HRU3 (e.g. BOTRY-ZEN® from Botry-Zen Ltd, NZ); or
one insecticidal compound IB selected from the group consisting of
M-1 .A acetylcholine esterase inhibitors from the class of carbamates:
aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, tri- methacarb, XMC, xylylcarb, and triazamate;
M-1 .B acetylcholine esterase inhibitors from the class of organophosphates: acephate, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvin- phos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton- S-methyl, diazinon, dichlorvos/ DDVP, dicrotophos, dimethoate, dimethylvinphos, disul- foton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, mono- crotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phentho-
ate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos- methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion; M-2 GABA-gated chloride channel antagonists:
M-2.A cyclodiene organochlorine compounds: endosulfan; or
M-2.B fiproles: ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
M-2. Others: 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]- N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1 -carboxamide (known from WO 2007/079162), 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl- N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide (known from WO 05/085216);
M-3 sodium channel modulators from the class of pyrethroids:
acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioalle- thrin S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cyper- methrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvali- nate, halfenprox, imiprothrin, meperfluthrin,metofluthrin, momfluorothrin, permethrin, phe- nothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tet- ramethylfluthrin, tetramethrin, tralomethrin, transfluthrin, DDT and methoxychlor;
M-4 nicotinic acteylcholine receptor agonists from the class of neonicotinoids: acetamiprid, chlothianidin, cycloxaprid, dinotefuran, flupyradifurone, imidacloprid, nitenpyram, sulfoxa- flor, thiacloprid, thiamethoxam, 1 -[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy- 3,5,6,7-tetrahydro-2H-imidazo[1 ,2-a]pyridine (known from WO 2007/101369), 1 -[(6-chloro- 3-pyridyl)methyl]-2-nitro-1 -[(E)-pentylideneamino]guanidine (known from
WO 2013/003977);
M-5 allosteric nicotinic acteylcholine receptor activators from the class of spinosyns: spi- nosad, spinetoram;
M-6 chloride channel activators from the class of mectins:
abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
M-7 juvenile hormone mimics:
hydroprene, kinoprene, methoprene, fenoxycarb or pyriproxyfen;
M-8 non-specific multi-site inhibitors: methyl bromide and other alkyl halides, chloropicrin, sulfuryl fluoride, borax or tartar emetic;
M-9 selective homopteran feeding blockers: pymetrozine, flonicamid, pyrifluquinazon, 2-(5- fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride;
M-10 mite growth inhibitors: clofentezine, hexythiazox, diflovidazin or etoxazole;
M-1 1 inhibitors of mitochondrial ATP synthase: diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, or tetradifon;
M-12 uncouplers of oxidative phosphorylation: chlorfenapyr, DNOC or sulfluramid;
M-13 nicotinic acetylcholine receptor channel blockers:
bensultap, cartap hydrochloride, thiocyclam, thiosultap sodium;
M-14 inhibitors of the chitin biosynthesis type 0 (benzoylurea class):
bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron,
lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron;
M-15 inhibitors of the chitin biosynthesis type 1 : buprofezin;
M-16 moulting disruptors: cyromazine;
M-17 Ecdyson receptor agonists: methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide;
M-18 Octopamin receptor agonists: amitraz;
M-19 Mitochondrial complex III electron transport inhibitors: hydramethylnon, acequinocyl, flometoquin, fluacrypyrim or pyriminostrobin;
M-20 Mitochondrial complex I electron transport inhibitors: fenazaquin, fenpyroximate, py- rimidifen, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim, or rotenone;
M-21 Voltage-dependent sodium channel blockers: indoxacarb, metaflumizone or
1 -[(E)-[2-(4-cyanophenyl)-1 -[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluorometh- oxy)phenyl]urea (known from CN101715774);
M-22 Inhibitors of the lipid synthesis, inhibitors of acetyl CoA carboxylase:
spirodiclofen, spiromesifen or spirotetramat;
M-23 Mitochondrial complex II electron transport inhibitors:
cyenopyrafen, cyflumetofen or pyflubumide;
M-24 Ryanodine receptor-modulators from the class of diamides:
flubendiamide, chlorantraniliprole (rynaxypyr), cyantraniliprole (cyazypyr), (R)-3-chloro-
N 1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2-me- thylsulfonylethyl)phthalamide or (S)-3-chloro-N1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 -(tri- fluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2-methylsulfonylethyl)phthalamidr (both known from WO 2007/101540), 3-bromo-N-{2-bromo-4-chloro-6-[(1 -cyclopropylethyl)carbamoyl]- phenyl}-1 -(3-chloropyridin-2-yl)-1 H-pyrazole-5-carboxamide (known from
WO 2005/077934), methyl-2-[3,5-dibromo-2-({[3-bromo-1 -(3-chloropyridin-2-yl)-1 H-pyr- azol-5-yl]carbonyl}amino)benzoyl]-1 ,2-dimethylhydrazinecarboxylate (known from
WO 2007/043677), N2-[2-(3-chloro-2-pyridyl)-5-[(5-methyltetrazol-2-yl)methyl]pyrazol-3-yl]-
5-cyano-N1 ,3-dimethyl-phthalamide (known from WO 2007/144100), N2-(1 -cyano-1 -meth- yl-ethyl)-N1 -(2,4-dimethylphenyl)-3-iodo-phthalamide (known from CN102613183), 3-chlo- ro-N2-(1 -cyano-1 -methyl-ethyl)-N1 -(2,4-dimethylphenyl)phthalamide (known from
CN102613183), 2-(3-chloro-2-pyridyl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-
5- [[5-(trifluoromethyl)tetrazol-2-yl]methyl]pyrazole-3-carboxamide (known from
WO 2007/144100), N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyri- dyl)-5-(fluoromethoxy)pyrazole-3-carboxamide (known from WO2012/034403), 5-bromo- N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carbox- amide (known from US201 1/046186), 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-
6- [(1 -cyano-1 -methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide (known from
WO 2008/134969), N-[2-(5-amino-1 ,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bro- mo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from WO201 1/085575);
M-25 Others, for example afidopyropen, flumetoquin, 2-(5-ethylsulfinyl-2-fluoro-4-methyl- phenyl)-5-methyl-1 ,2,4-triazol-3-amine (known from WO 06/043635), 1 -(5-ethylsulfinyl- 2,4-dimethyl-phenyl)-3-methyl-1 ,2,4-triazole (known from WO 06/043635), metaldehyde, triflumezopyrim, 8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-
imidazo[1 ,2-a]pyridine-2-carboxamide (known from WO 2013/055584), 5-[3-[2,6-dichloro-
4- (3,3-dichloroallyloxy)phenoxy]propoxy]-1 H-pyrazole (known from WO2010/060379), N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro- 3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide, N-[1 -[(6-bromo-3-py- ridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(2-chloropyrimidin-5-yl)methyl]- 2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyri- dylidene]-2,2,2-trifluoro-acetamide, 2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyridyl)methyl]-2-pyri- dylidene]acetamide, 2-chloro-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide, N-[1 -[1 -(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide (all known from WO 2012/029672); 1 1 -(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1 ,4-dioxa-9-azadispi- ro[4.2.4.2]-tetradec-1 1 -en-10-one (known from WO 2006/089633), 3-(4'-fluoro-2,4-di- methylbiphenyl-3-yl)-4-hydroxy-8-oxa-1 -azaspiro[4.5]dec-3-en-2-one (known from
WO 2008/06791 1 ), 2-(5-fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydro- fluoride, 2-(3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole, 5-[6-(1 ,3-dioxan-2-yl)-2-pyridyl]- 2-(3-pyridyl)thiazole (all known from WO 2010/006713), 4-[5-[3-chloro-5-(trifluoromethyl)- phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]- naphthalene-1 -carboxamide (known from WO 2009/002809), 4-[5-(3,5-dichlorophenyl)-
5- (trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)- ethyl]benzamide (known from WO 05/085216), 4-[5-(3,5-dichlorophenyl)-5-(trifluoro- methyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 -oxothietan-3-yl)benzamide (known from
WO 2013/050317);
M-26: Bacillus firmus (e.g. Bacillus firmus CNCM 1-1582; WO 09/126473 and
WO 09/124707, commercially available as "Votivo");
or
one compound IC having plant growth regulator activity selected from the group consisting of:
- Antiauxins: clofibric acid, 2,3,5-tri-iodobenzoic acid;
- Auxins: 4-CPA ((4-chlorophenoxy)acetic acid), 2,4-D ((2,4-dichlorophenoxy)acetic acid), 2,4-DB (4-(2,4-dichlorophenoxy)butyric acid), 2,4-DEP (tris[2-(2,4-dichlorophenoxy)ethyl] phosphite), dichlorprop, fenoprop, IAA (1 H-indol-3-ylacetic acid), IBA (4-(1 H-indol-3- yl)butyric acid), naphthaleneacetamide, onaphthaleneacetic acid, 1 -naphthol, naphthox- yacetic acid, potassium naphthenate, sodium naphthenate, 2,4,5-T ((2,4,5-trichloro- phenoxy)acetic acid);
- Cytokinins: 2iP (N-(3-methylbut-2-enyl)adenine), 6-benzylaminopurine (6-BA) (= N-6- benzyladenine), N-Oxide-2,6-lutidine, 2,6-dimethylpyridine, kinetin, zeatin;
- Defoliants: calcium cyanamide, dimethipin, endothal, merphos, metoxuron, pentachloro- phenol, thidiazuron, tribufos, tributyl phosphorotrithioate;
- Ethylene modulators: aviglycine, 1 -methylcyclopropene (1 -MCP), prohexadione, prohex- adione calcium, trinexapac, trinexapac-ethyl;
- Ethylene releasers: 1 -aminocyclopropane-1 -carboxylic acid (ACC), etacelasil, ethephon, glyoxime;
- Gibberellins: gibberelline, gibberellic acid;
- Growth inhibitors : abscisic acid, ancymidol, butralin, carbaryl, chlorphonium, chlorprop- ham, dikegulac, flumetralin, fluoridamid, fosamine, glyphosine, isopyrimol, jasmonic acid, maleic hydrazide, mepiquat, mepiquat chloride, mepiquat pentaborate, piproctanyl, pro- hydrojasmon, propham, 2,3,5-tri-iodobenzoic acid;
- Morphactins: chlorfluren, chlorflurenol, dichlorflurenol, flurenol;
- Growth retardants: chlormequat, chlormequat chloride, daminozide, flurprimidol, mefluid- ide, paclobutrazol, tetcyclacis, uniconazole, metconazole;
- Growth stimulators: brassinolide, forchlorfenuron, hymexazol;
- Unclassified plant growth regulators / classification unknown: amidochlor, benzofluor, buminafos, carvone, choline chloride, ciobutide, clofencet, cloxyfonac, cyanamide, cyclanilide, cycloheximide, cyprosulfamide, epocholeone, ethychlozate, ethylene, fen- ridazon, fluprimidol, fluthiacet, heptopargil, holosulf, inabenfide, karetazan, lead arsenate, methasulfocarb, pydanon, sintofen, triapenthenol; and
4) Bacillus subtilis MBI600 as compound II having the accession number NRRL B-50595.
The above-referred mixtures and all further embodiments of mixtures described herein below are for the purpose of this application also referred to as "inventive mixtures".
Bacillus subtilis MBI600 (defined herein as compound II) having the accession number NRRL B- 50595 is deposited with the United States Department of Agriculture on Nov. 10, 201 1 under the strain designation Bacillus subtilis 1430. It has also been deposited at The National Collections of Industrial and Marine Bacteria Ltd. (NCIB), Torry Research Station, P.O. Box 31 , 135 Abbey Road, Aberdeen, AB9 8DG, Scotland. under accession number 1237 on December 22, 1986. Bacillus subtilis MBI600 is known as plant growth-promoting rice seed treatment from Int. J. Microbiol. Res. ISSN 0975-5276, 3(2) (201 1 ), 120-130 and further described e.g. in US
2012/0149571 A1. This strain MBI600 is commercially available as liquid formulation product Integral® (Becker-Underwood Inc., USA).
Several plant-associated strains of the genus Bacillus described as belonging to the species Bacillus amyloliquefaciens or Bacillus subtilis are used commercially to promote the growth and improve the health of crop plants (Phytopathology 96, 145-154, 2006). Recently, the strain MBI600 has been re-classified as Bacillus amyloliquefaciens subsp. plantarum based on poly- phasic testing which combines classical microbiological methods relying on a mixture of traditional tools (such as culture-based methods) and molecular tools (such as genotyping and fatty acids analysis). Thus, Bacillus subtilis MBI600 (or MBI 600 or MBI-600) is identical to Bacillus amyloliquefaciens subsp. plantarum MBI600, formerly Bacillus subtilis MBI600. For the purpose of this invention, Bacillus subitilis MBI600 shall mean Bacillus amyloliquefaciens subsp. plantarum MBI600, formerly Bacillus subtilis MBI600.
The bacteria Bacillus amyloliquefaciens and/or Bacillus subitlis are naturally occurring spore-
forming bacteria found e.g. in soils or on plant surfaces all over the world. The Bacillus subtilis strain MBI600 was isolated from a faba bean plant leaf surface growing at Nottingham University School of Agriculture, Sutton Boningham, United Kingdom.
Bacillus subtilis MBI600 were cultivated using media and fermentation techniques known in the art, e.g. in Tryptic Soy Broth (TSB) at 27°C for 24-72 hrs. The bacterial cells (vegatitive cells and spores) were washed and concentrated (e.g. by centrifugation at room temperature for 15 min at 7000 x g). To produce a dry formulation, bacterial cells, preferably spores were suspended in a suitable dry carrier (e.g. clay). To produce a liquid formulation, cells, preferably spores, were re-suspended in a suitable liquid carrier (e.g. water-based) to the desired spore density. The spore density number of spores per ml. was determined by identifying the number of heat- resistant colony-forming units (70°C for 10 min) on Trypticase Soy Agar after incubation for 18- 24 hrs at 37°C.
Bacillus subtilis MBI600 is active in temperatures between 7°C and 52°C (Holtmann, G. & Bremer, E. (2004), J. Bacteriol. 186, 1683-1693).
Thus, the present invention relates to synergistic mixtures comprising Bacillus subtilis MBI600 as compound II having the accession number NRRL B-50595 and one compound IA.
The present invention furthermore relates to synergistic mixtures comprising Bacillus subtilis MBI600 as compound II having the accession number NRRL B-50595 and one compound IB.
The remaining compounds IA, IB, as well as their pesticidal action and methods for producing them are generally known. For instance, they may be found in the e-Pesticide Manual V5.2 (ISBN 978 1 901396 85 0) (2008-201 1 ) among other publications or in the references given above.
One typical problem arising in the field of pest control lies in the need to reduce the dosage rates of the active ingredient in order to reduce or avoid unfavorable environmental or toxicolog- ical effects whilst still allowing effective pest control.
In regard to the instant invention the term pests embrace animal pests, and harmful fungi.
Another problem encountered concerns the need to have available pest control agents which are effective against a broad spectrum of pests, e.g. both animal pests and harmful fungi.
There also exists the need for pest control agents that combine knock-down activity with prolonged control, that is, fast action with long lasting action.
Another difficulty in relation to the use of pesticides is that the repeated and exclusive application of an individual pesticidal compound leads in many cases to a rapid selection of pests, that means animal pests, and harmful fungi, which have developed natural or adapted resistance against the active compound in question. Therefore there is a need for pest control agents that help prevent or overcome resistance.
Another problem underlying the present invention is the desire for compositions that improve plants, a process which is commonly and hereinafter referred to as "plant health".
It was therefore an object of the present invention to provide pesticidal mixtures which solve the problems of reducing the dosage rate and / or enhancing the spectrum of activity and / or combining knock-down activity with prolonged control and / or to resistance management and/or promoting (increasing) the health of plants.
We have found that this object is in part or in whole achieved by the mixtures comprising the active compounds defined in the outset.
In particular, it has been found that the action of the inventive mixtures goes far beyond the fungicidal and/or insecticidal and/or plant health improving action of the active compounds I and II present in the mixture alone (synergism).
As used herein, the term "insecticidal" (or "insect attack") also denotes not only action against (or attack by) insects, but also against (by) arachnids and nematodes.
Herein, we have found that simultaneous, that is joint or separate, application of the compound I and the compound II or successive application of the compound I and the compound II allows enhanced control of pests, that means harmful fungi or animal pests, compared to the control rates that are possible with the individual compounds (synergistic mixtures).
Thus, the present invention relates to the inventive mixtures having synergistically enhanced action of controlling harmful fungi.
Moreover, the invention relates to a method for controlling pest, using the inventive mixtures having synergistically enhanced action for controlling pests and to the use of compound I and compound II for preparing such mixtures, and also to compositions comprising such mixtures, wherein such methods relate to soil application. Herein, we have found that simultaneous, that is joint or separate, application of the compound I and the compound II or successive application of the compound I and compound II provides enhanced plant health effects compared to the plant health effects that are possible with the individual compounds (synergistic mixtures).
Thus, the present invention relates to inventive mixtures having synergistically enhanced action of increasing the health of plants.
Moreover, the invention relates to a method for improving the health of plants, using the inventive mixtures having synergistically enhanced action for improving the health of plants and to the use of compound I and compound II for preparing such mixtures, and also to compositions comprising such mixtures, wherein such methods relate to soil application.
In particular, the present invention relates to a method for protection of plant propagation material from pests and/or improving the health of plants grown from said plant propagation material, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount
of an inventive mixture.
In particular, the present invention relates to a method for protection of plant propagation material from pests, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
In particular, the present invention relates to a method for protection of plant propagation material from harmful fungi, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
In particular, the present invention relates to a method for protection of plant propagation material from animal pests (insects, acarids or nematodes), wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture. In particular, the present invention relates to a method for improving the health of plants grown from plant propagation material, wherein the soil, wherein plant propagation material is sown, is treated with an effective amount of an inventive mixture.
In all methods as described above, the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession.
The term "plant propagation material" is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring. In a particular preferred embodiment, the term propagation material denotes seeds.
In general, "pesticidally effective amount" means the amount of the inventive mixtures or of compositions comprising the mixtures needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The pesticidally effective amount can vary for the various mixtures / compositions used in the invention. A pesticidally effective amount of the mixtures / compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like. The term "plant health effective amount" denotes an amount of the inventive mixtures, which is sufficient for achieving plant health effects as defined herein below. More exemplary information about amounts, ways of application and suitable ratios to be used is given below. Anyway, the skilled artisan is well aware of the fact that such an amount can vary in a broad range and is
dependent on various factors, e.g. the treated cultivated plant or material and the climatic conditions.
Healthier plants are desirable since they result among others in better yields and/or a better quality of the plants or crops, specifically better quality of the harvested plant parts. Healthier plants also better resist to biotic and/or abiotic stress. A high resistance against biotic stresses in turn allows the person skilled in the art to reduce the quantity of pesticides applied and consequently to slow down the development of resistances against the respective pesticides. It was therefore an object of the present invention to provide a pesticidal composition which solves the problems outlined above, and which should, in particular, improve the health of plants, in particular the yield of plants.
The term "health of a plant" or "plant health" is defined as a condition of the plant and/or its products which is determined by several aspects alone or in combination with each other such as increased yield, plant vigor, quality of harvested plant parts and tolerance to abiotic and/or biotic stress.
It has to be emphasized that the above mentioned effects of the inventive mixtures, i.e. en- hanced health of the plant, are also present when the plant is not under biotic stress and in particular when the plant is not under pest pressure.
For example, for soil applications, it is evident that a plant suffering from fungal or insecticidal attack shows reduced germination and emergence leading to poorer plant or crop establishment and vigor, and consequently, to a reduced yield as compared to a plant propagation material which has been subjected to curative or preventive treatment against the relevant pest and which can grow without the damage caused by the biotic stress factor. However, the methods according to the invention lead to an enhanced plant health even in the absence of any biotic stress. This means that the positive effects of the mixtures of the invention cannot be explained just by the pesticidal activities of the compounds (I) and (II), but are based on further activity profiles. Accordingly, the application of the inventive mixtures can also be carried out in the absence of pest pressure.
Each plant health indicator listed below, which is selected from the groups consisting of yield, plant vigor, quality and tolerance of the plant to abiotic and/or biotic stress, is to be understood as a preferred embodiment of the present invention either each on its own or preferably in combination with each other.
According to the present invention, "increased yield" of a plant means that the yield of a product of the respective plant is increased by a measurable amount over the yield of the same product of the plant produced under the same conditions, but without the application of the inventive mixture.
For soil application forms, increased yield can be characterized, among others, by the following improved properties of the plant:
increased plant weight; and/or increased plant height; and/or increased biomass such as higher overall fresh weight (FW); and/or increased number of flowers per plant; and/or higher grain and/or fruit yield ; and/or more tillers or side shoots (branches); and/or larger leaves; and/or increased shoot growth; and/or increased protein content; and/or increased oil content; and/or increased starch content; and/or increased pigment content; and/or increased chlorophyll content (chlorophyll content has a positive correlation with the plant's photosynthesis rate and accordingly, the higher the chlorophyll content the higher the yield of a plant), increased quality of a plant.
"Grain" and "fruit" are to be understood as any plant product which is further utilized after harvesting, e.g. fruits in the proper sense, vegetables, nuts, grains, seeds, wood (e.g. in the case of silviculture plants), flowers (e.g. in the case of gardening plants, ornamentals) etc., that is any- thing of economic value that is produced by the plant.
According to the present invention, the yield is increased by at least 4%. In general, the yield increase may even be higher, for example 5 to 10 %, more preferable by 10 to 20 %, or even 20 to 30 %
According to the present invention, the yield - if measured in the absence of pest pressure - is increased by at least 2 % In general, the yield increase may even be higher, for example until 4%-5% or even more.
Another indicator for the condition of the plant is the plant vigor. The plant vigor becomes mani- fest in several aspects such as the general visual appearance.
For soil treatment applications, improved plant vigor can be characterized, among others, by the following improved properties of the plant: improved vitality of the plant; and/or improved plant growth; and/or improved plant development; and/or improved visual appearance; and/or im- proved plant stand (less plant verse/lodging); and/or improved emergence; and/or enhanced root growth and/or more developed root system; and/or enhanced nodulation, in particular rhi- zobial nodulation;-and/or increased plant height; and/or increased tiller number; and/or increased number of side shoots; and/or increased number of flowers per plant; and/or increased shoot growth;-and/or less non-productive tillersand/or less input needed (such as fertilizers or water); and/or less seeds neededf and/or stronger and/or more productive tillersand/or improved quality of seeds (for being seeded in the following seasons for seed production);-and/or field establishment.
Another indicator for the condition of the plant is the "quality" of a plant and/or its products. Ac- cording to the present invention, enhanced quality means that certain plant characteristics such as the content or composition of certain ingredients are increased or improved by a measurable or noticeable amount over the same factor of the plant produced under the same conditions, but without the application of the mixtures of the present invention. Enhanced quality can be char-
acterized, among others, by following improved properties of the plant or its product: increased nutrient content; and/or increased protein content; and/or increased oil content; and/or increased starch content; and/or increased content of fatty acids; and/or increased metabolite content; and/or increased carotenoid content; and/or increased sugar content; and/or increased amount of essential amino acids; and/or improved nutrient composition; and/or improved protein composition; and/or improved composition of fatty acids; and/or improved metabolite composition; and/or improved carotenoid composition; and/or improved sugar composition; and/or improved amino acids composition ; and/or improved or optimal fruit color; and/or improved leaf color; and/or higher storage capacity; and/or better processability of the harvested products.
Another indicator for the condition of the plant is the plant's tolerance or resistance to biotic and/or abiotic stress factors. Biotic and abiotic stress, especially over longer terms, can have harmful effects on plants. Biotic stress is caused by living organisms while abiotic stress is caused for example by environmental extremes. According to the present invention, "enhanced tolerance or resistance to biotic and/or abiotic stress factors" means (1 .) that certain negative factors caused by biotic and/or abiotic stress are diminished in a measurable or noticeable amount as compared to plants exposed to the same conditions, but without being treated with an inventive mixture and (2.) that the negative effects are not diminished by a direct action of the inventive mixture on the stress factors, e.g. by its fungicidal or insecticidal action which directly destroys the microorganisms or pests, but rather by a stimulation of the plants' own defensive reactions against said stress factors. Negative factors caused by biotic stress such as pathogens and pests are widely known and are caused by living organisms, such as competing plants (for example weeds), microorganisms (such as phythopathogenic fungi and/or bacteria) and/or viruses.
Negative factors caused by abiotic stress are also well-known and can often be observed as reduced plant vigor (see above), for example:
less yield and/or less vigor, for both effects examples can be burned leaves, less flowers, premature ripening, later crop maturity, reduced nutritional value amongst others.
Abiotic stress can be caused for example by: extremes in temperature such as heat or cold (heat stress / cold stress); and/or strong variations in temperature; and/or temperatures unusual for the specific season; and/or drought (drought stress); and/or extreme wetness; and/or high salinity (salt stress); and/or radiation (for example by increased UV radiation due to the decreasing ozone layer); and/or increased ozone levels (ozone stress); and/or organic pollution (for example by phythotoxic amounts of pesticides); and/or inorganic pollution (for example by heavy metal contaminants).
As a result of biotic and/or abiotic stress factors, the quantity and the quality of the stressed plantsrdecrease. As far as quality (as defined above) is concerned, reproductive development
is usually severely affected with consequences on the crops which are important for fruits or seeds. Synthesis, accumulation and storage of proteins are mostly affected by temperature; growth is slowed by almost all types of stress; polysaccharide synthesis, both structural and storage is reduced or modified: these effects result in a decrease in biomass (yield) and in changes in the nutritional value of the product.
As pointed out above, the above identified indicators for the health condition of a plant may be interdependent and may result from each other. For example, an increased resistance to biotic and/or abiotic stress may lead to a better plant vigor, e.g. to better and bigger crops, and thus to an increased yield. Inversely, a more developed root system may result in an increased resistance to biotic and/or abiotic stress. However, these interdependencies and interactions are neither all known nor fully understood and therefore the different indicators are described separately. In one embodiment the inventive mixtures effectuate an increased yield of a plant or its product.
In another embodiment the inventive mixtures effectuate an increased vigor of a plant or its product. In another embodiment the inventive mixtures effectuate in an increased quality of a plant or its product.
In yet another embodiment the inventive mixtures effectuate an increased tolerance and/or resistance of a plant or its product against biotic stress.
In yet another embodiment the inventive mixtures effectuate an increased tolerance and/or resistance of a plant or its product against abiotic stress.
In a preferred embodiment of the invention, the inventive mixtures effect an increase in the yield.
In another preferred embodiment of the invention, the inventive mixtures effect an improvement of the plant vigor. In another preferred embodiment of the invention, the plant health effects of the inventive mixtures effect increased resistance of plant against biotic stress.
In another preferred embodiment of the invention, the plant health effects of the inventive mixtures effect increased resistance of plant against abiotic stress.
In a more preferred embodiment of the invention, the inventive mixtures effect an increase in the yield.
In a more preferred embodiment of the invention, the inventive mixtures effect an increase in the vigor.
The mass ratio of any two ingredients in each combination is selected to give the desired, for example, synergistic action. In general, the mass ratio would vary depending on the specific compound I. Generally, the ratio by weight between any two ingredients in any combination of the present invention (compound I: compound II / compound ll:lll) [in the ternary mixtures ratios between any of the compounds I, II and III or compounds I, II and IV, or compounds I, III and IV or in the quaternary mixtures the ratios between any of the compounds I, II, III and IV], inde- pendently of one another, is from 1000:1 to 1 :1000, preferably from 500:1 to 1 :500, more preferably the ratios from 100:1 to 1 :100 (for example ratios from 99:1 , 98:2, 97:3, 96:4, 95:5, 94:6, 93:7, 92:8, 91 :9, 90:10, 89:1 1 , 88:12, 87:13, 86:14, 85:15, 84:16, 83:17, 82:18, 81 :19, 80:20, 79:21 , 78:22, 77:23, 76:24, 75:25, 74:26, 73:27, 72:28, 71 :29, 70:30, 69:31 , 68:32, 67:33, 66:34, 65:45, 64:46, 63:47, 62:48, 61 :49, 60:40, 59:41 , 58:42, 57:43, 56:44, 55:45, 54:46, 53:47, 52:48, 51 :49, 50:50, 49:51 , 48:52, 47:53, 46:54, 45:55, 44:56, 43:57, 42:58, 41 :59, 40:60, 39:61 , 38:62, 37:63, 36:64, 35:65, 34:66, 33:67, 32:68, 31 :69, 30:70, 29:71 , 28:72, 27:73, 26:74, 25:75, 24:76, 23:77, 22:78, 21 :79, 20:80, 19:81 , 18:82, 17:83, 16:84, 15:85, 14:86, 13:87, 12:88, 1 1 :89, 10:90, 9:91 , 8:92, 7:93, 6:94, 5:95, 4:96, 3:97, 2:98, to 1 :99). Herein, preferred mass ratios are those between any two components of present invention are from 75:1 to 1 :75, more preferably, 50:1 to 1.50, especially 25:1 to 1 :25, advantageously 10:1 to 1 :10, such as 5:1 to 1 :5.
These ratios are suitable for inventive mixtures applied by soil treatment. For compound II, all of these ratios refer to a preparation with at least 106 CFU/g ("colony forming units per gram").
Herein, compound II may be supplied in any physiological state such as active or dormant. Dormant compound II may be supplied for example frozen, dried, or lyophilized or partly desiccated (procedures to produce these partly desiccated organisms are given in WO2008/002371 ) or for compound II in form of spores.
Organisms in an active state can be delivered in a growth medium without any additional additives or materials or in combination with suitable nutrient mixtures.
However, the compound II is preferably delivered and formulated in a dormant stage. In the case of mixtures comprising a further microorganism e.g. from class L), the microorganisms as used according to the invention can be cultivated continuously or discontinuously in the batch process or in the fed batch or repeated fed batch process. A review of known methods of cultivation will be found in the textbook by Chmiel (Bioprozesstechnik 1 . Einfuhrung in die Bioverfahrenstechnik (Gustav Fischer Verlag, Stuttgart, 1991 )) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)). The culture medium that is to be used must satisfy the requirements of the particular strains in an appropriate manner. Descriptions of culture media for various microorganisms are given in the handbook "Manual of Methods for General Bacteriology" of the American Society for Bacte-
riology (Washington D. C, USA, 1981 ). These culture media that can be used according to the invention generally comprise one or more sources of carbon, sources of nitrogen, inorganic salts, vitamins and/or trace elements. Preferred sources of carbon are sugars, such as mono-, di- or polysaccharides. Very good sources of carbon are for example glucose, fructose, man- nose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch or cellulose. Sugars can also be added to the media via complex compounds, such as molasses, or other by-products from sugar refining. It may also be advantageous to add mixtures of various sources of carbon. Other possible sources of carbon are oils and fats such as soybean oil, sunflower oil, peanut oil and coconut oil, fatty acids such as palmitic acid, stearic acid or linoleic acid, alcohols such as glycerol, methanol or ethanol and organic acids such as acetic acid or lactic acid. Sources of nitrogen are usually organic or inorganic nitrogen compounds or materials containing these compounds. Examples of sources of nitrogen include ammonia gas or ammonium salts, such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates, urea, amino acids or complex sources of ni- trogen, such as corn-steep liquor, soybean flour, soybean protein, yeast extract, meat extract and others. The sources of nitrogen can be used separately or as a mixture. Inorganic salt compounds that may be present in the media comprise the chloride, phosphate or sulfate salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron. Inorganic sulfur-containing compounds, for example sulfates, sulfites, dithionites, tetrathi- onates, thiosulfates, sulfides, but also organic sulfur compounds, such as mercaptans and thiols, can be used as sources of sulfur. Phosphoric acid, potassium dihydrogenphosphate or dipotassium hydrogenphosphate or the corresponding sodium-containing salts can be used as sources of phosphorus. Chelating agents can be added to the medium, in order to keep the metal ions in solution. Especially suitable chelating agents comprise dihydroxyphenols, such as catechol or protocatechuate, or organic acids, such as citric acid. The culture media used may also contain other growth factors, such as vitamins or growth promoters, which include for example biotin, riboflavin, thiamine, folic acid, nicotinic acid, pantothenate and pyridoxine. Growth factors and salts often come from complex components of the media, such as yeast extract, molasses, corn-steep liquor and the like. In addition, suitable precursors can be added to the culture medium. The precise composition of the compounds in the medium is strongly dependent on the particular experiment and must be decided individually for each specific case. Information on media optimization can be found in the textbook "Applied Microbiol. Physiology, A Practical Approach" (Publ. P.M. Rhodes, P.F. Stanbury, IRL Press (1997) p. 53-73, ISBN 0 19 963577 3). Growing media can also be obtained from commercial suppliers, such as Standard 1 (Merck) or BHI (Brain heart infusion, DIFCO) etc. All components of the medium are sterilized, either by heating (20 min at 2.0 bar and 121 °C) or by sterile filtration. The components can be sterilized either together, or if necessary separately. All the components of the medium can be present at the start of growing, or optionally can be added continuously or by batch feed. The temperature of the culture of the respective microorganism is normally between 15°C and 45°C, preferably 25°C to 40°C and can be kept constant or can be varied during the experiment. The pH value of the medium should be in the range from 5 to 8.5, preferably around 7.0. The pH value for growing can be controlled during growing by adding basic compounds such as sodium hydroxide, potassium hydroxide, ammonia or ammonia water or acid compounds such as phos-
phoric acid or sulfuric acid. Antifoaming agents, e.g. fatty acid polyglycol esters, can be used for controlling foaming. To maintain the stability of plasmids, suitable substances with selective action, e.g. antibiotics, can be added to the medium. Oxygen or oxygen-containing gas mixtures, e.g. the ambient air, are fed into the culture in order to maintain aerobic conditions. The temperature of the culture is normally from 20°C to 45°C. Culture is continued until a maximum of the desired product has formed. This is normally achieved within 10 hours to 160 hours. To obtain cell-free extracts, the cells can be disrupted optionally by high-frequency ultrasound, by high pressure, e.g. in a French pressure cell, by osmolysis, by the action of detergents, lytic enzymes or organic solvents, by means of homogenizers or by a combination of several of the methods listed. The methodology of the present invention can further include a step of recovering individual compositions such as cell-free extracts, supernatants, metabolites or alike. The term "recovering" includes extracting, harvesting, isolating or purifying of an extract, supernatant or metabolite e.g. from whole culture broth. Recovering can be performed according to any conventional isolation or purification methodology known in the art including, but not limited to, treatment with a conventional resin (e.g., anion or cation exchange resin, non-ionic adsorption resin, etc.), treatment with a conventional adsorbent (e.g., activated charcoal, silicic acid, silica gel, cellulose, alumina, etc.), alteration of pH, solvent extraction (e.g., with a conventional solvent such as an alcohol, ethyl acetate, hexane and the like), distillation, dialysis, filtration, concentration, crystallization, recrystallization, pH adjustment, lyophilization and the like. For exam- pie the agent can be recovered from culture media by first removing the microorganisms. The remaining broth is then passed through or over a cation exchange resin to remove unwanted cations and then through or over an anion exchange resin to remove unwanted inorganic anions and organic acids. Preferred inventive mixtures are those comprising compound II and fungicidal compound I A selected from the group consisting of
A) Respiration inhibitors
Inhibitors of complex III at Qo site: coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester, 2-(2-(3-(2,6-di- chlorophenyl)-1 -methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acet- amide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;
inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl- 3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine- 2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl]-2-methylpropanoate, [(3S,6S,7R,8R)- 8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo- 1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1 ,3-benzodioxol-5-yl- methoxy)-4-methoxy-pyridine-2-car-bonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl- 4,9-dioxo-8-(phenylmethyl)-1 ,5-dioxonan-7-yl-2-methylpropanoate;
inhibitors of complex II: bixafen, boscalid, carboxin, fluopyram, flutolanil, fluxapyroxad,
isopyrazam, penflufen, penthiopyrad, sedaxane, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-di- fluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-di- methyl-5-fluoro-1 H-pyrazole-4-carboxamide, benzovindiflupyr, 3-(difluoromethyl)-1 -methyl- N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 -methyl-N-(1 ,1 ,3-tri- methylindan-4-yl)pyrazole-4-carboxamide, 1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-
4- carboxamide, 3-(trifluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-car- boxamide, 3-(difluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide;
other respiration inhibitors: (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethyl- pyridin-2-yloxy)-phenyl]-ethyl}-amine, fluazinam; ametoctradin; and silthiofam;
B) Sterol biosynthesis inhibitors (SBI fungicides)
C14 demethylase inhibitors (DMI fungicides): bitertanol, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fluquinconazole, flusilazole, flutriafol, ipconazole, metconazole, myclobutanil, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadi- menol, triticonazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-
5- thiocyanato-1 H-[1 ,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxira- nylmethyl]-2H[1 ,2,4]triazole-3-thiol, imazalil, pefurazoate, prochloraz;
Delta14-reductase inhibitors: fenpropimorph, spiroxamine;
C) Nucleic acid synthesis inhibitors
- phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, oxadixyl;
others: hymexazole, oxolinic acid, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro- 2-(4-fluorophenylmethoxy)pyrimidin-4-amine;
D) Inhibitors of cell division and cytoskeleton
- tubulin inhibitors, such as benzimidazoles, thiophanates: fuberidazole, thiabendazole, thiophanate-methyl;
other cell division inhibitors:, ethaboxam, pencycuron, metrafenone;
E) Inhibitors of amino acid and protein synthesis
methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, pyrimethanil;
F) Signal transduction inhibitors: iprodione, fludioxonil;
G) Lipid and membrane synthesis inhibitors
Phospholipid biosynthesis inhibitors: iprobenfos;
lipid peroxidation: quintozene, tolclofos-methyl, etridiazole;
phospholipid biosynthesis and cell wall deposition: dimethomorph, mandipropamid, N-(1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;
compounds affecting cell membrane permeability and fatty acides: propamocarb, pro- pamocarb-hydrochloride;
H) Inhibitors with Multi Site Action
inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
thio- and dithiocarbamates: ferbam, maneb, metiram, thiram;
organochlorine compounds (e.g. phthalimides, sulfamides, chloronitriles): chlorothalonil, captan, folpet;
guanidines and others: guanidine, dodine, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1 H,5H- [1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;
J) Plant defence inducers
- acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium, 4-cyclopropyl- N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide, fosetyl, fosetyl-aluminum;
K) Unknown mode of action: cymoxanil, flusulfamide, oxine-copper, tecloftalam, triazoxide,
2- (4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide, 4,4-difluoro-3,3-dimethyl-1 -(3-quinolyl)isoquinoline, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetam- ide, 2-methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methyl- phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-
3- yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1 -(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole;
L) Antifungal biological Control Agents:
Ampelomyces quisqualis (e.g. AQ 10® from Intrachem Bio GmbH & Co. KG, Germany), Aspergillus flavus (e.g. AFLAGUARD® from Syngenta, CH), Aureobasidium pullulans (e.g. BO- T ECTOR® from bio-ferm GmbH, Germany), Bacillus pumilus (e.g. NRRL B-30087 in SONATA® and BALLAD® Plus from AgraQuest Inc., USA), Bacillus subtilis (e.g. isolate NRRL B-21661 in RHAPSODY®, SERENADE® MAX and SERENADE® ASO from AgraQuest Inc., USA), Bacillus subtilis var. amyloliquefaciens FZB24 (e.g. TAEGRO® from Novozyme Biologi- cals, Inc., USA), Candida oleophila I-82 (e.g. ASPIRE® from Ecogen Inc., USA), Candida sai- toana (e.g. BIOCURE® (in mixture with lysozyme) and BIO-COAT® from Micro Flo Company, USA (BASF SE) and Arysta), Chitosan (e.g. ARMOUR-ZEN from BotriZen Ltd., NZ), Clonosta- chys rosea f. catenulata, also named Gliocladium catenulatum (e.g. isolate J 1446: PRESTOP® from Verdera, Finland), Coniothyrium minitans (e.g. CONTANS® from Prophyta, Germany), Cryphonectria parasitica (e.g. Endothia parasitica from CNICM, France), Cryptococcus albidus (e.g. YIELD PLUS® from Anchor Bio-Technologies, South Africa), Fusarium oxysporum (e.g. BIOFOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France),
Metschnikowia fructicola (e.g. SHEMER® from Agrogreen, Israel), Microdochium dimerum (e.g. ANTIBOT® from Agrauxine, France), Phlebiopsis gigantea (e.g. ROTSOP® from Verdera, Finland), Pseudozyma flocculosa (e.g. SPORODEX® from Plant Products Co. Ltd., Canada), Pythium oligandrum DV74 (e.g. POLYVERSUM® from Remeslo SSRO, Biopreparaty, Czech Rep.), Reynoutria sachlinensis (e.g. REGALIA® from Marrone Biolnnovations, USA), Talaromy- ces flavus V1 17b (e.g. PROTUS® from Prophyta, Germany), Trichoderma asperellum SKT-1 (e.g. ECO-HOPE® from Kumiai Chemical Industry Co., Ltd., Japan), T. atroviride LC52 (e.g. SENTINEL® from Agrimm Technologies Ltd, NZ), T. harzianum T-22 (e.g. PLANTSHIELD® der Firma BioWorks Inc., USA), T. harzianum TH 35 (e.g. ROOT PRO® from Mycontrol Ltd., Israel), T. harzianum T-39 (e.g. TRICHODEX® and TRICHODERMA 2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel), T. harzianum and T. viride (e.g. TRICHOPEL from Agrimm Technologies Ltd, NZ), T. harzianum ICC012 and T. viride ICC080 (e.g. REMEDIER® WP from Isa- gro Ricerca, Italy), T. polysporum and T. harzianum (e.g. BINAB® from BINAB Bio-Innovation AB, Sweden), T. stromaticum (e.g. TRICOVAB® from C.E.P.L.A.C., Brazil), T. virens GL-21
(e.g. SOILGARD® from Certis LLC, USA), T. viride (e.g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO-CURE® F from T. Stanes & Co. Ltd., Indien), T. viride TV1 (e.g. T. viride TV1 from Agribiotec srl, Italy), Ulocladium oudemansii HRU3 (e.g. BOTRY-ZEN® from Botry- Zen Ltd, NZ).
Preferred inventive mixtures especially useful for soil treatment are those comprising compound II and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl, Fludioxonil, Oryzastro- bin, Boscalid, Penthiopyrad, Iprodione, Dimethomorph and Mandipropamid; more preferably selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl and Fludioxonil.
Equally preferred inventive mixtures are those comprising compound II and insecticidal compound IA selected from the group consisting of
M-1 .A acetylcholine esterase inhibitors from the class of carbamates: aldicarb, benfuracarb, carbofuran, carbosulfan, isoprocarb, methiocarb, methomyl, oxamyl, pirimicarb, thiodicarb, triazamate;
M-1 .B acetylcholine esterase inhibitors from the class of organophosphates: acephate, cadu- safos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, diazinon, dichlorvos/ DDVP, dimethoate, disulfoton, ethoprophos, fenamiphos, fenitrothion, fosthiazate, imicyafos, isofenphos, isoxathion, methamidophos, phorate, phoxim, pirimiphos- methyl, profenofos, tebupirimfos, terbufos;
M-2 GABA-gated chloride channel antagonists:
M-2.B fiproles (phenylpyrazoles): ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
M-2. Others: 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]- N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1 -carboxamide, 4-[5-(3,5-dichloro- phenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)- ethyl]benzamide;
M-3 sodium channel modulators from the class of pyrethroids: bifenthrin, cyfluthrin, beta-cyflu- thrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenvalerate, flucythrinate, permethrin, silafluofen, tefluthrin;
M-4 nicotinic acteylcholine receptor agonists from the class of neonicotinoids: acetamiprid, chlo- thianidin, cycloxaprid, dinotefuran, flupyradifurone, imidacloprid, nitenpyram, sulfoxaflor, thia- cloprid, thiamethoxam, 1 -[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5,6,7-tetra- hydro-2H-imidazo[1 ,2-a]pyridine;
M-5 allosteric nicotinic acteylcholine receptor activators from the class of spinosyns: spinosad, spinetoram;
M-6 chloride channel activators from the class of mectins: abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
M-9 selective homopteran feeding blockers: pymetrozine, pyrifluquinazon, 2-(5-fluoro-3-pyridyl)- 5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride;
M-12 uncouplers of oxidative phosphorylation: chlorfenapyr;
M-13 nicotinic acetylcholine receptor channel blockers: cartap hydrochloride;
M-14 inhibitors of the chitin biosynthesis type 0 (benzoylurea class): diflubenzuron, flufenox- uron, lufenuron, novaluron, teflubenzuron;
M-15 inhibitors of the chitin biosynthesis type 1 : buprofezin;
M-17 Ecdyson receptor agonists: methoxyfenozide;
M-20 Mitochondrial complex I electron transport inhibitors: tebufenpyrad;
M-21 Voltage-dependent sodium channel blockers: indoxacarb or metaflumizone;
M-22 Inhibitors of the lipid synthesis, inhibitors of acetyl CoA carboxylase: spirodiclofen, spiro- tetramat;
M-24 Ryanodine receptor-modulators from the class of diamides: flubendiamide,
chlorantraniliprole, cyantraniliprole, (R)-3-chloro-N1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoro- methyl)ethyl]phenyl}-N2-(1 -methyl-2-methylsulfonylethyl)phthalamide, (S)-3-chloro-N1 -{2- methyl-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2-methylsulfonyl- ethyl)phthalamide, 3-bromo-N-{2-bromo-4-chloro-6-[(1 -cyclopropylethyl)carbamoyl]phenyl}-1 -(3- chloropyridin-2-yl)-1 H-pyrazole-5-carboxamide, methyl-2-[3,5-dibromo-2-({[3-bromo-1 -(3-chlo- ropyridin-2-yl)-1 H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1 ,2-dimethylhydrazinecarboxylate,
N2-[2-(3-chloro-2-pyridyl)-5-[(5-methyltetrazol-2-yl)methyl]pyrazol-3-yl]-5-cyano-N1 ,3-dimethyl- phthalamide;
M-25 Others: afidopyropen, flumetoquin, 2-(5-ethylsulfinyl-2-fluoro-4-methyl-phenyl)-5-methyl- 1 ,2,4-triazol-3-amine, 1 -(5-ethylsulfinyl-2,4-dimethyl-phenyl)-3-methyl-1 ,2,4-triazole, metalde- hyde;
M-26: Bacillus firmus (e.g. Bacillus firmus CNCM 1-1582).
More preferred inventive mixtures are those comprising compound II and fungicidal compound IA displayed in Table 1A: In Table 1A, the following abbreviations are used:
Bacillus subtilis MBI600 having the accession number NRRL B-50595 = A
IA = Compound IA II = Compound II
No IA II No IA II
M-1 . azoxystrobin A nyl)amino]-6-methyl-
M-2. dimoxystrobin A 4,9-dioxo-1 ,5-di-
M-3. fluoxastrobin A oxonan-7-yl]
M-4. kresoxim-methyl A 2-methylpropanoate
M-5. orysastrobin A M-13. [(3S,6S,7R,8R)-8- A
M-6. picoxystrobin A benzyl-3-[[3-(acet-
M-7. pyraclostrobin A oxymethoxy)-4-
M-8. trifloxystrobin A methoxy-pyridine-
M-9. pyribencarb A 2-carbonyl]amino]-6-
M-10. cyazofamid A methyl-4,9-dioxo-
M-1 1 . amisulbrom A 1 ,5-dioxonan-7-yl]
S,7R,8R)-8- A 2-methylpropanoate
M-12. [(3S,6
benzyl-3-[(3-ace- M-14. [(3S,6S,7R,8R)-8- A toxy-4-methoxy- benzyl-3-[(3-isobut- pyridine-2-carbo- oxycarbonyloxy-4-
No IA II No IA II methoxy-pyridine- M-29. 3-(difluoromethyl)-1 - A
2-carbonyl)amino]-6- methyl-N-(1 ,1 ,3-tri- methyl-4,9-dioxo- methylindan-4-yl)-
1 ,5-dioxonan-7-yl] 2- pyrazole-4-carbox- methylpropanoate amide
M-15. [(3S,6S,7R,8R)-8- A M-30. 3-(trifluoromethyl)-1 - A benzyl-3-[[3-(1 ,3- methyl-N-(1 ,1 ,3-tri- benzodioxol-5- methylindan-4-yl)- ylmethoxy)-4-meth- pyrazole-4-carbox- oxy-pyridine-2-car- amide
bonyl]amino]-6- M-31 . 1 ,3-dimethyl-N- A methyl-4,9-dioxo- (1 ,1 ,3-trimethyl-
1 ,5-dioxonan-7-yl] 2- indan-4-yl)pyrazole- methylpropanoate; 4-carboxamide
M-16. (3S,6S,7R,8R)-3- A M-32. 3- (trifluoromethyl)- A
[[(3-hydroxy-4-meth- 1 ,5-dimethyl-N- oxy-2-pyridinyl)- (1 ,1 ,3-trimethyl- carbonyl]amino]- indan-4-yl)pyrazole-
6-methyl-4,9-dioxo- 4- carboxamide
8-(phenylmethyl)- M-33. 3- (difluoromethyl)- A
1 ,5-dioxonan-7-yl 1 ,5-dimethyl-N-
2-methylpropanoate (1 ,1 ,3-trimethyl-
M-17. bixafen A indan-4-yl)pyrazole-
M-18. boscalid A 4- carboxamide
M-19. carboxin A M-34. 1 ,3,5-trimethyl-N- A
M-20. fluopyram A (1 ,1 ,3-trimethyl-
M-21 . fluxapyroxad A indan-4-yl)pyrazole-
M-22. isopyrazam A 4-carboxamide
M-23. penflufen A M-35. (5,8-difluoroquinazo- A
M-24. penthiopyrad A lin-4-yl)-{2-[2-fluoro-
M-25. sedaxane A 4-(4-trifluoromethyl-
M-26. N-(4'-trifluoromethyl- A pyridin-2-yloxy)- thiobiphenyl-2-yl)- phenyl]-ethyl}-amine
3- difluoromethyl-1 - M-36. ametoctradin A methyl-1 H-pyrazole- M-37. silthiofam A
4- carboxamide M-38. cyproconazole A
M-27. N-(2-(1 ,3,3-trimethyl- A M-39. difenoconazole A butyl)-phenyl)-1 ,3- M-40. diniconazole A dimethyl-5-fluoro- M-41 . diniconazole-M A 1 H-pyrazole- M-42. epoxiconazole A 4-carboxamide M-43. fluquinconazole A
M-28. benzovinidlupyr A M-44. ipconazole A
No IA II No IA II
M-45. metconazole A M-73. quintozene A
M-46. propiconazole A M-74. tolclofos-methyl A
M-47. prothioconazole A M-75. dimethomorph A
M-48. tebuconazole A M-76. flumorph A
M-49. triadimenol A M-77. mandipropamid A
M-50. triticonazole, A M-78. N-(1 -(1 -(4-cyano- A
M-51 . 1 -[re/-(2S;3R)-3-(2- A phenyl)ethane- chlorophenyl)-2-(2,4- sulfonyl)-but-2-yl) difluorophenyl)- carbamic acid-(4- oxiranylmethyl]- fluorophenyl) ester
5-thiocyanato-1 H- M-79. propamocarb A
[1 ,2,4]triazole M-80. propamocarb hydroA
M-52. 2-[re/-(2S;3R)-3-(2- A chloride
chlorophenyl)-2-(2,4- M-81 . mancozeb A difluorophenyl)- M-82. maneb A oxiranylmethyl]- M-83. metiram A
2H-[1 ,2,4]triazole-3- M-84. thiram A thiol M-85. chlorothalonil A
M-53. prochloraz A M-86. captan A
M-54. fenpropimorph A M-87. dithianon A
M-55. benalaxyl A M-88. 2,6-dimethyl-1 H,5H- A
M-56. benalaxyl-M A [1 ,4]dithiino[2,3-
M-57. kiralaxyl A c:5,6-c']dipyrrole-
M-58. metalaxyl A 1 ,3,5,7(2H,6H)-
M-59. oxadixyl A tetraone
M-60. 5-fluoro-2-(p-tolyl- A M-89. validamycin A methoxy)pyrimidin- M-90. isotianil A
4-amine M-91 . tiadinil A
M-61 . 5-fluoro-2-(4-fluoro- A M-92. prohexadione- A phenylmethoxy)- calcium
pyrimidiri-4-amine M-93. 4-cyclopropyl-N- A
M-62. hymexazole A (2,4-dimethoxyphen-
M-63. carbendazim A yl)thiadiazole-5-car-
M-64. thiabendazole A boxamide
M-65. thiophanate-methyl A M-94. triazoxide A
M-66. ethaboxam A M-95. 2-(4-chloro-phenyl)- A
M-67. metrafenone, A N-[4-(3,4-dimethoxy-
M-68. cyprodinil A phenyl)-isoxazol-5-
M-69. pyrimethanil A yl]-2-prop-2-ynyloxy-
M-70. fludioxonil A acetamide
M-71 . iprodione A M-96. 4,4-difluoro-3,3-di- A
M-72. iprobenfos A methyl-1 -(3-quinol-
No IA II No IA II yl)isoquinoline No. B-30087
M-97. 2- butoxy-6-iodo- A M-1 10. Bacillus subtilis A
3- propylchromen- M-1 1 1 . Bacillus subtilis A
4- one NRRL-Nr. B-21661
M-98. N-(cyclopropylmeth- A M-1 12. Bacillus subtilis var. A oxyimino-(6-difluoro- amylolique-faciens methoxy-2,3-di- FZB24
fluoro-phenyl)- M-1 13. Candida oleophila I- A methyl)-2-phenyl 82
acetamide M-1 14. Candida saitoana A
M-99. 2-methoxy-acetic A M-1 15. Chitosan A acid 6-tert-butyl-8- M-1 16. Clonostachys rosea A fluoro-2,3-dimethyl- f. catenulate
quinolin-4-yl ester M-1 17. Clonostachys rosea A
M-100. 3-[5-(4- A f. catenulate isolate methylphenyl)-2,3- J 1446
dimethyl- M-1 18. Coniothyrium mini- A isoxazolidin-3-yl]- tans
pyridine M-1 19. Cryphonectria paraA
M-101 . 3-[5-(4-chloro- A sitica
phenyl)-2,3- M-120. Endothia parasitica A dimethyl- M-121 . Cryptococcus albi- A isoxazolidin-3-yl]- dus
pyridine (pyrisoxa- M-122. Fusarium ox- A zole) ysporum
M-102. N-(6-methoxy- A M-123. FUSACLEAN® A pyridin-3-yl) cyclo- M-124. Metschnikowia fruc- A propanecarboxylic ticola
acid amide
M-125. Microdochium dime- A
M-103. 5-chloro-1 -(4,6-di- A rum
methoxy-pyrimidin-
M-126. Phlebiopsis gig an tea A 2-yl)-2-methyl-1 H-
M-127. Pseudozyma floccu- A benzoimidazole.
losa
M-104. flutolanil A
M-128. Pythium oligandrum A
M-105. Ampelomyces A DV74
quisqualis
M-129. Reynoutria sach- A
M-106. Aspergillus flavus A
linensis
M-107. Aureobasidium pul- A
M-130. Talaromyces flavus A lulans
V1 17b
M-108. Bacillus pumilus A
M-131 . Trichoderma A
M-109. Bacillus pumilus A asperellum SKT-1
NRRL Accession
M-132. T. atroviride LC52 A
No IA II No IA II
M-133. T. harzianum T-22 A M-138. T. polysporum and A
M-134. T. harzianum TH 35 A T. harzianum
M-135. T. harzianum T-39 A M-139. T. stromaticum A
M-136. T. harzianum and T. A M-140. T. virens GL-21 A viride M-141 . T. viride A
M-137. T. harzianum A M-142. T. viride TV1 A
I CC012 and T. viride M-143. Ulocladium A
ICC080 oudemansii HRU3
Preferred inventive mixtures especially useful for soil treatment are those comprising compound I I and fungicidal compound IA selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl, Fludioxonil, Oryzastro- bin, Boscalid, Penthiopyrad, Iprodione, Dimethomorph and Mandipropamid, more preferably selected from Pyraclostrobin, Azoxystrobin, Trifloxystrobin, Picoxystrobin, Fluoxapyroxad, Fluopyram, Benzovindiflupyr, Metalaxyl and Fludioxonil.
Equally more preferred inventive mixtures are those comprising compound II and insecticidal compound I B displayed in Table 1 B:
In Table 1 B, the following abbreviations are used:
Bacillus subtilis MBI600 having the accession number NRRL B-50595
I B = Comopund I B I I = Compound I I
No IB II No IB II
M'-1 . aldicarb A M'-20. dimethoate A
M'-2. benfuracarb A M'-21 . disulfoton A
M'-3. carbofuran A M'-22. ethoprophos A
M'-4. carbosulfan A M'-23. fenamiphos A
M'-5. isoprocarb A M'-24. fosthiazate A
M'-6. methiocarb A M'-25. imicyafos A
M'-7. methomyl A M'-26. isofenphos A
M'-8. oxamyl A M'-27. isoxathion A
M'-9. pirimicarb A M'-28. methamidophos A
M'-10. thiodicarb A M'-29. phorate A
M'-1 1 . triazamate A M'-30. pirimiphos- methyl A
M'-12. acephate A M'-31 . tebupirimfos A
M'-13. cadusafos A M'-32. terbufos A
M'-14. chlorethoxyfos A M'-33. ethiprole A
M'-15. chlorfenvinphos A M'-34. fipronil A
M'-16. chlormephos A M'-35. pyri prole A
M'-17. chlorpyrifos A M'-36. 4-[5-[3-chloro-5-(tri- A
M'-18. chlorpyrifos-methyl A fluoromethyl)phe-
M'-19. dichlorvos/ DDVP A nyl]-5-(trifluorometh-
No IB II No IB II yl)-4H-isoxazol-3-yl]- M'-62. spinosad A
N-[2-oxo-2-(2,2,2-tri- M'-63. spinetoram A fluoroethyla- M'-64. abamectin A mino)ethyl]- M'-65. emamectin benzoate A naphthalene-1 -car- M'-66. 2-(5-fluoro-3-pyrid- A boxamide yl)-5-(6-pyrimidin-2-
M'-37. 4-[5-(3,5-dichloro- A yl-2-pyridyl)thiazole phenyl)-5-(trifluoro- hydrofluoride
methyl)-4H-isoxazol- M'-67. chlorfenapyr A
3-yl]-2-methyl-N-[2- M'-68. diflubenzuron A oxo-2-(2,2,2-triflu- M'-69. flufenoxuron A oroethylamino)eth- M'-70. novaluron A yl]benzamide M'-71 . teflubenzuron A
M'-38. bifenthrin A M'-72. tebufenpyrad
M'-39. cyfluthrin A M'-73. indoxacarb A
M'-40. beta-cyfluthrin A M'-74. metaflumizone A
M'-41 . lambda-cyhalothrin A M'-75. flubendiamide A
M'-42. cypermethrin A M'-76. chlorantraniliprole A
M'-43. alpha-cypermethrin A M'-77. cyantraniliprole A
M'-44. zeta-cypermethrin A M'-78. (R)-3-chloro-N 1 -{2- A
M'-45. deltamethrin A methyl-4-[1 ,2,2,2-te-
M'-46. fenvalerate A trafluoro-1 -(trifluoro-
M'-47. flucythrinate A methyl)ethyl]phenyl}-
M'-48. permethrin A N2-(1 -methyl-2-me-
M'-49. silafluofen A thylsulfonylethyl)-
M'-50. tefluthrin A phthalamide
M'-51 . acetamiprid A M'-79. (S)-3-chloro-N 1 -{2- A
M'-52. chlothianidin A methyl-4-[1 ,2,2,2-te-
M'-53. cycloxaprid A trafluoro-1 -(trifluoro-
M'-54. dinotefuran A methyl)ethyl]phenyl}-
M'-55. flupyradifurone A N2-(1 -methyl-2-me-
M'-56. imidacloprid A thylsulfonylethyl)-
M'-57. nitenpyram A phthalamide
M'-58. sulfoxaflor A M'-80. 3-bromo-N-{2- A
M'-59. thiacloprid A bromo-4-chloro-6-
M'-60. thiamethoxam A [(1 -cyclopropylethyl)
M'-61 . 1 -[(6-chloro-3- A carbamoyl] phenyl}- pyridyl)methyl]-7- 1 -(3-chloropyridin-2- methyl-8-nitro-5-pro- yl)-1 H-pyrazole-5- poxy-3,5,6,7-tetra- carboxamide
hydro-2H-imid- M'-81 . methyl-2-[3,5-dibro- A azo[1 ,2-a]pyridine mo-2-({[3-bromo-1 -
No IB II No IB II
(3-chloropyridin-2- fluoro-4-methyl- yl)-1 H-pyrazol-5-yl]- phenyl)-5-methyl- carbonyl}amino)ben- 1 ,2,4-triazol-3-amine zoyl]-1 ,2-dimethylhy- M'-86. 1 -(5-ethylsulfinyl- A drazinecarboxylate 2,4-dimethyl-
M'-82. N2-[2-(3-chloro-2- A phenyl)-3-methyl- pyridyl)-5-[(5-meth- 1 ,2,4-triazole
yltetrazol-2-yl)meth- M'-87. metaldehyde A yl]pyrazol-3-yl]-5-cy- M'-88. Bacillus firmus A ano-N1 ,3-dimethyl- M'-89. Bacillus firmus A phthalamide CNCM 1-1582
M'-83. afidopyropen A
M'-84. flumetoquin A
M'-85. 2-(5-ethylsulfinyl-2- A
More preferred inventive mixtures especially useful for soil treatment are those comprising compound II and insecticidal compound IB selected from momfluorothrin; 1 -[(6-chloro-3-pyridyl)- methyl]-2-nitro-1 -[(E)-pentylideneamino]guanidine; 1 -[(E)-[2-(4-cyanophenyl)-1 -[3-(trifluoro- methyl)phenyl]ethylidene]amino]-3-[4-(difluoromethoxy)phenyl]urea; N2-(1 -cyano-1 -methyl- ethyl)-N1 -(2,4-dimethylphenyl)-3-iodo-phthalamide, 3-chloro-N2-(1 -cyano-1 -methyl-ethyl)- N1 -(2,4-dimethylphenyl)phthalamide, 2-(3-chloro-2-pyridyl)-N-[4-cyano-2-methyl-6-(methylcar- bamoyl)phenyl]-5-[[5-(trifluoromethyl)tetrazol-2-yl]methyl]pyrazole-3-carboxamide, N-[2-(tert-but- ylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-car- boxamide, 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyr- azole-3-carboxamide, 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1 -cyano-1 -methyl- ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide, N-[2-(5-amino-1 ,3,4-thiadiazol-2-yl)-4-chloro- 6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide; triflumezopyrim, 8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1 ,2-a]pyridine-2-car- boxamide, 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1 H-pyrazole,
N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-3-py- ridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide, N-[1 -[(6-bromo-3-pyridyl)- methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(2-chloropyrimidin-5-yl)methyl]-2-pyri- dylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]- 2,2,2-trifluoro-acetamide, 2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acet- amide, 2-chloro-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide, N-[1 -[1 -(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-3-py- ridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; 1 1 -(4-chloro-2,6-dimethylphenyl)-12- hydroxy-1 ,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-1 1 -en-10-one, 3-(4'-fluoro-2,4-dimethylbi- phenyl-3-yl)-4-hydroxy-8-oxa-1 -azaspiro[4.5]dec-3-en-2-one, 2-(5-fluoro-3-pyridyl)-5-(6-pyrimi- din-2-yl-2-pyridyl)thiazole hydrofluoride, 2-(3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole, 5-[6-(1 ,3-dioxan-2-yl)-2-pyridyl]-2-(3-pyridyl)thiazole, 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]- 5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-
1 -carboxamide, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl- N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide and 4-[5-(3,5-dichlorophenyl)-5-(trifluoro- methyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 -oxothietan-3-yl)benzamide. Equally preferred inventive mixtures are those comprising compound II and compound IC having plant growth regulating activity displayed in Table 1 C:
In Table 1 C, the following abbreviations are used:
Bacillus subtilis MBI600 having the accession number NRRL B-50595 = A
IC = Compound IC II = Compound II
More preferred inventive mixtures especially useful for soil treatment are those comprising compound II and compound IC having plant growth regulating activity selected from 6- benzylaminopurine, chlormequat, chlormequat chloride, choline chloride, cyclanilide, dikegulac, diflufenzopyr, dimethipin, ethephon, flumetralin, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, maleic hydrazide, mepiquat, mepiquat chloride, 1 -MCP, paclobutrazol, prohexadione, prohexadione calcium, prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, trinexapac-ethyl and uniconazole.
Even more preferred inventive mixtures especially useful for soil treatment are those comprising compound II and compound IC having plant growth regulating activity selected from
chlormequat, chlormequat chloride, choline chloride, cyclanilide, dimethipin, ethephon, forchlorfenuron, gibberellic acid, maleic hydrazide, mepiquat, mepiquat chlorid, 1 -MCP, prohex- adione, prohexadione calcium, pthidiazuron and trinexapac-ethyl.
Most preferred inventive mixtures are those comprising compound II and fungicidal compound
IA displayed in Table 2A:
In Table 2A, the following abbreviations are used:
Bacillus subtilis MBI600 having the accession number NRRL B-50595 = A
IA = Compound IA II = Compound II
No IA II No IA II
C-1 . azoxystrobin A methylpropanoate
C-2. dimoxystrobin A C-14. [(3S,6S,7R,8R)-8- A
C-3. fluoxastrobin A benzyl-3-[[3-(1 ,3-
C-4. kresoxim-methyl A benzodioxol-5-
C-5. orysastrobin A ylmethoxy)-4-
C-6. picoxystrobin A methoxy-pyridine-2-
C-1. pyraclostrobin A carbonyl]amino]-6-
C-8. trifloxystrobin A methyl-4,9-dioxo-
C-9. pyribencarb A 1 ,5-dioxonan-7-yl] 2-
C-10. amisulbrom A methylpropanoate;
C-1 1 . [(3S,6S,7R,8R)-8- A (3S,6S,7R,8R)-3- benzyl-3-[(3- [[(3-hydroxy-4- acetoxy-4-methoxy- methoxy-2- pyridine-2-carbo- pyridi- nyl)amino]-6-methyl- nyl)carbonyl]amino]-
4,9-dioxo-1 ,5-di- 6-methyl-4,9-dioxo- oxonan-7-yl] 8-(phenylmethyl)-
2-methylpropanoate 1 ,5-dioxonan-7-yl 2-
C-12. [(3S,6S,7R,8R)-8- A methylpropanoate
benzyl-3-[[3-(acet- C-15. bixafen A oxymethoxy)-4- C-16. boscalid A methoxy-pyridine- C-17. fluopyram A
2-carbonyl]amino]-6- C-18. fluxapyroxad A methyl-4,9-dioxo- C-19. isopyrazam A
1 ,5-dioxonan-7-yl] C-20. penflufen A
2-methylpropanoate C-21 . penthiopyrad A
C-13. [(3S,6S,7R,8R)-8- A C-22. sedaxane A benzyl-3-[(3-isobut- C-23. N-[9-(dichlorometh- A oxycarbonyloxy-4- ylene)-1 ,2,3,4-tetra- methoxy-pyridine- hydro-1 ,4-methano-
2-carbonyl)amino]-6- naphthalen-5-yl]-3- methyl-4,9-dioxo- (difluoromethyl)-l -
1 ,5-dioxonan-7-yl] 2- methyl-1 H-pyrazole-
No IA II No IA II
4-carboxamide C-37. fluquinconazole A (benzovindiflupyr) C-38. ipconazole A
C-24. 3-(difluoromethyl)-1 - A C-39. metconazole A methyl-N-(1 , 1 ,3- C-40. prothioconazole A trimethylindan-4- C-41 . tebuconazole A yl)pyrazole-4- C-42. triticonazole, A carboxamide C-43. 1 -[re/-(2S;3R)-3-(2- A
C-25. 3-(trifluoromethyl)-1 - A chlorophenyl)-2-(2,4- methyl-N-(1 , 1 ,3- difluorophenyl)- trimethylindan-4- oxiranylmethyl]- yl)pyrazole-4- 5-thiocyanato-1 H- carboxamide [1 ,2,4]triazole
C-26. 1 ,3-dimethyl-N- A C-44. 2-[re/-(2S;3R)-3-(2- A
(1 , 1 ,3-trimethyl- chlorophenyl)-2-(2,4- indan-4-yl)pyrazole- difluorophenyl)- 4-carboxamide oxiranylmethyl]-
C-27. 3- (trifluoromethyl)- A 2H-[1 ,2,4]triazole-3- 1 ,5-dimethyl-N- thiol
(1 , 1 ,3-trimethyl- C-45. prochloraz A indan-4-yl)pyrazole- C-46. fenpropimorph A
4- carboxamide C-47. oxadixyl A
C-28. 3- (difluoromethyl)- A C-48. metalaxyl A
1 ,5-dimethyl-N- C-49. hymexazole A (1 , 1 ,3-trimethyl- C-50. carbendazim A indan-4-yl)pyrazole-
C-51 . thiophanate-methyl A
4- carboxamide
C-52. metrafenone, A
C-29. 1 ,3,5-trimethyl-N- A
C-53. pyrimethanil A (1 , 1 ,3-trimethyl-
C-54. fludioxonil A indan-4-yl)pyrazole-
C-55. iprobenfos A 4-carboxamide
C-56. quintozene A
C-30. (5,8-difluoroquin- A
C-57. tolclofos-methyl A azolin-4-yl)-{2-[2-
C-58. dimethomorph A fluoro-4-(4-trifluoro-
C-59. N-(1 -(1 -(4-cyano- A methylpyridin-2-yl- phenyl)ethanesul- oxy)-phenyl]-ethyl}- fonyl)-but-2-yl) car- amine
bamic acid-(4-
C-31 . ametoctradin A
fluorophenyl) ester
C-32. silthiofam A
C-60. propamocarb A
C-33. difenoconazole A
C-61 . propamocarb hydroA
C-34. diniconazole A
chloride
C-35. diniconazole-M A
C-62. mancozeb A
C-36. epoxiconazole A
C-63. metiram A
No IA II No IA II
C-64. dithianon A C-79. N-(6-methoxy- A
C-65. 2,6-dimethyl-1 H,5H- A pyridin-3-yl) cyclo-
[1 ,4]dithiino[2,3- propanecarboxylic c:5,6-c']dipyrrole- acid amide
1 ,3,5,7(2H,6H)- C-80. 5-chloro-1 -(4,6-di- A tetraone methoxy-pyrimidin-
C-66. validamycin A 2-yl)-2-methyl-1 H-
C-67. isotianil A benzoimidazole
C-68. tiadinil A C-81 . flutolanil A
C-69. prohexadione- A C-82. Ampelomyces
calcium quisqualis
C-70. 4- cyclopropyl- A C-83. Aspergillus flavus
N-(2,4-dimethoxy- C-84. Aureobasidium pul- A phenyl)thiadiazole- lulans
5- carboxamide C-85. Bacillus pumilus A
C-71 . fosetyl A C-86. Bacillus pumilus A
C-72. flusulfamide A NRRL Accession
C-73. 4,4-difluoro-3,3- A No. B-30087
dimethyl-1 -(3- C-87. Bacillus subtilis A quinolyl)isoquinoline C-88. Bacillus subtilis A
C-74. 2- butoxy-6-iodo- A NRRL-Nr. B-21661
3- propylchromen- C-89. Bacillus subtilis var. A
4- one amylolique-faciens
C-75. N-(cyclopropylmeth- A FZB24
oxyimino-(6-difluoro- C-90. Candida oleophila I- A methoxy-2,3-di- 82
fluoro-phenyl)- C-91 . Candida saitoana A methyl)-2-phenyl C-92. Chitosan A acetamide C-93. Clonostachys rosea A
C-76. 2-methoxy-acetic A f. catenulate
acid 6-tert-butyl-8- C-94. Clonostachys rosea A fluoro-2,3-dimethyl- f. catenulate isolate quinolin-4-yl ester J 1446
C-77. 3-[5-(4- A C-95. Coniothyrium mini- A methylphenyl)-2,3- tans
dimethyl-isoxazo- C-96. Cryphonectria paraA lidin-3-yl]-pyridine sitica
C-78. 3-[5-(4-chloro- A C-97. Endothia parasitica A phenyl)-2,3-dimeth- C-98. Cryptococcus albi- A yl-isoxazolidin-3-yl]- dus
pyridine (pyrisoxa- C-99. Fusarium ox- A zole) ysporum
No IA II No IA II
C-100. FUSACLEAN® A C-1 10. T. harzianum T-22 A
C-101 . Metschnikowia fruc- A C-1 1 1 . T. harzianum TH 35 A ticola C-1 12. T. harzianum T-39 A
C-102. Microdochium dime- A C-1 13. T. harzianum and T. A rum viride
C-103. Phlebiopsis gig an tea A C-1 14. T. harzianum A
C-104. Pseudozyma floccu- A I CC012 and T. viride
losa ICC080
C-105. Pythium oligandrum A C-1 15. T. polysporum and A
DV74 T. harzianum
C-106. Reynoutria sach- A C-1 16. T. stromaticum A linensis C-1 17. T. virens GL-21 A
C-107. Talaromyces flavus A C-1 18. T. viride A
V1 17b C-1 19. T. viride TV1 A
C-108. Trichoderma A C-120. Ulocladium A asperellum SKT-1 oudemansii HRU3
C-109. T. atroviride LC52 A
Equally most preferred inventive mixtures are those comprising compound I I and insecticidal compound I B displayed in Table 2B:
In Table 2B, the following abbreviations are used:
Bacillus subtilis MBI600 having the accession number NRRL B-50595 = A
I B = Compound I B I I = Compound I I
No IB II No IB II
C-1 . aldicarb A phenyl]-5-(trifluoro-
C-2. benfuracarb A methyl)-4H-isoxazol-
C-3. carbofuran A 3-yl]-N-[2-oxo-2-
C-4. carbosulfan A (2,2,2-trifluoroethyl-
C-5. oxamyl A amino)ethyl]naph-
C-6. pirimicarb A thalene-1 -carbox-
C-7. thiodicarb A amide
C-8. chlorfenvinphos A C-17. 4-[5-(3,5-dichloro- A
C-9. chlorpyrifos A phenyl)-5-(trifluoro-
C-10. chlorpyrifos-methyl A methyl)-4H-isoxazol-
3-yl]-2-methyl-N-[2-
C-1 1 . dichlorvos/ DDVP A
C-12. terbufos A oxo-2-(2,2,2-triflu- oroethylamino)-
C-13. ethiprole A
ethyl]benzamide
C-14. fipronil A
C-18. lambda-cyhalothrin A
C-15. pyri prole A
C-19. alpha-cypermethrin A
C-16. 4-[5-[3-chloro-5- A
C-20. fenvalerate A (trifluoromethyl)-
No IB II No IB II
C-21 . permethrin A C-46. (S)-3-chloro-N 1 -{2- A
C-22. tefluthrin A methyl-4-[1 ,2,2,2-te-
C-23. acetamiprid A trafluoro-1 -(trifluoro-
C-24. chlothianidin A methyl)ethyl]phenyl}-
C-25. cycloxaprid A N2-(1 -methyl-2-me-
C-26. dinotefuran A thylsulfonylethyl)-
C-21. flupyradifurone A phthalamide
C-28. imidacloprid A C-47. 3-bromo-N-{2-bro- A
C-29. nitenpyram A mo-4-chloro-6-[(1 -
C-30. sulfoxaflor A cyclopropylethyl)-
A carbamoyl]phenyl}-
C-31 . thiacloprid
1 -(3-chlorpyridin-2-
C-32. thiamethoxam A
yl)-1 H-pyrazole-5-
C-33. 1 -[(6-chloro-3-pyri- A
carboxamide
dyl)methyl]-7-meth-
C-48. methyl-2-[3,5-dibro- A yl-8-nitro-5-propoxy- mo-2-({[3-bromo-1 -
3,5,6,7-tetrahydro-
(3-chlorpyridin-2-yl)-
2H-imidazo[1 ,2-a]-
1 H-pyrazol-5-yl]car- pyridine
bonyl}amino)benzo-
C-34. spinosad A
yl]-1 ,2-dimethylhy-
C-35. abamectin A
drazinecarboxylate
C-36. emamectin benzoate A
C-49. N2-[2-(3-chloro-2- A
C-37. 2-(5-fluoro-3-pyri- A
pyridyl)-5-[(5-meth- dyl)-5-(6-pyrimidin-2- yltetrazol-2-yl)meth- yl-2-pyridyl)thiazole
yl]pyrazol-3-yl]-5-cy- hydrofluoride
ano-N 1 ,3-dimethyl-
C-38. chlorfenapyr A
phthalamide)
C-39. flufenoxuron A
C-50. afidopyropen A
C-40. teflubenzuron A
C-51 . flumetoquin A
C-41 . metaflumizone A
C-52. 2-(5-ethylsulfinyl-2- A
C-42. flubendiamide A
fluoro-4-methyl-
C-43. chlorantraniliprole A
phenyl)-5-methyl- (rynaxypyr)
1 ,2,4-triazol-3-amine
C-44. cyantraniliprole A
C-53. 1 -(5-ethylsulfinyl- A (cyazypyr)
2,4-dimethyl-phe-
C-45. (R)-3-chloro-N 1 -{2- A
nyl)-3-methyl-1 ,2,4- methyl-4-[1 ,2,2,2-te- triazole
trafluoro-1 -(trifluoro-
C-121 . Bacillus firmus A methyl)ethyl]phenyl}-
C-54. Bacillus firmus A
N2-(1 -methyl-2-me- CNCM 1-1582 thylsulfonylethyl)- phthalamide
The present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Bradyrhizobium japonicum (B. japonicum). These mixtures are particularly suitable in soybean. Preferably, B. japonicum is not one of the strains TA-1 1 or 532c. B. japonicum strains were cultivated using media and fermentation tech- niques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days. These mixtures are particularly suitable in soybean. Preferably B. japonicum is not one of the strains TA-1 1 or 532c. B. japonicum strains were cultivated using media and fermentation techniques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days. References for various B. japonicum strains are given e.g. in US 7,262,151 (B. japonicum strains USDA 1 10 (= IITA 2121 , SEMIA 5032, RCR 3427, ARS 1-1 10, Nitragin 61A89; isolated from Glycine max in Florida in 1959, Serogroup 1 10; AppI Environ Microbiol 60, 940-94, 1994), USDA 31 (= Nitragin 61A164; isolated from Glycine max in Wisoconsin in 1941 , USA,
Serogroup 31 ), USDA 76 (plant passage of strain USDA 74 which has been isolated from Gly- cine max in California, USA, in 1956, Serogroup 76), USDA 121 (isolated from Glycine max in Ohio, USA, in 1965), USDA 3 (isolated from Glycine max in Virginia, USA, in 1914, Serogroup 6) and USDA 136 (= CB 1809, SEMIA 586, Nitragin 61A136, RCR 3407; isolated from Glycine max in Beltsville, Maryland in 1961 ; AppI Environ Microbiol 60, 940-94, 1994). USDA refers to United States Department of Agriculture Culture Collection, Beltsville, Md., USA (see e.g. Belts- ville Rhizobium Culture Collection Catalog March 1987 ARS-30). Further suitable B. japonicum strain G49 (INRA, Angers, France) is described in Fernandez-Flouret, D. & Cleyet-Marel, J. C. (1987) C R Acad Agric Fr 73, 163-171 ), especially for soybean grown in Europe, in particular in France. Further suitable B. japonicum strain TA-1 1 (TA1 1 NOD+) (NRRL B-18466) is i.a. described in US 5,021 ,076; AppI Environ Microbiol (1990) 56, 2399-2403 and commercially avail- able as liquid inoculant for soybean (VAULT® NP, Becker Underwood, USA). Further B. japonicum strains as example for compound III are described in US2012/0252672A. Further suitable and especially in Canada commercially available strain 532c (The Nitragin Company, Milwaukee, Wisconsin, USA, field isolate from Wisconsin; Nitragin strain collection No. 61A152; Can J Plant Sci 70 (1990), 661 -666).
Further B. japonicum strains as example for compound II are described in US2012/0252672A. Further suitable and especially in Canada commercially available strain 532c (The Nitragin Company, Milwaukee, Wisconsin, USA, field isolate from Wisconsin; Nitragin strain collection No. 61A152; Can J Plant Sci 70 (1990), 661 -666).
Other suitable and commercially available B. japonicum strains (see e.g. AppI Environ Microbiol 2007, 73(8), 2635) are SEMIA 566 (isolated from North American inoculant in 1966 and used in Brazilian commercial inoculants from 1966 to 1978), SEMIA 586 (= CB 1809; originally isolated in Maryland, USA but received from Austrailia in 1966 and used in Brazilian inoculants in 1977), CPAC 15 (= SEMIA 5079; a natural varaiant of SEMIA 566 used in commercial inoculants since 1992) and CPAC 7 (= SEMIA 5080; a natural variant of SEMIA 586 used in commercial inoculants since 1992). These strains are especially suitable for soybean grown in Australia or South America, in particular in Brazil. Some of the abovementioned strains have been re-classified as a novel species Bradyrhizobium elkanii, e.g. strain USDA 76 (Can. J. Microbiol., 1992, 38, 501 -
505).
Mixtures consisting of B. japonicum strain 532c and B. subtilis MBI600 have been disclosed earlier in World J Microbiol Biotechnol (2012) 28, 2541 -2550. Thus, the present invention also relates to mixtures consisting of as active ingredients compound II and comprising compound III, wherein compound III is selected from Bradyrhizobium japonicum (B. japonicum), provided that compound III is not B. japonicum TA-1 1 or 532c.
The present invention also relates to mixtures comprising compound II and comprising com- pound III and compound IV, wherein compound III is selected from Bradyrhizobium japonicum (B. japonicum) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
The present invention also relates to mixtures comprising compound II and comprising com- pound III, wherein compound III is selected from Bradyrhizobium elkanii and Bradyrhizobium liaoningense (B. elkanii and B. liaoningense), more preferably from B. elkanii. These mixtures are particularly suitable in soybean. B. elkanii and liaoningense were cultivated using media and fermentation techniques known in the art, e.g. in yeast extract-mannitol broth (YEM) at 27°C for about 5 days.
Suitable and commercially available B. elkanii strains are SEMIA 587 and SEMIA 5019 (=29W) (see e.g. Appl Environ Microbiol 2007, 73(8), 2635) and USDA 3254 and USDA 76 and USDA 94. These strains are especially suitable for soybean grown in Australia or South America, in particular in Brazil. The present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Bradyrhizobium elkanii and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
The present invention also relates to mixtures comprising compound II and comprising com- pound III, wherein compound III is selected from Bradyrhizobium sp. (Arachis) (B. sp. Arachis) which shall describe the cowpea miscellany cross-inoculation group which includes inter alia indigenous cowpea bradyrhizobia on cowpea (Vigna unguiculata), siratro (Macroptilium atropur- pureum), lima bean (Phaseolus lunatus), and peanut (Arachis hypogaea). This mixture comprising compound II and B. sp. Arachis is especially suitable for use in peanut, Cowpea, Mung bean, Moth bean, Dune bean, Rice bean, Snake bean and Creeping vigna, in particular peanut.
Suitable and commercially available B. sp. (Arachis) strain is CB1015 (= IITA 1006, USDA 3446 presumably originally collected in India; from Australian Inoculants Research Group; see e.g. http://www.qaseeds.com.au/inoculant_applic.php; Beltsville Rhizobium Culture Collection Cata- log March 1987 USDA-ARS ARS-30). These strains are especially suitable for peanut grown in Australia, North America or South America, in particular in Brazil. Further suitable strain is bradyrhizobium sp. PNL01 (Becker Underwood; ISO Rep Marita McCreary, QC Manager Padma Somasageran; IDENTIFICATION OF RHIZOBIA SPECIES THAT CAN ESTABLISH NITRO-
GEN-FIXING NODULES IN CROTALARIA LONGI ROSTRATA. April 29, 2010, University of Massachusetts Amherst: http://www.wpi.edu/Pubs/E-project/Available/E-project-042810- 163614/unrestricted/Bisson.Mason._ldentification_of_Rhizobia_Species_That_can_Establish_Nit rogen-Fixing_Nodules_in_Crotalia_Longirostrata.pdf).
The present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Bradyrhizobium sp. (Ara- chis) and wherein compound IV is selected from jasmonates or salts or derivatives thereof. The present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Bradyrhizobium sp. (Lupine) (also called B. lupini). This mixture is especially suitable for use in dry beans and lupins.
Suitable and commercially available B. lupini strain is LL13 (INRA, Angers, France;
http://agriculture.gouv.fr/IMG/pdf/ch20060216.pdf). This strain is especially suitable for lupins grown in Australia, North America or Europe, in particular in Europe.
Further suitable and commercially available B. lupini strains WU245 (isolated in Esperance, Western Australia from a non-Australian legume Ornthopus compressus), WSM4024 (isolated from lupins in Australia by CRS during a 2005 survey) and WSM471 (isolated from Ornithopus pinnatus in Oyster Harbour, Western Australia) are described e.g. in Palta J.A. and Berger J.B. (eds), 2008, Proceedings 12th International Lupin Conference, 14-18 Sept. 2008, Fremantle, Western Australia. International Lupin Association, Canterbury, New Zealand. 47-50, ISBN 0- 86476-153-8:
http://www.lupins.org/pdf/conference/20Q8/Agronomy%20and%20Production/John%20Howieso n%20and%20G%20OHara.pdf; Appl Environ Microbiol (2005) 71 , 7041 -7052.
The present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Bradyrhizobium sp. (Lupine) (B. lupini) and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
The present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Mesorhizobium spp., more preferably Mesorhi- zobium ciceri. These mixtures are particularly suitable in cowpea.
Suitable and commercially available M. ciceri strains are e.g. CC1 192 (=UPM 848, CECT 5549; from Horticultural Research Station, Gosford, Australia; Can J Microbial (2002) 48, 279-284), and WSM1271 . The present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Mesorhizobium ciceri and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
The present invention also relates to mixtures comprising compound II and comprising compound III, wherein compound III is selected from Mesorhizobium huakuii, also referred to as Rhizobium huakii (see e.g. Appl. Environ. Microbiol. 201 1 , 77(15), 5513-5516). These mixtures are particularly suitable in Astralagus, e.g. Astalagus sinicus (Chinese milkwetch), Thermopsis, e.g. Thermopsis luinoides (Goldenbanner) and alike.
The present invention also relates to mixtures comprising compound II and comprising compound III and compound IV, wherein compound III is selected from Mesorhizobium huakuii and wherein compound IV is selected from jasmonates or salts or derivatives thereof.
Salts of jasmonic acid or derivatives include without limitation the jasmonate salts potassium jasmonate, sodium jasmonate, lithium jasmonate, ammonium jasmonate, dimethylammonium jasmonate, isopropylammonium jasmonate, diolammonium jasmonate, diethtriethanolammoni- um jasmonate, jasmonic acid methyl ester, jasmonic acid amide, jasmonic acid methylamide, jasmonic acid-L-amino acid (amide-linked) conjugates (e.g., conjugates with L- isoleucine, L- valine, L-leucine, or L-phenylalanine), 12-oxo-phytodienoic acid, coronatine, coronafacoyl- L- serine, coronafacoyl-L-threonine, methyl esters of 1 - oxo-indanoyl-isoleucine, methyl esters of 1 -oxo-indanoyl-leucine, coronalon (2- [ (6- ethyl-l-oxo-indane-4-carbonyl) -amino] -3- methyl - pentanoic acid methyl ester), linoleic acid or derivatives thereof, or combinations of any of the above.
Preferred amongst the group of salts of jasmonic acid or derivatives are jasmonic acid, methyl jasmonate, sodium jasmonate, potassium jasmonate, lithium jasmonate and ammonium jasmonate. More preferred is jasmonic acid methyl ester.
Thus, the present invention also relates to mixtures comprising compound II and comprising compound III and compound II, compound III and compound IV as set forth in Table 3 below:
In Table 3, the following abbreviations are used:
Bacillus subtilis MBI600 having the accession number NRRL B-50595
II = Compound II B. japonicum 532c = 532c
III = Compound III B. japonicum TA-1 1 = 1 1
IV=Compound IV Mixture of B. japonicum 532c and TA-1 1 = B. japonicum = B. 532c/1 1
B. japonicum (strain USDA 1 10) Mixture of B. japonicum SEMIA 5079 and B. japonicum USDA31 = 31 SEMIA 5080 = 79/80
B. japonicum USDA76 = 76 Mixture of B. elkanii SEMIA 587 and SEMIA B. japonicum USDA121 = 121 5019 = 87/19
B. japonicum USDA3 = 3
B. japonicum E-109 = E-109 jasmonic acid = No.1
B. japonicum G49 = G49 methyl jasmonate = No.2
the jasmonate salt sodium jasmonate, potassium jasmonate, lithium jasmonate or ammonium
jasmonate = No.3
The present invention also relates to mixtures comprising compound I, compound II and com- pound I I I as third component, wherein compound I II is selected from Bradyrhizobium japonicum (B. japonicum).
In particular, the present invention furthermore relates to ternary mixtures, wherein compound I I I is B. japonicum and the combination of compounds I and I I in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound I II is B. japonicum strain USDA 1 10 and the combination of compounds I and I I in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound I II is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corre- sponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corre- sponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corre- sponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corre- sponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corre-
sponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corre- sponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA 1 10 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum USDA31 , and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA76, and the combination of compounds I and II in each case corre- sponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA121 , and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain USDA3 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain E-109 and the combination of compounds I and II in each case corre-
sponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corre- sponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain 532c and compound IV is B. japonicum strain TA-1 1 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain SEMIA 5079 and compound IV is B. japonicum strain SEMIA 5080 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. elkanii strain SEMIA 587 and compound IV is B. elkanii strain SEMIA 5019 and the combination of compounds I and II in each case corresponds to a row of Table 2B.
The present invention also relates to ternary mixtures comprising compound IV as third component, wherein compound IV is selected from jasmonates or salts or derivatives thereof. Preferred amongst the group of salts of jasmonic acid or derivatives are jasmonic acid, methyl jasmonate, sodium jasmonate, potassium jasmonate, lithium jasmonate and ammonium jasmonate. More preferred is jasmonic acid methyl ester.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of com- pounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid or a salt or derivative thereof and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound
IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B..
The present invention furthermore relates to quaternary mixtuers comprising compound I, pound II, compound III and compound IV.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of com- pounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds
to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of com- pounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds
to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is jasmonic acid, and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is jasmonic acid and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA 1 10, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is methyl jasmonate and the combina- tion of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain E-109, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is methyl jasmonate and the combination of com- pounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is methyl jasmonate and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammo- nium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or am-
monium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lith- ium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium,
lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 1 C.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is me- thyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I
and II in each case corresponds to a row of Table 2A.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is Bradyrhizobium japonicum, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA 1 10, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum USDA31 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA76, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein com- pound III is B. japonicum strain USDA121 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain USDA3, compound IV is a jasmonate salt (e.g. potassium, lithi- um or ammonium and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quaternary mixtures, wherein compound III is B. japonicum strain E-109, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain G49, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain 532c, compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to ternary mixtures, wherein compound III is B. japonicum strain TA-1 1 , compound IV is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound
III is B. japonicum strain 532c, compound IV is B. japonicum strain TA-1 1 , compound V is methyl jasmonate, and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. japonicum strain SEMIA 5079, compound IV is B. japonicum strain SEMIA 5080, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
In particular, the present invention furthermore relates to quinary mixtures, wherein compound III is B. elkanii strain SEMIA 587, compound IV is B. elkanii strain SEMIA 5019, compound V is a jasmonate salt (e.g. potassium, lithium or ammonium) and the combination of compounds I and II in each case corresponds to a row of Table 2B.
The inventive mixtures can further contain one or more insecticides, fungicides, plant growth regulators and/or herbicides.
As stated above, the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession.
The inventive mixtures can further contain one or more insecticides, fungicides and/or, herbi- cides.
As stated above, the compounds of the inventive mixtures can be applied simultaneously, that is jointly or separately, or in succession. The mixtures according to the present invention can be converted jointly with formulation auxiliaries into individual formulations (compositions) or can be converted jointly with formulation auxiliaries into customary formulations (co-formulation).
If applied separately or in succession, compound I and compound II are naturally be formulated separately.
Thus, in one embodiment, the compounds of the inventive mixtures can be present in a kit of parts comprising as part one formulated compound I as defined above; and as second component one formulated compound II as defined above. According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e.g seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate. When living microorganisms, such as compound II, form part of such kit, it must be taken care that choice and amounts of the other parts of the kit (e.g. chemcial pesticidal agents) and of the further auxiliaries should not influence the viability of the microbial pesticides in the composition mixed by the user. Especially for bactericides and solvents, compatibility with the respective microbial pesticide has to be taken into account.
Consequently, one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit compring a) a composition comprising component 1 ) as defined herein and at least one auxiliary; or b) a composition comprising component 2) as defined herein and at least one auxiliary; or c) a composition comprising component 3) as defined herein and at least one auxiliary; and d) a composition comprising component 4) as defined herein and at least one auxiliary; and optionally e) a composition comprising at least one auxiliary and o further active ingedrients such as compound III and/or compound IV as defined herein.
The present invention therefore also relates to a kit of parts comprising as part one formulated compound I as defined above; and as second component one formulated compound II as defined above. This applies also to combinations of compound II and III.
The kit of part may also optionally additionally comprise additional components III (and/ or IV) as outlined above, which can be also be provided separately packed, or, alternatively be present in combination with compound I or compound II.
The inventive mixtures can be converted individually or jointly into customary types of agro- chemical compositions, e. g. solutions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. General examples for composition types for compound I and/or compound II are suspensions (e.g. SC, OD, FS), emulsifiable concentrates, capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations (e.g. GF). These and further compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.
The compositions are prepared in a known manner, such as described by Mollet and Grube- mann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.
Preferred examples of soil formulation types for pre-mix compositions are:
GR: Granules
WP: wettable powders
WG: water dispersable granules (powders)
SG: water soluble granules
SL: soluble concentrates
ME: micro-emulsion
SC: aqueous suspension concentrate
CS: aqueous capsule suspension
OD: oil-based suspension concentrate, and SE: aqueous suspo-emulsion.
Examples for suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective col-
loids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, stabilizers or nutrients, UV protectants, tackifiers and binders.
Especially for bactericides, choice and amounts of this auxiliary should not influence the viability of compound II (also if present in formulations comprising compound I).
Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, al- kylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof. However, if such solvents are used, compatibility with compound II needs to be taken into account.
Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. ce- real meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective col- loid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.
Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides.
Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar- based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or al- kylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrroli- done, vinylalcohols, or vinylacetate.
Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or pol- yethyleneamines.
Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the inventive mixtures on the target. Examples are surfactants, mineral or vegetable oils, and other auxilaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.
Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.
Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water- soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanofer- rate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).
Suitable tackifiers or binders are polyvinylpyrrolidone, polyvinylacetates, polyvinyl alcohols, pol- yacrylates, biological or synthetic waxes, and cellulose ethers.
When living microorganisms, such as compound II, form part of the compositions, such compo- sitions can be prepared as compositions comprising besides the active ingredients at least one auxiliary (inert ingredient) by usual means (see e.g. H.D. Burges: Formulation of Micobial Bi- opestcides, Springer, 1998). Suitable customary types of such compositions are suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e.g. SC, OD, FS), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). Herein, it has to be taken into account that each formulation type or choice of auxiliary should not influence the viability of
the microorganism during storage of the composition and when finally applied to the plant propagation material. Suitable formulations are e.g. mentioned in WO 2008/002371 , US 6955,912, US 5,422,107. Examples for suitable auxiliaries are those mentioned earlier herein, wherein it must be taken care that choice and amounts of such auxiliaries should not influence the viability of the microbial pesticides in the composition. Especially for bactericides and solvents, compatibility with the respective microorganism of the respective microbial pesticide has to be taken into account. In addition, compositions with microbial pesticides may further contain stabilizers or nutrients and UV protectants.
Suitable stabilizers or nutrients (H.D. Burges: Formulation of Micobial Biopestcides) are e.g. alpha-tocopherol, trehalose, glutamate, potassium sorbate, various sugars like glucose, sucrose, lactose, maltodextrine.
Suitable UV protectants are e.g. inorganic compounds like titan dioxide, zinc oxide and iron oxide pigments or organic compounds like benzophenones, benzotriazoles, phenyltriazines.
The compositions may in addition to auxiliaries mentioned for compositions comprising compounds I herein optionally comprise 0.1 - 80% stabilizers or nutrients and 0.1 -10% UV protect- ants.
General examples of suitable ratios for multiple formulation types referenced above are given in Agrow Reports DS243, T&F Informa, London, 2005. Examples for composition types and their preparation are given below. It has to be noted that each compound present in the mixture of the present invention can be formulated separately and then, for preparation of the mixture, combined, e.g. in any spray device by consecutive or simultaneous application as outlined in more detail below.
CS formulations are particularly useful for compound I, less for compound II. In particular for compound II, granules, powders or suspensions (suspension concentrates) are preferred formulation type.
Herein, it has to be taken into account that each formulation type or choice of auxiliary should not influence the viability of the microorganism, if finally applied to the soil by spray application. As referenced above, a suitable formulation of compound II is referenced in WO 2008/002371 . i) Suspensions (SC, OD)
In an agitated vessel 1 -60 wt% of compound I or II or an inventive mixture are comminuted with addition of 2-10 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0.1 -2 wt% thickener (e.g. xanthan gum) and up to 100 wt% water or an suitable oil to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt% binder (e.g. polyvinylalcohol) is added.
ii) Water-dispersible granules and water-soluble granules (WG)
1 -80 wt% of compound I or II or an inventive mixture are are mixed to 100 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) and prepared as water- dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray- drying, fluidized bed). Dilution with water gives a stable dispersion or solution of the active sub- stance.
iii) Water-dispersible powders and water-soluble powders (WP)
1 -80 wt% a of compound I or II or an inventive mixture are are mixed with addition of 1 -5 wt% dispersants (e.g. sodium lignosulfonate), 1 -3 wt% wetting agents (e.g. alcohol ethoxylate) and up to 100 wt% solid carrier, e.g. silica gel. Dilution with water gives a stable dispersion or solution of the active substance.
iv) Gel (GW, GF)
In an mixer, 5-25 wt% of compound I or II or an inventive mixture are comminuted with addition of 3-10 wt% dispersants (e.g. sodium lignosulfonate), 1 -5 wt% thickener (e.g. carboxy- methylcellulose) and up to 100 wt% water to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.
v) Microcapsules (CS)
An oil phase comprising 5-50 wt% of a compound I, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e.g. methylmethacrylate, meth- acrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4'-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1 -10 wt%. The wt% relate to the total CS composition.
vi) Dustable powders (DP)
1 -10 wt% of compound I or II or an inventive mixture are mixed intimately with up to 100 wt% solid carrier, e.g. finely divided kaolin.
vii) Granules (GR)
The compositions types i) to xi) may optionally comprise further auxiliaries, such as 0.1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0.1 -1 wt% anti-foaming agents, and 0.1 -1 wt% colorants.
The soil treatment combinations and compositions comprising the inventive mixtures can also comprise or may be applied together and/or sequentially with further active compounds. These further useful active compounds can be fertilizers or micronutrient donors (such as Mo, Zn and / or Co).
The resulting agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to
100% (according to NMR spectrum).
Generally, a tank-mix formulation for soil application comprises 0.1 to 20 percent, especially 0.1 to 15 percent, of the desired ingredients, and 99.9 to 80 percent, especially 99.9 to 85 percent, of a solid or liquid auxiliaries (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 20 percent, especially 0.1 to 15 percent, based on the tank-mix formulation.
Typically, a pre-mix formulation for soil application comprises 0.1 to 99.9 percent, especially 1 to 95 percent, of the desired ingredients, and 99.9 to 0.1 percent, especially 99 to 5 percent, of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 50 percent, especially 0.5 to 40 percent, based on the pre-mix formulation. However, also granules can be directetly been added to the soil.
The term "soil application" or "soil treatment" includes methods of applying to the soil can be via any suitable method, which ensures that the combination penetrates the soil, for example, nursery tray application, in furrow application, soil drenching, soil injection, drip irrigation, appli- cation through sprinklers or central pivot, incorporation into soil (broad cast or in band) are such methods.
In a further embodiment, either individual compounds of the inventive mixtures formulated as composition or partially premixed components, e. g. components set forth in the inventive mix- tures may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate (tank mix).
In a further embodiment, either individual components of the inventive mixture or partially premixed components, e. g. components comprising the compound I and II (or the compounds in- ventive ternary and quaternary mixtures), can be applied jointly (e. g. after tankmix) or consecutively.
The rates of application (use) of a combination vary, for example, according to type of use, type of crop, the compound (I) in the combination with I, type of plant propagation material (if appro- priate), but is such that the active ingredients in the combination is an effective amount to provide the desired synergistically enhanced action (such as disease or pest control and plant heath effects) and can be determined by trials and routine experimentation known to one of ordinary skill in the art. When employed in plant protection by soil spray application, the amounts of active substances (compound I, IV, if present) applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.01 to 1.0 kg per ha, and in particular from 0.05 to 0.75 kg per ha.
In the case of compound II (or III), the application rates preferably range from about 1 x 106 to 5 x 1015 (or more) CFU/ha. Preferably, the spore concentration is about 1 x 107 to about 1 x 1011 CFU/ha. The methods according to the invention for controlling pests or increasing the health of plants of the abovementioned type is carried out in a manner known per se to those skilled in the art, depending on the intended aims and prevailing circumstances.
Advantageously, the inventive mixtures are suitable for controlling the following fungal plant diseases:
Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. Candida) and sunflowers (e. g. A. tragopogonis); Altemaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassi- cae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. altemata), tomatoes (e. g. A. solani or A. altemata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici (anthracnose) on wheat and A. hordei on barley; Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicola) on corn, e. g. spot blotch (B. sorokiniana) on cereals and e.g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) gram- inis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botry- otinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn (e.g. Gray leaf spot: C. zeae-maydis), rice, sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum: leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus (anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. sorokiniana) and rice (e. g. C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnose) on cotton (e. g. C. gossypii), corn (e. g. C. graminicola: Anthracnose stalk rot), soft fruits, potatoes (e. g. C. coccodes: black dot), beans (e. g. C. lindemu- thianum) and soybeans (e. g. C. truncatum or C. gloeosporioides); Corticium spp., e. g. C. sa- sakii (sheath blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamentals; Cycloconium spp., e. g. C. oleaginum on olive trees; Cylindrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.) on fruit trees, vines (e. g. C. lirio- dendri, teleomorph: Neonectria liriodendri: Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D.
phaseolorum (damping off) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyr- enophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formiti- poria (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (earlier Phaeo- acremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (£. pyri), soft fruits (£. veneta: anthracnose) and vines (£. ampelina:
anthracnose); Entyloma oryzae (leaf smut) on rice; Epicoccum spp. (black mold) on wheat; Ery- siphe spp. (powdery mildew) on sugar beets (£. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E. cichoracearum), cabbages, rape (e. g. E. cruciferarum); Eutypa lata (Eutypa canker or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental woods; Exserohilum (syn. Helminthosporium) spp. on corn (e. g. E. turcicum); Fusarium (teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. solani on soybeans and F. verticillioides on corn; Gaeumanno- myces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G. zeae) and rice (e. g. G. fujikuroi: Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants and G. gossypii on cotton; Grainstaining complex on rice; Gui- gnardia bidwellii (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G. sabinae (rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochli- obolus) on corn, cereals and rice; Hemileia spp., e. g. H. vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn.
phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bana- nas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici, Septo- ria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco (P. tabacina) and soybeans (e. g. P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets; Pho- mopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestans: late blight) and broad-leaved trees (e. g. P. ramorum: sudden oak death); Plasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Plas- mopara spp., e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples; Polymyxa spp., e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P. betae) and thereby transmitted viral diseases; Pseudocercosporella herpo- trichoides (eyespot, teleomorph: Tapesia yallundae) on cereals, e. g. wheat or barley; Pseu- doperonospora (downy mildew) on various plants, e. g. P. cubensis on cucurbits or P. humili on hop; Pseudopezicula tracheiphila (red fire disease or .rotbrenner', anamorph: Phialophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, P. kuehnii (orange rust) on sugar cane and P. asparagi on asparagus; Pyrenophora (anamorph: Drechslera) tritici-repentis
(tan spot) on wheat or P. teres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleo- morph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ramularia leaf spots, Physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhyn- chosporium secalis (scald) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici (Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Un- cinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckeri) on vines; Se- tospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf; Sphacelotheca spp. (smut) on corn, (e. g. S. miliaria: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina spp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans); Tilletia spp. (common bunt or stinking smut) on cereals, such as e. g. T. tritici (syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U. occulta (stem smut) on rye; Uro- myces spp. (rust) on vegetables, such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae); Ustilago spp. (loose smut) on cereals (e. g. U. nuda and U.
avaenae), corn (e. g. U. maydis: corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears; and Verticillium spp. (wilt) on various plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V. dahliae on strawberries, rape, potatoes and tomatoes.
The mixtures according to the present inventino and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. The term "protection of materials" is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and pa- perboard, textiles, leather, paint dispersions, plastics, colling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. As to the protection of wood and other materials, the particular attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans,
Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomy- cetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp.,
Cladosporium spp., Penicillium spp., Trichorma spp., Altemaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., and in addition in the protection of stored products and harvest the following yeast fungi are worthy of note: Candida spp. and Saccharomyces cerevisae. The inventive mixtures exhibit also outstanding action against animal pests from the following orders: insects from the order of the lepidopterans (Lepidoptera), for example Agrotis ypsilon, Agrotis segetum, Alabama argillacea, Anticarsia gemmatalis, Argyresthia conjugella, Autographa gam- ma, Bupalus piniarius, Cacoecia murinana, Capua reticulana, Cheimatobia brumata, Choris- toneura fumiferana, Choristoneura occidentalis, Cirphis unipuncta, Cydia pomonella, Dendroli- mus pini, Diaphania nitidalis, Diatraea grand iosella, Earias insulana, Elasmopalpus lignosellus, Eupoecilia ambiguella, Evetria bouliana, Feltia subterranea, Galleria mellonella, Grapholitha funebrana, Grapholitha molesta, Heliothis armigera, Heliothis virescens, Heliothis zea, Hellula undalis, Hibemia defoliaria, Hyphantria cunea, Hyponomeuta malinellus, Keiferia lycopersicella, Lambdina fiscellaria, Laphygma exigua, Leucoptera coffeella, Leucoptera scitella, Lithocolletis blancardella, Lobesia botrana, Loxostege sticticalis, Lymantria dispar, Lymantria monacha, Ly- onetia clerkella, Malacosoma neustria, Mamestra brassicae, Orgyia pseudotsugata, Ostrinia nubilalis, Panolis flammea, Pectinophora gossypiella, Peridroma saucia, Phalera bucephala, Phthorimaea operculella, Phyllocnistis citrella, Pieris brassicae, Plathypena scabra, Plutella xy- lostella, Pseudoplusia includens, Rhyacionia frustrana, Scrobipalpula absoluta, Sitotroga cere- alella, Sparganothis pilleriana, Spodoptera frugiperda, Spodoptera littoralis, Spodoptera litura, Thaumatopoea pityocampa, Tortrix viridana, Trichoplusia ni and Zeiraphera canadensis, beetles (Coleoptera), for example Agrilus sinuatus, Agriotes lineatus, Agriotes obscurus, Am- phimallus solstitialis, Anisandrus dispar, Anthonomus grand is, Anthonomus pomorum, Aphtho- na euphoridae, Athous haemorrhoidalis, Atomaria linearis, Blastophagus piniperda, Blitophaga undata, Bruchus rufimanus, Bruchus pisorum, Bruchus lentis, Byctiscus betulae, Cassida nebu- losa, Cerotoma trifurcata, Cetonia aurata, Ceuthorrhynchus assimilis, Ceuthorrhynchus napi, Chaetocnema tibialis, Conoderus vespertinus, Crioceris asparagi, Ctenicera ssp., Diabrotica longicornis, Diabrotica semipunctata, Diabrotica 12-punctata Diabrotica speciosa, Diabrotica virgifera, Epilachna varivestis, Epitrix hirtipennis, Eutinobothrus brasiliensis, Hylobius abietis, Hypera brunneipennis, Hypera postica, Ips typographus, Lema bilineata, Lema melanopus, Leptinotarsa decemlineata, Limonius californicus, Lissorhoptrus oryzophilus, Melanotus com- munis, Meligethes aeneus, Melolontha hippocastani, Melolontha melolontha, Oulema oryzae, Ortiorrhynchus sulcatus, Otiorrhynchus ovatus, Phaedon cochleariae, Phyllobius pyri, Phyllotre- ta chrysocephala, Phyllophaga sp., Phyllopertha horticola, Phyllotreta nemorum, Phyllotreta striolata, Popillia japonica, Sitona lineatus and Sitophilus granaria, flies, mosquitoes (Diptera), e.g. Aedes aegypti, Aedes albopictus, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles albimanus, Anopheles gam- biae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadri- maculatus, Calliphora vicina, Ceratitis capitata, Chrysomya bezziana, Chrysomya hominivorax,
Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Contarinia sorghicola Cordylobia anthropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinquefasciatus, Culex tarsalis, Culiseta inornata, Culiseta melanura, Dacus cucurbitae, Dacus oleae, Dasineura brassicae, Delia antique, Delia coarctata, Delia pla- tura, Delia radicum, Dermatobia hominis, Fannia canicularis, Geomyza Tripunctata, Gasterophi- lus intestinalis, Glossina morsitans, Glossina palpalis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates spp., Hylemyia platura, Hypoderma lineata, Leptoconops torrens, Liriomyza sativae, Liriomyza trifolii, Lucilia caprina, Lucilia cu- prina, Lucilia sericata, Lycoria pectoralis, Mansonia titillanus, Mayetiola destructor, Musca do- mestica, Muscina stabulans, Oestrus ovis, Opomyza florum, Oscinella frit, Pegomya hysocyami, Phorbia antiqua, Phorbia brassicae, Phorbia coarctata, Phlebotomus argentipes, Psorophora columbiae, Psila rosae, Psorophora discolor, Prosimulium mixtum, Rhagoletis cerasi, Rhago- letis pomonella, Sarcophaga haemorrhoidalis, Sarcophaga sp., Simulium vittatum, Stomoxys calcitrans, Tabanus bovinus, Tabanus atratus, Tabanus lineola, and Tabanus similis, Tipula oleracea, and Tipula paludosa thrips (Thysanoptera), e.g. Dichromothrips corbetti, Dichromothrips ssp, Frankliniella fusca, Frankliniella occidentalis, Frankliniella tritici, Scirtothrips citri, Thrips oryzae, Thrips palmi and Thrips tabaci, termites (Isoptera), e.g. Calotermes flavicollis, Leucotermes flavipes, Heterotermes aureus, Re- ticulitermes flavipes, Reticulitermes virginicus, Reticulitermes lucifugus, Termes natalensis, and Coptotermes formosanus, cockroaches (Blattaria - Blattodea), e.g. Blattella germanica, Blattella asahinae, Periplaneta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta aus- tralasiae, and Blatta orientalis, true bugs (Hemiptera), e.g. Acrosternum hilare, Blissus leucopterus, Cyrtopeltis notatus, Dysdercus cingulatus, Dysdercus intermedius, Eurygaster integriceps, Euschistus impictiventris, Leptoglossus phyllopus, Lygus lineolaris, Lygus pratensis, Nezara viridula, Piesma quadrata, Solubea insularis, Thyanta perditor, Acyrthosiphon onobrychis, Adelges laricis, Aphidula nastur- tii, Aphis fabae, Aphis forbesi, Aphis pomi, Aphis gossypii, Aphis grossulariae, Aphis schneideri, Aphis spiraecola, Aphis sambuci, Acyrthosiphon pisum, Aulacorthum solani, Bemisia argentifo- ///', Brachycaudus cardui, Brachycaudus helichrysi, Brachycaudus persicae, Brachycaudus pru- nicola, Brevicoryne brassicae, Capitophorus horni, Cerosipha gossypii, Chaetosiphon fragaefo- lii, Cryptomyzus ribis, Dreyfusia nordmannianae, Dreyfusia piceae, Dysaphis radicola, Dysaula- corthum pseudosolani, Dysaphis plantaginea, Dysaphis pyri, Empoasca fabae, Hyalopterus pruni, Hyperomyzus lactucae, Macrosiphum avenae, Macrosiphum euphorbiae, Macrosiphon rosae, Megoura viciae, Melanaphis pyrarius, Metopolophium dirhodum, Myzus persicae, Myzus ascalonicus, Myzus cerasi, Myzus varians, Nasonovia ribis-nigri, Nilaparvata lug ens, Pemphigus bursarius, Perkinsiella saccharicida, Phorodon humuli, Psylla mail, Psylla piri, Rhopalomy- zus ascalonicus, Rhopalosiphum maidis, Rhopalosiphum padi, Rhopalosiphum insertum, Sap-
paphis mala, Sappaphis mall, Schizaphis graminum, Schizoneura lanuginosa, Sitobion avenae, Trialeurodes vaporariorum, Toxoptera aurantiiand, Viteus vitifolii, Cimex lectularius, Cimex he- mipterus, Reduvius senilis, Triatoma spp., and Arilus critatus. ants, bees, wasps, sawflies (Hymenoptera), e.g. Athalia rosae, Atta cephalotes, Atta capiguara, Atta cephalotes, Atta laevigata, Atta robusta, Atta sexdens, Atta texana, Crematogaster spp., Hoplocampa minuta, Hoplocampa testudinea, Monomorium pharaonis, Solenopsis geminata, Solenopsis invicta, Solenopsis richteri, Solenopsis xyloni, Pogonomyrmex barbatus, Pogono- myrmex californicus, Pheidole megacephala, Dasymutilla occidentalis, Bombus spp. Vespula squamosa, Paravespula vulgaris, Paravespula pennsylvanica, Paravespula germanica, Doli- chovespula maculata, Vespa crabro, Polistes rubiginosa, Camponotus floridanus, and
Linepithema humile, crickets, grasshoppers, locusts (Orthoptera), e.g. Acheta domestica, Gryllotalpa gryllotalpa, Lo- custa migratoria, Melanoplus bivittatus, Melanoplus femurrubrum, Melanoplus mexicanus, Me- lanoplus sanguinipes, Melanoplus spretus, Nomadacris septemfasciata, Schistocerca america- na, Schistocerca gregaria, Dociostaurus maroccanus, Tachycines asynamorus, Oedaleus se- negalensis, Zonozerus variegatus, Hieroglyphus daganensis, Kraussaria angulifera, Callip- tamus italicus, Chortoicetes termini fera, and Locustana pardalina,
Arachnoidea, such as arachnids (Acarina), e.g. of the families Argasidae, Ixodidae and Sar- coptidae, such as Amblyomma americanum, Amblyomma variegatum, Ambryomma maculatum, Argas persicus, Boophilus annulatus, Boophilus decoloratus, Boophilus microplus, Dermacentor silvarum, Dermacentor andersoni, Dermacentor variabilis, Hyalomma truncatum, Ixodes ricinus, Ixodes rubicundus, Ixodes scapularis, Ixodes holocyclus, Ixodes pacificus, Ornithodorus mou- bata, Ornithodorus hermsi, Ornithodorus turicata, Ornithonyssus bacoti, Otobius megnini, Der- manyssus gallinae, Psoroptes ovis, Rhipicephalus sanguineus, Rhipicephalus appendiculatus, Rhipicephalus evertsi, Sarcoptes scabiei, and Eriophyidae spp. such as Aculus schlechtendali, Phyllocoptrata oleivora and Eriophyes sheldoni; Tarsonemidae spp. such as Phytonemus palli- dus and Polyphagotarsonemus latus; Tenuipalpidae spp. such as Brevipalpus phoenicis; Tetra- nychidae spp. such as Tetranychus cinnabarinus, Tetranychus kanzawai, Tetranychus pacificus, Tetranychus telarius and Tetranychus urticae, Panonychus ulmi, Panonychus citri, and Oligonychus pratensis; Araneida, e.g. Latrodectus mactans, and Loxosceles reclusa, fleas (Siphonaptera), e.g. Ctenocephalides felis, Ctenocephalides canis, Xenopsylla cheopis, Pulex irritans, Tunga penetrans, and Nosopsyllus fasciatus, silverfish, firebrat (Thysanura), e.g. Lepisma saccharina and Thermobia domestica, centipedes (Chilopoda), e.g. Scutigera coleoptrata, millipedes (Diplopoda), e.g. Narceus spp.,
Earwigs (DermapteraJ, e.g. forficula auricularia, lice (Phthiraptera), e.g. Pediculus humanus capitis, Pediculus humanus corporis, Pthirus pubis, Haematopinus eurystemus, Haematopinus suis, Linognathus vituli, Bovicola bovis, Menopon gallinae, Menacanthus stramineus and Solenopotes capillatus, plant parasitic nematodes such as root-knot nematodes, Meloidogyne arenaria, Meloidogyne chitwoodi, Meloidogyne exigua, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne java- nica and other Meloidogyne species; cyst nematodes, Globodera rostochiensis, Globodera pal- lida, Globodera tabacum and other Globodera species, Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; seed gall nematodes, Anguina funesta, Anguina tritici and other Anguina species; stem and foliar nematodes, Aphelenchoides besseyi, Aphelenchoides fragariae, Aphelenchoides ritzemabosi and other Aphelenchoides species; sting nematodes, Belonolaimus longicaudatus and other Belonolaimus species; pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species; ring nematodes, Criconema species, Criconemella species, Criconemoides species, and Mesocri- conema species; stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci, Dity- lenchus myceliophagus and other Ditylenchus species; awl nematodes, Dolichodorus species; spiral nematodes, Helicotylenchus dihystera, Helicotylenchus multicinctus and other Helicoty- lenchus species, Rotylenchus robustus and other Rotylenchus species; sheath nematodes, Hemicycliophora species and Hemicriconemoides species; Hirshmanniella species; lance nematodes, Hoplolaimus columbus, Hoplolaimus galeatus and other Hoplolaimus species; false root-knot nematodes, Nacobbus aberrans and other Nacobbus species; needle nematodes, Longidorus elongates and other Longidorus species; pin nematodes, Paratylenchus species; lesion nematodes, Pratylenchus brachyurus, Pratylenchus coffeae, Pratylenchus curvitatus, Pratylenchus goodeyi, Pratylencus neglectus, Pratylenchus penetrans, Pratylenchus scribneri, Pratylenchus vulnus, Pratylenchus zeae and other Pratylenchus species; Radinaphelenchus cocophilus and other Radinaphelenchus species; burrowing nematodes, Radopholus similis and other Radopholus species; reniform nematodes, Rotylenchulus reniformis and other Rotylen- chulus species; Scutellonema species; stubby root nematodes, Trichodorus primitivus and other Trichodorus species; Paratrichodorus minor and other Paratrichodorus species; stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species and Merlinius species; citrus nematodes, Tylenchulus semipenetrans and other Tylen- chulus species; dagger nematodes, Xiphinema americanum, Xiphinema index, Xiphinema di- versicaudatum and other Xiphinema species; and other plant parasitic nematode species.
The term "plant" denotes various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as oilseed rape, canola, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grape-
fruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn (maize), soybean, oilseed rape, canola, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants. Preferred plants are OSR/canola, cereals, rice, legumes/pulses, alfalfa, sugarbeet, mustard, sorghum, ornamentals, tobacco, corn, soybean, sugarcane, sunflower, potato, cotton, fruits (temperate and tropical), grapes and vegetables.
More preferred plants are corn, soybean, sugarcane, sunflower, potato, cotton, fruits (temperate and tropical), grapes and vegetables.
Most preferred plants are fruits (temperate and tropical), grapes and vegetables. The term " plants" is also to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties.
Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleacher herbicides such as hydroxylphenylpyruvate dioxy- genase (HPPD) inhibitors or phytoene desaturase (PDS) inhibittors; acetolactate synthase (ALS) inhibitors such as sulfonyl ureas or imidazolinones; enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynil (i. e. bromoxynil or ioxynil) herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or ACCase inhibitors. These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61 , 2005, 246; 61 , 2005, 258; 61 , 2005, 277; 61 , 2005, 269; 61 , 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1 185; and refer- ences quoted therein. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun® sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron. Genetic engineering methods
have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate-tolerant, Monsanto, U.S.A.), Cul- tivance® (imidazolinone tolerant, BASF SE, Germany) and LibertyLink® (glufosinate-tolerant, Bayer CropScience, Germany).
Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as δ-endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), CryllA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal pro- teins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdyster- oid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilben synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO 02/015701 ). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 und WO 03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of athropods, especially to beetles (Coelop- tera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard® (corn cultivars producing the CrylAb toxin), YieldGard® Plus (corn cultivars producing CrylAb and Cry3Bb1 toxins), Starlink® (corn cultivars producing the Cry9c toxin), Herculex® RW (corn cultivars producing Cry34Ab1 , Cry35Ab1 and the enzyme Phosphinothri- cin-N-Acetyltransferase [PAT]); NuCOTN® 33B (cotton cultivars producing the CrylAc toxin), Bollgard® I (cotton cultivars producing the CrylAc toxin), Bollgard® II (cotton cultivars producing CrylAc and Cry2Ab2 toxins); VIPCOT® (cotton cultivars producing a VIP-toxin); NewLeaf® (potato cultivars producing the Cry3A toxin); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Pro- tecta®, Bt1 1 (e. g. Agrisure® CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the CrylAb toxin and PAT enyzme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531
from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the CrylAc toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1 F toxin and PAT enzyme).
Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called "path- ogenesis-related proteins" (PR proteins, see, e. g. EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora in- festans derived from the mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.
Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.
Furthermore, plants are also covered that contain by the use of recombinant DNA tech- niques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera® rape, DOW Agro Sciences, Canada).
Furthermore, plants are also covered that contain by the use of recombinant DNA tech- niques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora® potato, BASF SE, Germany).
In the mixtures and compositions, the compound ratios are advantageously chosen so as to produce a synergistic effect.
The term "synergstic effect" is understood to refer in particular to that defined by Colby's formula (Colby, S. R., "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds, 15, pp. 20-22, 1967).
The term "synergistic effect" is also understood to refer to that defined by application of the Tammes method, (Tammes, P. M. L, "Isoboles, a graphic representation of synergism in pesti- cides", Netherl. J. Plant Pathol. 70, 1964).
According to the invention, the solid material (dry matter) of the microorganisms such as compound II, compound III or antifungal biocontrol agents (with the exception of oils) are considered as active components (e.g. to be obtained after drying or evaporation of the extraction medium or the suspension medium in case of liquid formulations of the microbial pesticides).
The total weight ratios of compositions comprising at least one microbial pesticide in the form of viable microbial cells including dormant forms, can be determined using the amount of CFU of the respective microorganism to calclulate the total weight of the respective active component with the following equation that 1 x 109 CFU equals one gram of total weight of the respective
active component. Colony forming unit is measure of viable microbial cells, in particular fungal and bacterial cells. In addition, here "CFU" may also be understood as the number of (juvenile) individual nematodes in case of (entomopathogenic) nematode biopesticides, such as
Steinernema feltiae.
In the binary mixtures and compositions according to the invention the weight ratio of the component 1 ) and the component 2) generally depends from the properties of the active components used, usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 , even more preferably in the range of from 1 :4 to 4:1 and in particular in the range of from 1 :2 to 2:1.
According to a further embodiments of the binary mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 1000:1 to 1 :1 , often in the range of from 100: 1 to 1 :1 , regularly in the range of from 50:1 to 1 :1 , preferably in the range of from 20:1 to 1 :1 , more preferably in the range of from 10:1 to 1 :1 , even more preferably in the range of from 4:1 to 1 :1 and in particular in the range of from 2:1 to 1 :1.
According to a further embodiments of the binary mixtures and compositions, the weight ratio of the component 1 ) and the component 2) usually is in the range of from 1 :1 to 1 :1000, often in the range of from 1 :1 to 1 :100, regularly in the range of from 1 :1 to 1 :50, preferably in the range of from 1 :1 to 1 :20, more preferably in the range of from 1 :1 to 1 :10, even more preferably in the range of from 1 :1 to 1 :4 and in particular in the range of from 1 :1 to 1 :2.
In the ternary mixtures, i.e. compositions according to the invention comprising the component 1 ) and component 2) and a compound III (component 3), the weight ratio of component 1 ) and component 2) depends from the properties of the active substances used, usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 and in particular in the range of from 1 :4 to 4: 1 , and the weight ratio of component 1 ) and component 3) usually it is in the range of from 1 :100 to 100:1 , regularly in the range of from 1 :50 to 50:1 , preferably in the range of from 1 :20 to 20:1 , more preferably in the range of from 1 :10 to 10:1 and in particular in the range of from 1 :4 to 4:1.
Any further active components are, if desired, added in a ratio of from 20:1 to 1 :20 to the component 1 ).
These ratios are also suitable for inventive mixtures applied by soil treatment.
The fungicidal action of the mixtures according to the invention can be shown by the tests described below.
Microtiter plate tests
The chemical pesticides (e.g. compounds IA, IB or IC) were formulated separately as a stock solution having a concentration of 10000 ppm in dimethyl sulfoxide.
The stock solutions of the chemical pesticides were mixed according to the ratio, diluted to the stated concentrations and pipetted onto a filter micro titer plate (MTP). A spore suspension of the pathogen (e.g. Botrytis cinerea, Septoria tritici, etc.) in e.g. aqueous biomalt solution was
added as well as different concentrations of spores or cells of the microbial pesticide (e.g. compound II). The plates were incubated at optimal temperature depending on the pathogen and further processed 1 -7 days after incubation. The supernatant was removed using CaptiVac Vacuum Collar and a vacuum filter pump. The remaining cell pellet was resolved in water and DNA was extracted. The growth of the pathogen was quantified via quantitative Real Time PCR using species- or strain-specific primers. To assess synergistic effects growth of the fungal pathogens was calculated in comparison to the different controls containing either the chemical pesticide or the microbial pesticide alone.
The measured parameters were compared to the growth of the active compound-free control variant (100%) and the fungus-free and active compound-free blank value to determine the relative growth in % of the pathogens in the respective active compounds.
The expected efficacies of active compound combinations were determined using Colby's formula (Colby, S.R., Calculating synergistic and antagonistic responses of herbicide combina- tions, Weeds, 15, pp. 20-22, 1967) and compared with the observed efficacies.
Colby's formula: E = x + y - x »y/100
E expected efficacy, expressed in % of the untreated control, when using the mixture of the active compounds A (e.g. compound IA, IB or IC) and B (e.g. compound II) at the concentrations a and b
x efficacy, expressed in % of the untreated control, when using the active compound A at the concentration a
y efficacy, expressed in % of the untreated control, when using the active compound B at the concentration b. Use example FM-1 : Activity against Septoria tritici, the causal agent of leaf blotch on wheat A spore suspension of Septoria tritici in an aqueous biomalt solution was used. The plates were placed in a water vapor-saturated chamber at a temperature of 18°C.
B) Greenhouse tests
The chemical pesticides (e.g. compounds IA, IB or IC) were formulated separately or together as a stock solution comprising 25 mg of active substance which was made up to 10 ml using a mixture of acetone and/or dimethyl sulfoxide (DMSO) and the emulsifier Wettol EM 31 (wetting agent having emulsifying and dispersing action based on ethoxylated alkylphenols) in a volume ratio of solvent/emulsifier of 99 to 1. This solution was then made up to 100 ml using water. This stock solution was diluted with the solvent/emulsifier/water mixture described to the active substance concentration given below. The microbial pesticide (e.g. compound II) was cultivated as described herein and was diluted with water to the concentration given below. Use example FG-1 : Activity against early blight on tomatoes caused by Phytophthora infestans with protective application
Young seedlings of tomato plants were grown in pots. The plants were sprayed to runoff with an aqueous suspension containing the concentration of chemical pesticide stated below. Simul-
taneously or up to 6 hours later, the plants were sprayed with an aquous suspension containg the concentration of the microbial pesticide stated below. The next day, the treated plants were inoculated with an aqueous suspension of sporangia of Phytophthora infestans. After inoculation, the trial plants were immediately transferred to a humid chamber. After 6 days at 18 to 200C and a relative humidity close to 100%, the extent of fungal attack on the leaves was visually assessed as % diseased leaf area.
Use example FG-2: Curative action against Puccinia recondita on wheat (brown rust of wheat) Leaves of potted wheat seedlings of the cultivar "Kanzler" were dusted with a suspension of spores of brown rust of wheat (Puccinia recondita). The plants were then placed in a chamber with high atmospheric humidity (90 to 95%), at 20-22°C, for 24 hours. During this time, the spores germinated and the germinal tubes penetrated into the leaf tissue. The next day, the infected plants were sprayed to runoff point with an aqueous suspension having the concentration of chemical pesticide stated below. Simultaneously or up to 6 hours later, the plants were sprayed with an aquous suspension containg the concentration of microbial pesticide stated below. After drying of the sprayed suspension, the test plants were returned into the greenhouse and cultivated at temperatures between 20 and 22°C and at 65 to 70% relative atmospheric humidity for a further 7 days. The extent of the rust development on the leaves was then determined visually.
Use example FG-3: Protective action against Puccinia recondita on wheat (brown rust of wheat)
Leaves of potted wheat seedlings of the cultivar "Kanzler" were sprayed to runoff point with an aqueous suspension having the concentration of chemical pesticide stated below. Simultaneously or up to 6 hours later, the plants were sprayed with an aquous suspension containg the concentration of microbial pesticide stated below. The next day, the treated plants were dusted with a suspension of spores of brown rust of wheat (Puccinia recondita). The plants were then placed in a chamber with high atmospheric humidity (90 to 95%), at 20-22°C, for 24 hours. During this time, the spores germinated and the germinal tubes penetrated into the leaf tissue. The next day, the test plants were returned into the greenhouse and cultivated at temperatures between 20 and 22°C and at 65 to 70% relative atmospheric humidity for a further 7 days. The extent of the rust development on the leaves was then determined visually.
Use example FG-4: Protective action against Blumeria graminis tritici on wheat (mildew of wheat)
Leaves of potted wheat seedlings of the cultivar "Kanzler" were sprayed to runoff point with an aqueous suspension having the concentration of chemical persticide stated below. Simultaneously or up to 6 hours later, the plants were sprayed with an aquous suspension containg the concentration of microbial pesticide stated below. The next day, the treated plants were dusted with a suspension of spores of mildew of wheat (Blumeria graminis tritici). The plants were then returned into the greenhouse and cultivated at temperatures between 20 and 24°C and at 60 to 90% relative atmospheric humidity for a further 7 days. The extent of the mildew development on the leaves was then determined visually.
Use example FG-5: Protective action against Sphaerotheca fuliginea on cucumber (mildew of cucumber)
Leaves of potted cucumber seedlings (in the germ layer stage) were sprayed to runoff point with an aqueous suspension having the concentration of chemical pesticide stated below. Sim- ultaneously or up to 6 hours later, the plants were sprayed with an aquous suspension containg the concentration of microbial pesticide stated below. The next day, the treated plants were dusted with a suspension of spores of mildew of cucumber (Sphaerotheca fuliginea). The plants were then returned into the greenhouse and cultivated at temperatures between 20 and 24°C and at 60 to 80% relative atmospheric humidity for a further 7 days. The extent of the mildew development on the seed leaves was then determined visually.
Use example FG-6: Action against Fusarium graminearum on lower roots in corn using pot trials
Triticonazole was applied as commercial seed treatment formulation PREMIS 25 FS (25 g/L a.i., BASF SE, Ludwigshafen, Germany). Pyraclostrobin was applied as commercial seed treatment formulation STAMINA (200 g/L a.i., BASF SE, Ludwigshafen, Germany).
In 4 pot tests in the greenhouse in Limburgerhof, Bacillus subtilis MBI600, as SC formulation of spores with CFU of about 4 x 1011 per ml, was tested in the crops corn and rape seed against different pathogens (Fusarium, Rhizoctonia, Sclerotinia) as solo product and in combination with triticonazole or pyraclostrobin. The application of the different products was done as seed treatment and the seeds were treated in the BASF Seed Solutions Technology Center (SSTC) Limburgerhof using a batch lab treater. The respective amounts of seeds was placed in the bowl of the treater and the slurry was dosed on the spinning disk.
For the infection, rye kernels inoculated with Fusarium graminearum were used. The trial was sown in 8 cm pots and Vermiculite was used as a substrate. The pots were filled with the substrate and the rye kernels inoculated with Fusarium graminearum were placed directly adjacent to the corn seeds. In each pot 5 corn seeds (cv. A Mid) were sown at a sowing depth of 2 cm and then covered with substrate. For each treatment 9 replications were made. After the sowing, the pots were irigateded with fertilized water (0,3 % Kamasol Blau 8+8+6) and placed according the randomization plan in a greenhouse cabin (16 h light, relative humidity < 95 %) for 7 days at 16°C, then 14 days at 20°C, followed for 7 days at 23°C. When necessary, they were irrigated with fertilized water.
For the assessment, the roots were washed out to evaluate the disease symptoms at the lower part of the roots. The visually determined percentages of infected areas were converted into efficacies in % of the untreated control and the efficacy (E) was calculated as follows using Abbot's formula.
The efficacy (E) was calculated using the Abbot's formula:
E = (1 - α/β) · 100
a corresponds to the fungicidal infection of the treated plants in % and
β corresponds to the fungicidal infection of the untreated (control) plants in %
An efficacy of 0 means that the infection level of the treated plants corresponds to that of the untreated control plants; an efficacy of 100 means that the treated plants were not infected. The expected efficacies of active compound combinations were determined using Colby's
formula (Colby, S.R. "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, pp. 20-22, 1967) and compared with the observed efficacies.
Colby's formula: ECoiby = PA + PB - PA * PB/100
Ecoiby expected efficacy, expressed in % of the untreated control, when using the mixture of the active compounds A and B at the concentrations a and b
PA efficacy, expressed in % of the untreated control, when using the active compound A at the concentration a
PB efficacy, expressed in % of the untreated control, when using the active compound B at the concentration b.
The results are shown in the following Table.
Use example FG-7: Action against Fusarium graminearum on mesocotyl of corn using pot trials Experimental setup was identical to Use example FG-6 unless described below.
For the assessment, the roots were washed out to evaluate the disease symptoms at the mesocotyl. The visually determined percentages of infected mesocotyl areas were converted into efficacies in % of the untreated control and the efficacy (E) was calculated as follows using Abbot's formula.
The results are shown in the following Table.
Product/Mix Product rate per Observed efficacy Calculated efficacy
100 kg seeds acc. to Colby untreated check - 0 (infection level:
44.4%)
Triticonazole 5 g ai 60
B. subtilis MBI600 50 ml 5
B. subtilis MBI600 600 ml 37.9
Product/Mix Product rate per Observed efficacy Calculated efficacy
100 kg seeds acc. to Colby
Pyraclostrobin + 5 g a.i. + 80 62
B. subtilis MBI600 50 ml
Pyraclostrobin + 5 g a.i. + 80 75.2
B. subtilis MBI600 600 ml
Use example FG-8: Action against Rhizoctonia solani on roots and fist leaves of corn using pot trials
Experimental setup was identical to Use example FG-6 unless described below.
For the infection, rye kernels inoculated with Rhizoctonia solani (AG 2) were used. The trial was sown in 8 cm pots and as a substrate a mix of peat substrate and sand in the ratio 1 : 4 was used. The pots were filled with the substrate and the rye kernels inoculated with Rhizoctonia solani were placed directly adjacent to the seeds. In each pot 5 rape seeds (cv. Titan) respectively 5 corn seeds (cv. P 8000) were sown at a sowing depth of 1 cm (rape seed) respectively 2 cm (corn), then covered with substrate. For each treatment 9 replications were made. After the sowing, the pots were irigateded with fertilized water (0,3 % Kamasol Blau 8+8+6) and placed according the randomization plan in a greenhouse cabin (16 h light, relative humidity < 95 %) for 3 weeks at 20°C. When necessary, they were irrigated with fertilized water. For the assessment, the roots were washed out to evaluate the disease symptoms on the roots. In rape seed a 2 class evaluation (healthy, diseased) was used, in corn the root mass was estimated in relation to the check without infection. In corn in addition the disease symptoms on the first leaf were evaluatead according to a 2 class evaluation. The figures from the class evalutation were converted into efficacies in % of the untreated control and the efficacy (E) was calculated as follows using Abbot's formula.
The results for efficacy against R. solani on roots are shown in the following Table.
Product/Mix Product rate per Observed efficacy Calculated efficacy (%)
100 kg seeds (%) acc. to Colby untreated check - 0 (infection level:
50.9%)
Pyraclostrobin 10 g ai 28.7
B. subtilis MBI600 80 ml 4.4
B. subtilis MBI600 320 ml 5.5
Pyraclostrobin + 10 g a.i. + 52.0 31.8
B. subtilis MBI600 80 ml
Product/Mix Product rate per Observed efficacy Calculated efficacy (%)
100 kg seeds (%) acc. to Colby
Pyraclostrobin + 10 g a.i. + 54.2 32.6
B. subtilis MBI600 320 ml
The results for root mass affected by R. solani are shown in the following Table.
The results for efficacy against R. solani assessed on first leaf are shown in the following Ta- ble.
Product/Mix Product rate per Observed efficacy Calculated efficacy (%)
100 kg seeds (%) acc. to Colby untreated check - 0 (infection level:
60%)
Pyraclostrobin 10 g ai 1 .9
B. subtilis MBI600 50 ml 35.5
B. subtilis MBI600 600 ml 29.6
Pyraclostrobin + 10 g a.i. + 45.1 36.7
B. subtilis MBI600 50 ml
Pyraclostrobin + 10 g a.i. + 66.7 30.9
B. subtilis MBI600 600 ml
The insecticidal action of the mixtures according to the invention can be shown by the tests as described below using the respective microbial pesticide (e.g. compound II) as formulated product or conidia/spores suspensions in sterile water with 0.05% v/v adjuvant (e.g. Tween® 80).
I. Compatibility of chemical pesticides (e.g. compound IA, IB or IC) with microbial pesticides (e.g. compound II) Materials:
- autoclaved medium adapted to the microbial pesticide to cultivate: potato dextrose agar (PDA), malt dextrose agar (MEA), potato carrot agar (PCA) or sabouraud dextrose agar (SDA)
- sterile plates (e.g. Petri dishes), vessels (e.g. bottles) and sterile water.
For dilution of oil formulations it may be recommended to use kerosene or add Tween® 80 at 0.05% v/v to the sterile water.
A) Liquid mixture in a bottle
Chemical pesticide formulations are prepared from stock solutions (see above) in sterile water or water with 0.05% v/v Tween® 80 using a logarithmic range of concentrations expressed in ppm. The spore/conidia solution of the microbial pesticide at the concentration stated below is pipetted into each vessel containing the chemical pesticide. The vessels are shaken to ensure the complete suspension of the microbial pesticide and kept at room temperature (24-26 °C) during the experiment.
The mixture is then diluted to a concentration of 1 x 106 spores/conidia per ml. A fixed vol- ume (i.e. 1 mL) of each treatment is pipetted at different time intervals and distributed aseptical- ly onto a plate containing the autoclaved medium for culture.
B) Solid plate assay
Chemical pesticide at various test concentrations is added to a series of vessels containing warm autoclaved medium before it gets solid, and then poured into separate pates using 4 replicates per treatment. After the medium solidified, the spore/conidia solution (i.e. 1 x 106 spores/conidia per mL) is pipetted into each plate.
In both methods, 4 replicates are used and the plates are cultured at 28 °C and 80% rel. hu- midity for 24 to 48 h. Compatibility is determined after 1 , 24 h and optionally 48 h as follwos: 1 ) by counting germinated vs. non-germinated spores/conidia (counted≥ 100) in the mixture using a microscope and hemacytometer to establish the germination rate in %, or number of germinated spores/conidia; or 2) by determining colony diameter in mm, speed of growth in mm/day, shape of the colony and/or color of the colony on the plates. All parameters are compared to a suspension of spores/conidia in absence of chemical pesticide (negative control).
II. Determination of sub-lethal rates of the chemical pesticide (e.g. compound IA, IB or IC) and microbial pesticide (e.g. compound II)
These studies can be conducted in the growth chamber, greenhouse and/or in the field. Test plants are either dipped or sprayed with spore/conidia suspensions of the microbial pesticide at various concentrations or with formulations of the chemical pesticide at various concentrations and subsequently left to dry. Then, the plants are artificially or naturally infested with the respec- tive target insect species. Assessments are carried out at different timings after treatment. The parameters evaluated are: efficacy (counting dead insects vs. alive), feeding damage, and/or plant vigor. All parameters are determined in comparison to the untreated insect-infested plants (free of microbialpesticide and chemical pesticide, respectively). III. Synergism trials
A synergism trial will contain at least the following treatments:
a) chemical pesticide at the sub-lethal rate a
b) microbial pesticide alone at the sub-lethal rate b
c) mixture of the chemical pesticide at rate a and the microbial pesticide at rate b
d) Untreated control.
The microbial pesticide suspensions and chemical pesticide formulations can be prepared as described above. The expected efficacies of the mixtures are determined using Colby's formula as described above and compared with the observed efficacies. Efficacy is determined as insect mortality (number of dead insects vs. number of insects tested in the experiment) and/or % feeding damage.
Use example 1-1 : Curative action against stink bugs (Nezara viridula) in the field
Soybean plants are grown in the field allowing natural infestation with stinkbugs. Plants were sprayed with the respective treatments. Efficacy was determined at 3, 7 and 14 days after treatment.
Use example I-2: Curative action against whiteflies (Bemisia tabaci) in the field
Tomato plants were grown in the field allowing natural infestation with whiteflies. Plants were sprayed with the respective treatments. Efficacy on adults was determined at 3, 7, 14 and 21 days after treatment, on larvae at 21 days after treatment.
Use example I-3: Protective action against thrips (Frankiniella occidentalis) in the growth chamber
Lima bean plants were grown in small pots. Plants were dipped into the respective treat- ments. Plants were put into plastic cups and left to dry. Once dried, plants were infested with 15 adult thrips and cups were closed. Efficacy was evaluated at 3, 7 and 10 days after treatment.
Use example I-4: Protective action against Southern armyworm (Spodoptera eridiana)
Lima bean leaves were cut and dipped into the respective treatments and placed in Petri dishes on wet filter paper to keep humidity. Once the surface of the leaves dried, 5 first/second instar larvae were infested per petri dish. Efficacy was evaluated at 3, 7 and 10 days after treatment.
Use example 1-5: Protective action against Colorado potato beetle (Leptinotarsa decemlineata) in the field
Potato plants were grown in the field allowing natural infestation with Colorado potato beetles. Plants were sprayed with the respective treatments. Efficacy was determined at 3, 7 and 14 days after treatment.
The plant health improving action of the mixtures according to the invention can be shown by the tests described below.
Use example H-1 : Action against drought stress
Drought stress tolerance can be tested e.g. on duckweed plants grown in 24-well microplates according to the method disclosed J. Plant Growth Regul. 30, 504-51 1 (201 1 ).
The measured parameters were compared to the growth of the active compound-free control variant under drought stress (e.g. PEG treatment) (0%) and the active compound-free blank value without drought stress (e.g. PEG-fee) (100%) to determine the relative growth in % in the respective active compounds. The expected efficacies of active compound combinations were determined using Colby's formula as described above.
Claims
1 . Synergistic mixtures comprising, as active components,
1 ) one fungicidal compound IA selected from the group consisting of
A) Respiration inhibitors
- Inhibitors of complex III at Qo site: azoxystrobin, coumethoxystrobin, coumoxystro- bin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy-strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyra- clostrobin, pyrametostrobin, pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phen- oxymethyl)-phenyl]-3-methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-di-chloro- phenyl)-1 -methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl- acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;
- inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-ben- zyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-di- oxonan-7-yl]-2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)- 4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl]-2-me- thylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy- pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl]-2-methylpropano- ate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1 ,3-benzodioxol-5-ylmethoxy)-4-methoxy-py- ridine-2-car-bonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl]-2-methylpropano- ate; (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl- 4,9-dioxo-8-(phenylmethyl)-1 ,5-dioxonan-7-yl-2-methylpropanoate;
- inhibitors of complex II: benodanil, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, N-(4'-trifluoromethylthiobiphenyl-
2- yl)-3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl- butyl)-phenyl)-1 ,3-dimethyl-5-fluoro-1 H-pyrazole-4-carboxamide, benzovindiflupyr,
3- (difluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide,
3- (trifluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide,
1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluorometh- yl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoro- methyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1 ,3,5-tri- methyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide;
- other respiration inhibitors: diflumetorim, (5,8-difluoro-quinazolin-4-yl)-{2-[2-fluoro-
4- (4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; nitrophenyl derivates: bina- pacryl, dinobuton, dinocap, fluazinam; ferimzone; organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin; and silthiofam;
B) Sterol biosynthesis inhibitors
- C14 demethylase inhibitors: triazoles: azaconazole, bitertanol, bromuconazole, cy- proconazole, difenoconazole,diniconazole, diniconazole-M, epoxiconazole, fenbu-
conazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ip- conazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadime- nol, triticonazole, uniconazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophen- yl)-oxiranylmethyl]-5-thiocyanato-1 H-[1 ,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophen- yl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1 ,2,4]triazole-3-thiol; imidazoles:
imazalil, pefurazoate, prochloraz, triflumizol; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine;
- Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph-acetate, fenpropi- morph, tridemorph, fenpropidin, piperalin, spiroxamine;
- Inhibitors of 3-keto reductase: fenhexamid;
C) Nucleic acid synthesis inhibitors
- phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, met- alaxyl, ofurace, oxadixyl;
- others: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-
2-(p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin- 4-amine;
D) Inhibitors of cell division and cytoskeleton
- tubulin inhibitors: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate- methyl; triazolopyrimidines: 5-chloro-7-(4-methylpiperidin-1 -yl)-6-(2,4,6-trifluoro- phenyl)-[1 ,2,4]triazolo[1 ,5-a]pyrimidine;
- other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;
E) Inhibitors of amino acid and protein synthesis
- methionine synthesis inhibitors: cyprodinil, mepanipyrim, pyrimethanil;
- protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride- hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;
F) Signal transduction inhibitors
- MAP / histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, fludioxonil;
- G protein inhibitors: quinoxyfen;
G) Lipid and membrane synthesis inhibitors
- Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos, isopro- thiolane;
- lipid peroxidation: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;
- phospholipid biosynthesis and cell wall deposition: dimethomorph, flumorph, mandi- propamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate and N-(1 -(1 -(4-cy- ano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;
- compounds affecting cell membrane permeability and fatty acides: propamocarb, propamocarb-hydrochloride;
- fatty acid amide hydrolase inhibitors: 1 -[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro- 3-isoxazolyl]-2-thiazolyl]-1 -piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1 H-pyrazol- 1 -yl]ethanone;
H) Inhibitors with Multi Site Action
- inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
- thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, thiram, zineb, ziram;
- organochlorine compounds: anilazine, chlorothalonil, captafol, captan, folpet, dichlo- fluanid, dichlorophen, hexachlorobenzene, pentachlorphenole and its salts, phthal- ide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;
- guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine- acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithia- non, 2,6-dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone; I) Cell wall synthesis inhibitors
- inhibitors of glucan synthesis: validamycin, polyoxin B; melanin synthesis inhibitors: pyroquilon, carpropamid, dicyclomet, fenoxanil;
J) Plant defence inducers
acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; 4-cyclopropyl-N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide; phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts;
K) Unknown mode of action
- bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclome- zine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumet- over, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxine- copper, picarbutrazox, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy- 6-iodo-3-propylchromen-4-one, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy- 2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N'-(4-(4-chloro-3-trifluoromethyl- phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N' (4-(4-fluoro-3-tri- fluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine,
N'-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl- N-methyl formamidine, N'-(5-difluoromethyl-2-methyl-4-(3-tri-methylsilanyl-propoxy)- phenyl)-N-ethyl-N-methyl formamidine, 2-methoxy-acetic acid 6-tert-butyl-8-fluoro- 2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin- 3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyris- oxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro- 1 -(4,6-di-methoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole, 2-(4-chloro-phenyl)- N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide, 4,4-difluoro- 3,3-dimethyl-1 -(3-quinolyl)isoquinoline;
L) Antifungal biological Control Agents:
- Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus pu- milus, Bacillus pumilus NRRL B-30087, Bacillus subtilis, Bacillus subtilis NRRL
B-21661 , Bacillus subtilis var. amylolique-faciens FZB24, Candida oleophila I-82, Candida saitoana, chitosan, Clonostachys rosea f. catenulate, Clonostachys rosea f. catenulate J 1446, Coniothyrium minitans, Cryphonectria parasitica, Endothia parasitica, Cryptococcus albidus, Fusarium oxysporum, Metschnikowia fructicola, Micro- dochium dimerum, Phlebiopsis gigantea, Pseudozyma flocculosa, Pythium oli- gandrum DMlA, Reynoutria sachlinensis, Talaromyces f/avus VH 7b, Trichoderma asperellum SKT-1 , 7 a tro viride LC 52, Γ. harzianum T '-22, Γ. harzianum TH 35, Γ. harzianum T-39, 7. harzianum and 7. v/r/c/e, 7. harzianum ICC012 and 7 v/r/c/e ICC080, 7 polysporum and 7 harzianum, T. stromaticum, T. virens GL-21 , 7 v/r/c/e, 7 v/r/c/e TV1 , Ulocladium oudemansii HRU3;
or
2) one insecticidal compound IB selected from the group consisting of
M-1 .A acetylcholine esterase inhibitors from the class of carbamates:
aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, car- baryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodi- carb, thiofanox, trimethacarb, XMC, xylylcarb, and triazamate;
M-1 .B acetylcholine esterase inhibitors from the class of organophosphates:
acephate, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethox- yfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/ DDVP, dicrotophos, dimetho- ate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, ox- ydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos- methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, teme- phos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion; M-2 GABA-gated chloride channel antagonists:
M-2.A cyclodiene organochlorine compounds: endosulfan;
M-2.B fiproles: ethiprole, fipronil, flufiprole, pyrafluprole, or pyriprole;
M-2. Others: 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-
3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1 -carboxamide, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo- 2-(2,2,2-trifluoroethylamino)ethyl]benzamide;
M-3 sodium channel modulators from the class of pyrethroids: acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopen- tenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda- cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cyper- methrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empen- thrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin,
tau-fluvalinate, halfenprox, imiprothrin, meperfluthrin, metofluthrin, momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethylfluthrin, tetramethrin, tralomethrin, transfluthrin, DDT and methoxychlor;
M-4 nicotinic acteylcholine receptor agonists from the class of neonicotinoids:
acetamiprid, chlothianidin, cycloxaprid, dinotefuran, flupyradifurone, imidacloprid, ni- tenpyram, sulfoxaflor, thiacloprid, thiamethoxam, 1 -[(6-chloro-3-pyridyl)methyl]- 7-methyl-8-nitro-5-propoxy-3,
5,
6,
7-tetrahydro-2H-imidazo[1 ,2-a]pyridine or 1 -[(6- chloro-3-pyridyl)methyl]-2-nitro-1 -[(E)-pentylideneamino]guanidine;
M-5 allosteric nicotinic acteylcholine receptor activators from the class of spinosyns: spinosad, spinetoram;
M-6 chloride channel activators from the class of mectins: abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
M-7 juvenile hormone mimics: hydroprene, kinoprene, methoprene, fenoxycarb or pyriproxyfen;
M-8 non-specific multi-site inhibitors: methyl bromide and other alkyl halides, chloro- picrin, sulfuryl fluoride, borax or tartar emetic;
M-9 selective homopteran feeding blockers: pymetrozine, flonicamid, pyrifluquina- zon, 2-(5-fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride;
M-10 mite growth inhibitors: clofentezine, hexythiazox, diflovidazin or etoxazole;
M-1 1 inhibitors of mitochondrial ATP synthase: diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, or tetradifon;
M-12 uncouplers of oxidative phosphorylation: chlorfenapyr, DNOC, or sulfluramid; M-13 nicotinic acetylcholine receptor channel blockers: bensultap, cartap hydrochlo- ride, thiocyclam, thiosultap sodium;
M-14 inhibitors of the chitin biosynthesis type 0: bistrifluron, chlorfluazuron, difluben- zuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflum- uron, teflubenzuron, triflumuron;
M-15 inhibitors of the chitin biosynthesis type 1 : buprofezin;
M-16 moulting disruptors: cyromazine;
M-17 Ecdyson receptor agonists: methoxyfenozide, tebufenozide, halofenozide, fufenozide or chromafenozide;
M-18 Octopamin receptor agonists: amitraz;
M-19 Mitochondrial complex III electron transport inhibitors: hydramethylnon, acequinocyl, flometoquin, fluacrypyrim or pyriminostrobin;
M-20 Mitochondrial complex I electron transport inhibitors: fenazaquin, fenpyroxi- mate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim, or rotenone;
M-21 Voltage-dependent sodium channel blockers: indoxacarb, metaflumizone or
1 -[(E)-[2-(4-cyanophenyl)-1 -[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(di- fluoromethoxy)phenyl]urea;
M-22 Inhibitors of the lipid synthesis, inhibitors of acetyl CoA carboxylase: spirodi- clofen, spiromesifen or spirotetramat;
M-23 Mitochondrial complex II electron transport inhibitors: cyenopyrafen, cyflumetofen or pyflubumide;
M-24 Ryanodine receptor-modulators from the class of diamides: flubendiamide, chlorantraniliprole, cyantraniliprole, (R)-3-chloro-N1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-
1 - (trifluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2-methylsulfonylethyl)phthalamide, (S)-3-chloro-N 1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl}- N2-(1 -methyl-2-methylsulfonylethyl)phthalamide, 3-bromo-N-{2-bromo-4-chloro- 6-[(1 -cyclopropylethyl)carbamoyl]phenyl}-1 -(3-chloropyridin-2-yl)-1 H-pyrazole-
5- carboxamide, methyl-2-[3,5-dibromo-2-({[3-bromo-1 -(3-chloropyridin-2-yl)-1 H-py- razol-5-yl]carbonyl}amino)benzoyl]-1 ,2-dimethylhydrazinecarboxylate, N2-[2-(3-chlo ro-2-pyridyl)-5-[(5-methyltetrazol-2-yl)methyl]pyrazol-3-yl]-5-cyano-N1 ,3-dimethyl- phthalamide, N2-(1 -cyano-1 -methyl-ethyl)-N1 -(2,4-dimethylphenyl)-3-iodo-phthal- amide, 3-chloro-N2-(1 -cyano-1 -methyl-ethyl)-N1 -(2,4-dimethylphenyl), 2-(3-chloro-
2- pyridyl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-5-[[5-(trifluoromethyl)- tetrazol-2-yl]methyl]pyrazole-3-carboxamide, N-[2-(tert-butylcarbamoyl)-4-chloro-
6- methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-3-carboxamide, 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyr- azole-3-carboxamide, 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1 -cyano-
1 -methyl-ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide, N-[2-(5-amino-1 ,3,4-thi- adiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-
3- carboxamide;
M-25 Others: afidopyropen, flumetoquin, 2-(5-ethylsulfinyl-2-fluoro-4-methyl-phenyl) 5-methyl-1 ,2,4-triazol-3-amine, 1 -(5-ethylsulfinyl-2,4- dimethyl-phenyl)-3-methyl- 1 ,2,4-triazole, metaldehyde, triflumezopyrim,
8-chloro-N-[2-chloro-5-methoxyphen- yl)sulfonyl]-6-trifluoromethyl)-imidazo[1 ,2-a]pyridine-2-carboxamide, 5-[3-[2,6-dichlo ro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1 H-pyrazole, N-[1 -[(6-chloro-3-pyridyl)- methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-3-pyridyl)methyl]- 2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide, N-[1 -[(6-bromo-3-pyridyl)methyl] 2-pyridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(2-chloropyrimidin-5-yl)methyl]-2-py- ridylidene]-2,2,2-trifluoro-acetamide, N-[1 -[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-py- ridylidene]-2,2,2-trifluoro-acetamide, 2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyridyl)methyl]- 2-pyridylidene]acetamide, 2-chloro-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]- 2,2-difluoro-acetamide, N-[1 -[1 -(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-triflu- oro-acetamide, N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide; 1 1 -(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1 ,4-dioxa-9-azadispi- ro[4.2.4.2]-tetradec-1 1 -en-10-one, 3-(4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy- 8-oxa-1 -azaspiro[4.5]dec-3-en-2-one, 2-(5-fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-py- ridyl)thiazole hydrofluoride, 2-(3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole, 5-[6-(1 ,3-dioxan-2-yl)-2-pyridyl]-2-(3-pyridyl)thiazole, 4-[5-[3-chloro-5-(trifluorometh- yl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethyl- amino)ethyl]naphthalene-1 -carboxamide, 4-[5-(3,5-dichlorophenyl)-5-(trifluoro- methyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benz-
amide, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-me- thyl-N-(1 -oxothietan-3-yl)benzamide;
M-26 Bacillus firmus, Bacillus CNCM 1-1582;
or
3) one compound IC having plant growth regulator activity selected from the group consisting of:
- Antiauxins: clofibric acid, 2,3,5-tri-iodobenzoic acid;
- Auxins: 4-CPA, 2,4-D, 2,4-DB, 2,4-DEP, dichlorprop, fenoprop, IAA, IBA, naphtha- leneacetamide, onaphthaleneacetic acid, 1 -naphthol, naphthoxyacetic acid, potassium naphthenate, sodium naphthenate, 2,4,5-T;
- Cytokinins: 2iP, 6-benzylaminopurine, N-Oxide-2,6-lutidine, 2,6-dimethylpyridine, kinetin, zeatin;
- Defoliants: calcium cyanamide, dimethipin, endothal, merphos, metoxuron, penta- chlorophenol, thidiazuron, tribufos, tributyl phosphorotrithioate;
- Ethylene modulators: aviglycine, 1 -MCP, prohexadione, prohexadione calcium, trinexapac, trinexapac-ethyl;
- Ethylene releasers: ACC, etacelasil, ethephon, glyoxime;
- Gibberellins: gibberelline, gibberellic acid;
- Growth inhibitors: abscisic acid, ancymidol, butralin, carbaryl, chlorphonium, chlor- propham, dikegulac, flumetralin, fluoridamid, fosamine, glyphosine, isopyrimol, jasmonic acid, maleic hydrazide, mepiquat, mepiquat chloride, mepiquat pentabo- rate, piproctanyl, prohydrojasmon, propham, 2,3,5-tri-iodobenzoic acid;
- Morphactins: chlorfluren, chlorflurenol, dichlorflurenol, flurenol;
- Growth retardants: chlormequat, chlormequat chloride, daminozide, flurprimidol, mefluidide, paclobutrazol, tetcyclacis, uniconazole, metconazole;
- Growth stimulators: brassinolide, forchlorfenuron, hymexazol;
- Unclassified plant growth regulators / classification unknown: amidochlor, benzo- fluor, buminafos, carvone, choline chloride, ciobutide, clofencet, cloxyfonac, cyan- amide, cyclanilide, cycloheximide, cyprosulfamide, epocholeone, ethychlozate, ethylene, fenridazon, fluprimidol, fluthiacet, heptopargil, holosulf, inabenfide, karet- azan, lead arsenate, methasulfocarb, pydanon, sintofen, triapenthenol; and
4) Bacillus subtilis MBI600 as compound II having the accession number NRRL
B-50595.
The mixture according to claim 1 comprising compound IA and compound II.
The mixture according to claim 1 comprising compound IB and compound II.
The mixture according to 2 comprising as compound IA one fungicidal compound selected from the group consisting of flutolanil, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orysastrobin, picoxystrobin, pyraclostrobin, pyribencarb, amisulbrom, [(3S,6S,7R,8R)-8- benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-di- oxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4- methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine- 2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate,
[(3S,6S,7R,8R)-8-benzyl-3-[[3-(1 ,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-car- bonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate; (3S,6S,7R,8R)-3- [[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,
9-dioxo-8-(phenylmethyl)- 1 ,5-dioxonan-7-yl 2-methylpropanoate, bixafen, boscalid, fluopyram, fluxapyroxad, iso- pyrazam, penflufen, penthiopyrad, sedaxane, benzovindiflupyr, 3-(difluoromethyl)-1 -me- thyl-N-(1 , 1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 -methyl- N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan- 4-yl)pyrazole-4-carboxamide, 3-(trifleoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)- pyrazole-4-carboxamide, 3-(difluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)- pyrazole-4-carboxamide, 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carbox- amide, (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]- ethyl}-amine, ametoctradin, silthiofam, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fluquinconazole, ipconazole, metconazole, prothioconazole, tebuconazole, triticonazole, 1 -[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thi- ocyanato-1 H-[1 ,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxira- nylmethyl]-2H-[1 ,2,4]triazole-3-thiol, prochloraz, fenpropimorph, oxadixyl, metalaxyl, hyme- xazole, thiophanate-methyl, metrafenone, pyrimethanil, fludioxonil, iprobenfos, quintozene, tolclofos-methyl, dimethomorph, N-(1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbam- ic acid-(4-fluorophenyl) ester, propamocarb, propamocarb hydrochloride, metiram, dithia- non, 2,6-dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone, valida- mycin, isotianil, tiadinil, prohexadione-calcium, 4-cyclopropyl-N-(2,4-dimethoxyphenyl)thia- diazole-5-carboxamide, fosetyl, flusulfamide, 4,4-difluoro-3,3-dimethyl-1 -(3-quinolyl)iso- quinoline, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclo-propylmethoxyimino-(6-di- fluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, 2-methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl- isoxazolidin-3-yl]-pyridine, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro- 1 -(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus pumilus, Bacillus pumilus NRRL B-30087, Bacillus subtilis, Bacillus subtilis NRRL B-21661 , Bacillus subtilis var. amylo- lique-faciens FZB24, Candida oleophila I-82, Candida saitoana, Chitosan, Clonostachys rosea f. catenulate, Clonostachys rosea f. catenulate isolate J 1446, Coniothyrium minitans, Cryphonectria parasitica, Endothia parasitica, Cryptococcus albidus, Fusarium oxysporum, Metschnikowia fructicola, Microdochium dimerum, Phlebiopsis gigantea, Pseudozyma floe-
culosa, Pythium oligandrum DV74, Reynoutria sachlinensis, Talaromyces flavus V1 17b, Trichoderma asperellum SKT-1 , T. atroviride LC52, T. harzianum T-22, T. harzianum TH 35, T. harzianum T-39, T. harzianum and Γ. viride, T. harzianum ICC012 and T. viride ICC080, T. polysporum and T. harzianum, T. stromaticum, T. virens GL-21 , Γ. viride, T. viride TV1 and Ulocladium oudemansii HRU3.
The mixture according to 3 comprising as compound IB one insecticidal compound selected from aldicarb, benfuracarb, carbofuran, carbosulfan, oxamyl, pirimicarb, thiodicarb, chlorfenvinphos, chlorpyrifos, chlorpyrifos-methyl, dichlorvos/ DDVP, terbufos, ethiprole, fipronil, pyriprole, 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol- 3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1 -carboxamide, 4-[5-(3,5- dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoro- ethylamino)ethyl]benzamide, lambda-cyhalothrin, alpha-cypermethrin, fenvalerate, perme- thrin, tefluthrin, acetamiprid, chlothianidin, cycloxaprid, dinotefuran, flupyradifurone, imida- cloprid, nitenpyram, sulfoxaflor, thiacloprid, thiamethoxam, 1 -[(6-chloro-3-pyridyl)methyl]- 7-methyl-8-nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1 ,2-a]pyridine, spinosad, aba- mectin, emamectin benzoate, 2-(5-fluoro-3-pyridyl)-5-(6-pyrimidin-2-yl-2-pyridyl)thiazole hydrofluoride, chlorfenapyr, flufenoxuron, teflubenzuron, metaflumizone, flubendiamide, chlorantraniliprole, cyantraniliprole, (R)-3-chloro-N 1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 -(tri- fluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2-methylsulfonylethyl)phthalamide, (S)-3-chloro- N 1 -{2-methyl-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]phenyl}-N2-(1 -methyl-2-methyl- sulfonylethyl)phthalamide, 3-bromo-N-{2-bromo-4-chloro-6-[(1 -cyclopropylethyl)carbamo- yl]phenyl}-1 -(3-chloropyridin-2-yl)-1 H-pyrazole-5-carboxamide, methyl-2-[3,5-dibromo- 2-({[3-bromo-1 -(3-chloropyridin-2-yl)-1 H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1 ,2-di- methylhydrazinecarboxylate, N2-[2-(3-chloro-2-pyridyl)-5-[(5-methyltetrazol-2-yl)methyl]- pyrazol-3-yl]-5-cyano-N1 ,3-dimethyl-phthalamide ), afidopyropen, flumetoquin, 2-(5-ethyl- sulfinyl-2-fluoro-4-methyl-phenyl)-5-methyl-1 ,2,4-triazol-3-amine, 1 -(5-ethylsulfinyl-2,4-di- methyl-phenyl)-3-methyl-1 ,2,4-triazole, Bacillus firmus and Bacillus firmus CNCM 1-1582.
The mixture according to claim 5 wherein compound IA is selected from pyraclostrobin, azoxystrobin, trifloxystrobin, picoxystrobin, fluoxapyroxad, fluopyram, benzovindiflupyr, metalaxyl and fludioxonil.
The mixture according to any of claims 1 to 6 comprising as further compound III selected from Bradyrhizobium japonicum.
The mixture according to any of claims 1 to 7 comprising as further compound IV jasmonates or salts or esters thereof.
The mixture according to claim 8, wherein the further compound IV is methyl jasmonate.
10. The mixture according to any of claims 1 to 9, wherein the ratio by weight from compound I to compound II is from 1 :500 to 500:1 .
1 1 . The mixture according to claim 7 comprising compound I, compound II, compound III, in which each combination of two ingredients in the mixture of three ingredients ranges from
500:1 to 1 :500.
12. The mixture according to claim 8 or 9 comprising compound I, compound II, and compound IV, in which each combination of two ingredients in the mixture of three ingredients ranges from 500:1 to 1 :500.
13. The mixture according to claim 8 or 9 comprising compound I, compound II, compound III and compound IV, in which each combination of four ingredients in the mixture of three ingredients ranges from 500:1 to 1 :500.
14. A kit for preparing a usable pesticidal composition, the kit comprising:
a) a composition comprising component 1 ) as defined in any of the abovementioned claims and at least one auxiliary; or
b) a composition comprising component 2) as defined as defined in any of the abovemen- tioned claims and at least one auxiliary; or
c) a composition comprising component 3) as defined as defined in any of the abovementioned claims and at least one auxiliary; and
d) a composition comprising component 4) as defined as defined in any of the abovementioned claims and at least one auxiliary.
15. A pesticidal composition, comprising a liquid or solid carrier and a mixture as defined in any of claims 1 to 13.
16. A method for protection of plant propagation material from pests and/or improving the
health of plants grown from said plant propagation material, wherein the soil, wherein seeds are sown, is treated with an effective amount of a mixture as defined in any of claims 1 to 13 or with an effective amount of a composition as defined in claim 15.
17. A method as claimed in claim 14, wherein the compounds as defined in any of claims 1 to 13 are applied simultaneously, that is jointly or separately, or in succession.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12193735.3 | 2012-11-22 | ||
EP12193735 | 2012-11-22 | ||
EP13182419.5 | 2013-08-30 | ||
EP13182419 | 2013-08-30 | ||
EP13185091.9 | 2013-09-19 | ||
EP13185091 | 2013-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014079804A1 true WO2014079804A1 (en) | 2014-05-30 |
Family
ID=49584751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2013/074054 WO2014079804A1 (en) | 2012-11-22 | 2013-11-18 | Pesticidal mixtures |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014079804A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015181009A1 (en) * | 2014-05-27 | 2015-12-03 | Basf Se | Ternary mixtures comprising biopesticides and qoi fungicides and sdhi fungicides |
CN107903110A (en) * | 2017-11-17 | 2018-04-13 | 浙江海洋大学 | A kind of plant vaccine and its preparation |
US10076119B2 (en) | 2012-11-22 | 2018-09-18 | Basf Corporation | Pesticidal mixtures |
CN109221168A (en) * | 2018-10-11 | 2019-01-18 | 四川省兰月科技有限公司 | Plant growth regulator containing Thidiazuron, olefin conversion and amino-oligosaccharide |
US10212934B2 (en) | 2014-06-25 | 2019-02-26 | BASF Agro B.V. | Pesticidal compositions |
US10251400B2 (en) | 2014-05-23 | 2019-04-09 | Basf Se | Mixtures comprising a Bacillus strain and a pesticide |
CN109769837A (en) * | 2019-03-01 | 2019-05-21 | 贵州大学 | A kind of pesticide synergistic combination preventing and treating fruits and vegetables gray mold |
US10512267B2 (en) | 2013-07-08 | 2019-12-24 | BASF Agro, B.V. | Compositions comprising a triazole compound and a biopesticide |
US10519122B2 (en) | 2013-01-09 | 2019-12-31 | BASF Agro B.V. | Process for the preparation of substituted oxiranes and triazoles |
US10537110B2 (en) | 2012-11-22 | 2020-01-21 | Basf Corporation | Pesticidal mixtures |
US10743535B2 (en) | 2017-08-18 | 2020-08-18 | H&K Solutions Llc | Insecticide for flight-capable pests |
US10759767B2 (en) | 2012-12-20 | 2020-09-01 | BASF Agro B.V. | Compositions comprising a triazole compound |
US10779536B2 (en) | 2014-11-07 | 2020-09-22 | Basf Se | Pesticidal mixtures |
US10905122B2 (en) | 2016-03-16 | 2021-02-02 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals |
US11241012B2 (en) | 2016-03-16 | 2022-02-08 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean |
US11425909B2 (en) | 2016-03-16 | 2022-08-30 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits |
Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0374753A2 (en) | 1988-12-19 | 1990-06-27 | American Cyanamid Company | Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines |
EP0392225A2 (en) | 1989-03-24 | 1990-10-17 | Ciba-Geigy Ag | Disease-resistant transgenic plants |
EP0427529A1 (en) | 1989-11-07 | 1991-05-15 | Pioneer Hi-Bred International, Inc. | Larvicidal lectins and plant insect resistance based thereon |
US5021076A (en) | 1989-03-17 | 1991-06-04 | The United States Of America As Represented By The Secretary Of Agriculture | Enhancement of nitrogen fixation with Bradyrhizobium japonicum mutants |
EP0451878A1 (en) | 1985-01-18 | 1991-10-16 | Plant Genetic Systems, N.V. | Modifying plants by genetic engineering to combat or control insects |
WO1993007278A1 (en) | 1991-10-04 | 1993-04-15 | Ciba-Geigy Ag | Synthetic dna sequence having enhanced insecticidal activity in maize |
US5422107A (en) | 1992-12-25 | 1995-06-06 | Hokkaido Green Kosan, Incorporated | Trichoderma harzianum SK-55 fungus, fungicide containing it, and method of manufacture of the same and its use |
WO1995034656A1 (en) | 1994-06-10 | 1995-12-21 | Ciba-Geigy Ag | Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
WO2002015701A2 (en) | 2000-08-25 | 2002-02-28 | Syngenta Participations Ag | Bacillus thuringiensis crystal protein hybrids |
WO2003018810A2 (en) | 2001-08-31 | 2003-03-06 | Syngenta Participations Ag | Modified cry3a toxins and nucleic acid sequences coding therefor |
WO2003052073A2 (en) | 2001-12-17 | 2003-06-26 | Syngenta Participations Ag | Novel corn event |
WO2005077934A1 (en) | 2004-02-18 | 2005-08-25 | Ishihara Sangyo Kaisha, Ltd. | Anthranilamides, process for the production thereof, and pest controllers containing the same |
WO2005085216A1 (en) | 2004-03-05 | 2005-09-15 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and noxious organism control agent |
US6955912B2 (en) | 2000-03-31 | 2005-10-18 | Yasuharu Sasaki | Process for producing Trichoderma harzianum ferm BP-4346 |
WO2006043635A1 (en) | 2004-10-20 | 2006-04-27 | Kumiai Chemical Industry Co., Ltd. | 3-triazolylphenyl sulfide derivative and insecticide/acaricide/nematicide containing the same as active ingredient |
WO2006089633A2 (en) | 2005-02-22 | 2006-08-31 | Bayer Cropscience Ag | Spiroketal-substituted cyclic ketoenols |
WO2007043677A1 (en) | 2005-10-14 | 2007-04-19 | Sumitomo Chemical Company, Limited | Hydrazide compound and pesticidal use of the same |
WO2007079162A1 (en) | 2005-12-30 | 2007-07-12 | E. I. Du Pont De Nemours And Company | Isoxazolines for controlling invertebrate pests |
US7262151B2 (en) | 2001-07-06 | 2007-08-28 | Mcgill University | Methods and compositions for production of lipo-chito oligosaccharides by rhizobacteria |
CN101028009A (en) * | 2007-04-03 | 2007-09-05 | 盐城苏滨生物农化有限公司 | Caprotrahol and Bacillus subtilis compound agricultural chemicals |
WO2007101369A1 (en) | 2006-03-09 | 2007-09-13 | East China University Of Science And Technology | Preparation method and use of compounds having high biocidal activities |
WO2007101540A1 (en) | 2006-03-06 | 2007-09-13 | Bayer Cropscience Ag | Combinations of active ingredients with insecticidal properties |
WO2007144100A1 (en) | 2006-06-13 | 2007-12-21 | Bayer Cropscience Ag | Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents |
WO2008002371A1 (en) | 2006-06-23 | 2008-01-03 | Becker Underwood Inc. | Improved shelf life and on seed stabilization of liquid bacterium inoculants |
WO2008067911A1 (en) | 2006-12-04 | 2008-06-12 | Bayer Cropscience Ag | Biphenyl-substituted spirocyclic ketoenols |
WO2008134969A1 (en) | 2007-04-30 | 2008-11-13 | Sinochem Corporation | Benzamide compounds and applications thereof |
WO2009002809A2 (en) | 2007-06-26 | 2008-12-31 | E. I. Du Pont De Nemours And Company | Naphthalene isoxazoline invertebrate pest control agents |
WO2009126473A1 (en) | 2008-04-07 | 2009-10-15 | Bayer Cropscience Lp | Stable aqueous spore-containing formulation |
WO2009124707A2 (en) | 2008-04-07 | 2009-10-15 | Bayer Cropscience Ag | Combinations of biological control agents and insecticides or fungicides |
WO2010006713A2 (en) | 2008-07-17 | 2010-01-21 | Bayer Cropscience Ag | Heterocyclic compounds used as pesticides |
CN101697736A (en) * | 2009-11-09 | 2010-04-28 | 江苏省农业科学院 | Bacillus subtilis and propiconazole compound wettable sterilizing powder and use thereof |
CN101697737A (en) * | 2009-11-09 | 2010-04-28 | 江苏省农业科学院 | Bacillus subtilis and compound wettable sterilizing powder and use thereof |
CN101715774A (en) | 2008-10-09 | 2010-06-02 | 浙江化工科技集团有限公司 | Preparation and use of compound having insecticidal activity |
WO2010060379A1 (en) | 2008-11-28 | 2010-06-03 | 中国中化集团公司 | Ether compounds with nitrogen-containing 5-member heterocycle and the uses thereof |
US20110046186A1 (en) | 2008-07-07 | 2011-02-24 | Bin Li | 1-Substituted Pyridyl-Pyrazolyl Amide Compounds and Uses Thereof |
WO2011085575A1 (en) | 2010-01-15 | 2011-07-21 | 江苏省农药研究所股份有限公司 | Ortho-heterocyclyl formanilide compounds, their synthesis methods and use |
WO2012029672A1 (en) | 2010-08-31 | 2012-03-08 | Meiji Seikaファルマ株式会社 | Noxious organism control agent |
WO2012034403A1 (en) | 2010-09-14 | 2012-03-22 | 中化蓝天集团有限公司 | Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof |
US20120149571A1 (en) | 2010-12-10 | 2012-06-14 | Auburn University | Inoculants Including Bacillus Bacteria for Inducing Production of Volatile Organic Compounds in Plants |
CN102613183A (en) | 2012-03-07 | 2012-08-01 | 中化蓝天集团有限公司 | Insecticide |
US20120252672A1 (en) | 2011-03-31 | 2012-10-04 | Novozymes Biologicals, Inc. | Competitive and Effective Bacterial Strains |
WO2013003977A1 (en) | 2011-07-01 | 2013-01-10 | 合肥星宇化学有限责任公司 | Compound of 2,5-disubstituted-3-nitroimino-1,2,4-triazoline and preparation method and use as pesticide thereof |
WO2013050317A1 (en) | 2011-10-03 | 2013-04-11 | Syngenta Limited | Polymorphs of an isoxazoline derivative |
WO2013055584A1 (en) | 2011-10-13 | 2013-04-18 | E. I. Du Pont De Nemours And Company | Solid forms of nematocidal sulfonamides |
-
2013
- 2013-11-18 WO PCT/EP2013/074054 patent/WO2014079804A1/en active Application Filing
Patent Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0451878A1 (en) | 1985-01-18 | 1991-10-16 | Plant Genetic Systems, N.V. | Modifying plants by genetic engineering to combat or control insects |
EP0374753A2 (en) | 1988-12-19 | 1990-06-27 | American Cyanamid Company | Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines |
US5021076A (en) | 1989-03-17 | 1991-06-04 | The United States Of America As Represented By The Secretary Of Agriculture | Enhancement of nitrogen fixation with Bradyrhizobium japonicum mutants |
EP0392225A2 (en) | 1989-03-24 | 1990-10-17 | Ciba-Geigy Ag | Disease-resistant transgenic plants |
EP0427529A1 (en) | 1989-11-07 | 1991-05-15 | Pioneer Hi-Bred International, Inc. | Larvicidal lectins and plant insect resistance based thereon |
WO1993007278A1 (en) | 1991-10-04 | 1993-04-15 | Ciba-Geigy Ag | Synthetic dna sequence having enhanced insecticidal activity in maize |
US5422107A (en) | 1992-12-25 | 1995-06-06 | Hokkaido Green Kosan, Incorporated | Trichoderma harzianum SK-55 fungus, fungicide containing it, and method of manufacture of the same and its use |
WO1995034656A1 (en) | 1994-06-10 | 1995-12-21 | Ciba-Geigy Ag | Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
US6955912B2 (en) | 2000-03-31 | 2005-10-18 | Yasuharu Sasaki | Process for producing Trichoderma harzianum ferm BP-4346 |
WO2002015701A2 (en) | 2000-08-25 | 2002-02-28 | Syngenta Participations Ag | Bacillus thuringiensis crystal protein hybrids |
US7262151B2 (en) | 2001-07-06 | 2007-08-28 | Mcgill University | Methods and compositions for production of lipo-chito oligosaccharides by rhizobacteria |
WO2003018810A2 (en) | 2001-08-31 | 2003-03-06 | Syngenta Participations Ag | Modified cry3a toxins and nucleic acid sequences coding therefor |
WO2003052073A2 (en) | 2001-12-17 | 2003-06-26 | Syngenta Participations Ag | Novel corn event |
WO2005077934A1 (en) | 2004-02-18 | 2005-08-25 | Ishihara Sangyo Kaisha, Ltd. | Anthranilamides, process for the production thereof, and pest controllers containing the same |
WO2005085216A1 (en) | 2004-03-05 | 2005-09-15 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and noxious organism control agent |
WO2006043635A1 (en) | 2004-10-20 | 2006-04-27 | Kumiai Chemical Industry Co., Ltd. | 3-triazolylphenyl sulfide derivative and insecticide/acaricide/nematicide containing the same as active ingredient |
WO2006089633A2 (en) | 2005-02-22 | 2006-08-31 | Bayer Cropscience Ag | Spiroketal-substituted cyclic ketoenols |
WO2007043677A1 (en) | 2005-10-14 | 2007-04-19 | Sumitomo Chemical Company, Limited | Hydrazide compound and pesticidal use of the same |
WO2007079162A1 (en) | 2005-12-30 | 2007-07-12 | E. I. Du Pont De Nemours And Company | Isoxazolines for controlling invertebrate pests |
WO2007101540A1 (en) | 2006-03-06 | 2007-09-13 | Bayer Cropscience Ag | Combinations of active ingredients with insecticidal properties |
WO2007101369A1 (en) | 2006-03-09 | 2007-09-13 | East China University Of Science And Technology | Preparation method and use of compounds having high biocidal activities |
WO2007144100A1 (en) | 2006-06-13 | 2007-12-21 | Bayer Cropscience Ag | Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents |
WO2008002371A1 (en) | 2006-06-23 | 2008-01-03 | Becker Underwood Inc. | Improved shelf life and on seed stabilization of liquid bacterium inoculants |
WO2008067911A1 (en) | 2006-12-04 | 2008-06-12 | Bayer Cropscience Ag | Biphenyl-substituted spirocyclic ketoenols |
CN101028009A (en) * | 2007-04-03 | 2007-09-05 | 盐城苏滨生物农化有限公司 | Caprotrahol and Bacillus subtilis compound agricultural chemicals |
WO2008134969A1 (en) | 2007-04-30 | 2008-11-13 | Sinochem Corporation | Benzamide compounds and applications thereof |
WO2009002809A2 (en) | 2007-06-26 | 2008-12-31 | E. I. Du Pont De Nemours And Company | Naphthalene isoxazoline invertebrate pest control agents |
WO2009126473A1 (en) | 2008-04-07 | 2009-10-15 | Bayer Cropscience Lp | Stable aqueous spore-containing formulation |
WO2009124707A2 (en) | 2008-04-07 | 2009-10-15 | Bayer Cropscience Ag | Combinations of biological control agents and insecticides or fungicides |
US20110046186A1 (en) | 2008-07-07 | 2011-02-24 | Bin Li | 1-Substituted Pyridyl-Pyrazolyl Amide Compounds and Uses Thereof |
WO2010006713A2 (en) | 2008-07-17 | 2010-01-21 | Bayer Cropscience Ag | Heterocyclic compounds used as pesticides |
CN101715774A (en) | 2008-10-09 | 2010-06-02 | 浙江化工科技集团有限公司 | Preparation and use of compound having insecticidal activity |
WO2010060379A1 (en) | 2008-11-28 | 2010-06-03 | 中国中化集团公司 | Ether compounds with nitrogen-containing 5-member heterocycle and the uses thereof |
CN101697737A (en) * | 2009-11-09 | 2010-04-28 | 江苏省农业科学院 | Bacillus subtilis and compound wettable sterilizing powder and use thereof |
CN101697736A (en) * | 2009-11-09 | 2010-04-28 | 江苏省农业科学院 | Bacillus subtilis and propiconazole compound wettable sterilizing powder and use thereof |
WO2011085575A1 (en) | 2010-01-15 | 2011-07-21 | 江苏省农药研究所股份有限公司 | Ortho-heterocyclyl formanilide compounds, their synthesis methods and use |
WO2012029672A1 (en) | 2010-08-31 | 2012-03-08 | Meiji Seikaファルマ株式会社 | Noxious organism control agent |
WO2012034403A1 (en) | 2010-09-14 | 2012-03-22 | 中化蓝天集团有限公司 | Fluoromethoxypyrazole anthranilamide compounds, synthesization methods and uses thereof |
US20120149571A1 (en) | 2010-12-10 | 2012-06-14 | Auburn University | Inoculants Including Bacillus Bacteria for Inducing Production of Volatile Organic Compounds in Plants |
US20120252672A1 (en) | 2011-03-31 | 2012-10-04 | Novozymes Biologicals, Inc. | Competitive and Effective Bacterial Strains |
WO2013003977A1 (en) | 2011-07-01 | 2013-01-10 | 合肥星宇化学有限责任公司 | Compound of 2,5-disubstituted-3-nitroimino-1,2,4-triazoline and preparation method and use as pesticide thereof |
WO2013050317A1 (en) | 2011-10-03 | 2013-04-11 | Syngenta Limited | Polymorphs of an isoxazoline derivative |
WO2013055584A1 (en) | 2011-10-13 | 2013-04-18 | E. I. Du Pont De Nemours And Company | Solid forms of nematocidal sulfonamides |
CN102613183A (en) | 2012-03-07 | 2012-08-01 | 中化蓝天集团有限公司 | Insecticide |
Non-Patent Citations (43)
Title |
---|
"Applied Microbiol. Physiology, A Practical Approach", 1997, IRL PRESS, pages: 53 - 73 |
"e-Pesticide Manual V5.2", 2008, ISBN: 9781901396850 |
"Manual of Methods for General Bacteriology", 1981, AMERICAN SOCIETY FOR BACTE RIOLOGY |
"McCutcheon's, Vol. 1 : Emulsifiers & Detergents", vol. 1, 2008, MCCUTCHEON'S DIRECTORIES |
"Technical Monograph No. 2", May 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide formulation types and international coding system" |
APPL ENVIRON MICROBIOL, vol. 56, 1990, pages 2399 - 2403 |
APPL ENVIRON MICROBIOL, vol. 60, 1994, pages 940 - 94 |
APPL ENVIRON MICROBIOL, vol. 73, no. 8, 2007, pages 2635 |
APPL. ENVIRON. MICROBIOL., vol. 77, no. 15, 2011, pages 5513 - 5516 |
AUSTRAL. J. AGRICULT. RES., vol. 58, 2007, pages 708 |
CAN J MICROBIAL, vol. 48, 2002, pages 279 - 284 |
CAN J PLANT SCI, vol. 70, 1990, pages 661 - 666 |
CAN. J. MICROBIOL., vol. 38, 1992, pages 501 - 505 |
CHMIEL: "Bioprozesstechnik 1. Einfuhrung in die Bioverfahrenstechnik", 1991, GUSTAV FISCHER VERLAG |
COLBY, S. R.: "Calculating synergistic and antagonistic responses of herbicide combinations", WEEDS, vol. 15, 1967, pages 20 - 22 |
COLBY, S.R.: "Calculating synergistic and antagonistic responses of herbicide combinations", WEEDS, vol. 15, 1967, pages 20 - 22 |
FERNANDEZ-FLOURET, D; CLEYET-MAREL, J. C, C R ACAD AGRIC FR, vol. 73, 1987, pages 163 - 171 |
H.D. BURGES: "Formulation of Micobial Biopestcides", 1998, SPRINGER |
HOLTMANN, G.; BREMER, E., J. BACTERIOL., vol. 186, 2004, pages 1683 - 1693 |
INT. J. MICROBIOL. RES., vol. 3, no. 2, 2011, pages 120 - 130 |
J. PLANT GROWTH REGUL., vol. 30, 2011, pages 504 - 511 |
KNOWLES: "Adjuvants and additives, Agrow Reports DS256", 2006, T&F INFORMA |
KNOWLES: "Agrow Reports DS243", 2005, T&F INFORMA, article "New developments in crop protection product formulation" |
MCKNIGHT S E ET AL: "ROOT COLONIZATION OF COTTON SEEDLINGS BY BACILLUS-SUBTILIS MBI 600", SECOND INTERNATIONAL WORKSHOP ON PLANT GROWTH-PROMOTING RHIZOBACTERIA,, 1 January 1991 (1991-01-01), pages 365 - 369, XP009168106 * |
MOLLET; GRUBE- MANN: "Formulation technology", 2001, WILEY VCH |
PALTA J.A. AND BERGER J.B.: "Proceedings 12th International Lupin Conference", 14 September 2008, INTERNATIONAL LUPIN ASSOCIATION |
PEST MANAGEM. SCI, vol. 61, 2005, pages 269 |
PEST MANAGEM. SCI., vol. 61, 2005, pages 246 |
PEST MANAGEM. SCI., vol. 61, 2005, pages 258 |
PEST MANAGEM. SCI., vol. 61, 2005, pages 277 |
PEST MANAGEM. SCI., vol. 61, 2005, pages 286 |
PEST MANAGEM. SCI., vol. 64, 2008, pages 326 |
PEST MANAGEM. SCI., vol. 64, 2008, pages 332 |
PHYTOPATHOLOGY, vol. 96, 2006, pages 145 - 154 |
R.S.LEISSO, P.R.MILLER, M.E.BURROWS: "The influence of biological and fungicidal seed treatments on chickpea (cicer arietinum) damping off", CAN.J.PLANT PATHOL., vol. 31, 2009, pages 38 - 46, XP009168079 * |
SCIENCE, vol. 316, 2007, pages 1185 |
STORHAS: "Bioreaktoren und periphere Einrichtungen", 1994, VIEWEG VERLAG |
TAMMES, P. M. L.: "Isoboles, a graphic representation of synergism in pesticides", NETHERL. J. PLANT PATHOL., 1964, pages 70 |
WEED SCI, vol. 57, 2009, pages 108 |
WORLD J MICROBIOL BIOTECHNOL, vol. 28, 2012, pages 2541 - 2550 |
WRIGHT B ET AL: "Application of Beneficial Microorganisms to Seeds during Drum Priming", 1 January 2003, BIOCONTROL SCIENCE AND TECHNOLOGY, ABINGDON, GB, PAGE(S) 599 - 614, ISSN: 0958-3157, XP009167986 * |
ZHANG SHOUAN ET AL: "Evaluation of Microbial Products for Management of Powdery Mildew on Summer Squash and Cantaloupe in Florida", PLANT DISEASE, THE AMERICAN PHYTOPATHOLOGICAL SOCIETY, vol. 95, no. 4, 1 April 2011 (2011-04-01), pages 461 - 468, XP009168081, ISSN: 0191-2917, DOI: 10.1094/PDIS-07-10-0521 * |
ZHOU X G ET AL: "Field evaluation of a beneficial Bacillus strain for biocontrol of sheath blight in rice", PHYTOPATHOLOGY, AMERICAN PHYTOPATHOLOGICAL SOCIETY, US, vol. 101, no. 6, Suppl. S, 1 June 2011 (2011-06-01), pages S204, XP009168083, ISSN: 0031-949X * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11284623B2 (en) | 2012-11-22 | 2022-03-29 | Basf Corporation | Pesticidal mixtures |
US10076119B2 (en) | 2012-11-22 | 2018-09-18 | Basf Corporation | Pesticidal mixtures |
US10537110B2 (en) | 2012-11-22 | 2020-01-21 | Basf Corporation | Pesticidal mixtures |
US10759767B2 (en) | 2012-12-20 | 2020-09-01 | BASF Agro B.V. | Compositions comprising a triazole compound |
US10981883B2 (en) | 2013-01-09 | 2021-04-20 | BASF Agro B.V. | Process for the preparation of substituted oxiranes and triazoles |
US10519122B2 (en) | 2013-01-09 | 2019-12-31 | BASF Agro B.V. | Process for the preparation of substituted oxiranes and triazoles |
US10512267B2 (en) | 2013-07-08 | 2019-12-24 | BASF Agro, B.V. | Compositions comprising a triazole compound and a biopesticide |
US11083202B2 (en) | 2014-05-23 | 2021-08-10 | Basf Se | Mixtures comprising a bacillus strain and a pesticide |
US10251400B2 (en) | 2014-05-23 | 2019-04-09 | Basf Se | Mixtures comprising a Bacillus strain and a pesticide |
WO2015181009A1 (en) * | 2014-05-27 | 2015-12-03 | Basf Se | Ternary mixtures comprising biopesticides and qoi fungicides and sdhi fungicides |
US10212934B2 (en) | 2014-06-25 | 2019-02-26 | BASF Agro B.V. | Pesticidal compositions |
US10779536B2 (en) | 2014-11-07 | 2020-09-22 | Basf Se | Pesticidal mixtures |
US10905122B2 (en) | 2016-03-16 | 2021-02-02 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on cereals |
US11241012B2 (en) | 2016-03-16 | 2022-02-08 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean |
US11425909B2 (en) | 2016-03-16 | 2022-08-30 | Basf Se | Use of tetrazolinones for combating resistant phytopathogenic fungi on fruits |
US10743535B2 (en) | 2017-08-18 | 2020-08-18 | H&K Solutions Llc | Insecticide for flight-capable pests |
CN107903110A (en) * | 2017-11-17 | 2018-04-13 | 浙江海洋大学 | A kind of plant vaccine and its preparation |
CN109221168A (en) * | 2018-10-11 | 2019-01-18 | 四川省兰月科技有限公司 | Plant growth regulator containing Thidiazuron, olefin conversion and amino-oligosaccharide |
CN109769837A (en) * | 2019-03-01 | 2019-05-21 | 贵州大学 | A kind of pesticide synergistic combination preventing and treating fruits and vegetables gray mold |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11284623B2 (en) | Pesticidal mixtures | |
AU2017204506B2 (en) | Pesticidal mixtures | |
AU2013349928B2 (en) | Pesticidal mixtures | |
AU2013349881B2 (en) | Pesticidal mixtures | |
WO2014079772A1 (en) | Pesticidal mixtures | |
WO2014079841A1 (en) | Pesticidal mixtures | |
WO2014079724A1 (en) | Pesticidal mixtures | |
WO2014079728A1 (en) | Pesticidal mixtures | |
WO2014079766A1 (en) | Pesticidal mixtures | |
WO2014079774A1 (en) | Pesticidal mixtures | |
WO2014079754A1 (en) | Pesticidal mixtures | |
WO2014079804A1 (en) | Pesticidal mixtures | |
MX2015003719A (en) | Pesticidal mixtures comprising jasmonic acid or a derivative thereof. | |
WO2014079813A1 (en) | Pesticidal mixtures | |
WO2014079771A1 (en) | Pesticidal mixtures | |
WO2014079770A1 (en) | Pesticidal mixtures | |
WO2014079730A1 (en) | Pesticidal mixtures | |
WO2014079769A1 (en) | Pesticidal mixtures | |
WO2014079752A1 (en) | Pesticidal mixtures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13791835 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13791835 Country of ref document: EP Kind code of ref document: A1 |